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Collaborative Filtering, a popular method for recommendation engines, models its pre-
dictions using past interactions between the entities in question (aka users/movies or cus-
tomers/products etc). The method does not rely on the explicit properties of the entities,
the identification of which may be intractable. In this work, we leverage this advantage
rendered by Collaborative Filtering where the explicit features need not be defined apriori
by evaluating its application to the domain of Ligand based Virtual Screening. We further
attempt to address the drawback of Collaborative Filtering , ie the lack of interpret ability of
the factors discovered through collaborative filtering by creating a novel class of generative
deep learning models ,called Collaborative Filtering based Generative Networks (CFGen-
Nets). We show the utility of CFGenNets in 2 domains 1) Ligand based Virtual Screening
and 2) Image generation from keyword tags/meta descriptors.
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Collaborative filtering algorithms have been historically used in the context of designing
recommendation systems such as movie recommendation engines, as well as up-sell and cross-
sell recommendation engines for e-commerce sites [4–7]. In general, collaborative filtering is a
method for making automatic predictions (filtering) about the interests of a user by collecting
preferences or taste information from other users (collaborating) [8]. This approach relies
on modeling predictions using past interactions between the users and the items rated. The
method aims to infer the missing ratings and impute them into a sparse “rating” matrix. This
is in contrast to traditional machine learning that models individual users or items based
on their attributes. For example in the context of a movie recommendation application,
a movie could be described by its genre, reviews, starring actors, and awards, and a user
could be described by her/his demographic information, any past reviews, genre preferences,
friends reviews, and so on. It quickly becomes evident that identifying the entire gamut of
properties that accurately represent the users and movies is a daunting, if not an intractable,
task. Collaborative filtering, then, is an alternate technique which relies on past transactions
without relying on explicit attributes of the user or movie—which has both positive and
negative consequences. Positively, the features of items and users need not be defined apriori.
Negatively, the factors discovered through collaborative filtering are not readily interpretable.
In this work, we attempt to mitigate this lack of interpretability through creating generative
models. We show utility in two application domains: (1) ligand based virtual screening
and (2) image generation from key word tags . Because our ligand based virtual screening
research is more mature, we motivate and explain its motivation more fully.
1
1.1.1 Ligand-based Virtual Screening Motivation
We extend the concept of collaborative filtering to the domain of ligand based virtual
screening. Ligand based Virtual screening is an automated computational method of filtering
candidate ligands (e.g., drugs) based upon their inferred relationship with a given target (e.g.,
a cancer protein). Typically the aim is to assess binding affinity for a ligand-target pair. That
is, the objective is to understand if the ligand and protein will interact with one another. In
order to test the applicability of collaborative filtering algorithms to this domain, we liken
the targets to users and ligands to movies. The “rating” between targets and ligands can be
represented by the known binding affinities (active or inactive). These binding affinities are
collected by scientists around the world that assay the given target and ligands and provide
the result of the assay to a network of databases.
The original movie recommendation algorithm proposed by Simon Funk [9] factorized
the user-movie rating matrix as the product of two lower dimensional matrices, the first
one has a row for each user, while the second has a column for each movie. The row
or column associated to a specific user or movie is referred to as a latent factor. In the
context of the movie recommendation engine, the latent factors of the users and the movies
intuitively encode key features of the users, movies, and the context (when the interaction
occurs), resulting in the recommendations. However, the collaborative filtering algorithms
do not provide a mechanism to establish the set of such features that are encoded in the
shared latent spaces of the items and users. That is, the factors are mathematical constructs
that might also have a semantically meaningful interpretations but those meanings are not
immediately obvious.
Therefore, we investigate the possibility of using the latent factors obtained from collabo-
rative filtering to map back to the corresponding known molecular structures. In particular,
we find that deep learning algorithms are highly suitable for this process. The ability to
navigate from desired binding affinity between ligands and targets to the explicit structure
of the ligand can be a potent utility in the field of de-novo drug design. To this extent,
we introduce a novel class of generative algorithms called CFGenNet, Collaborative Fil-
tering based Generative Networks. In the context of de-novo drug design, CFGenNet aims
to generate novel ligands from the latent factors obtained from collaborative filtering. To
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the best of our knowledge, this is the first use of generative algorithms to extend the utility
of discovered latent space from collaborative filtering. In order to extend the conclusions
of this concept to other application domains beyond virtual screening, we further wish to
investigate the cross domain applicability of CFGenNets by applying the said methods to a
completely different data set. For this purpose, we intend to evaluate the abilities of CF-
GenNets to generate images from their corresponding implicit image fingerprints obtained
from collaborative filtering.
In the remainder of this chapter, we provide an introduction to certain relevant topics of
cheminformatics to help orient the readers to the broader context before we begin describing
our research. Subsequently, we present an overview of our research objectives followed by
our contributions to the field. Subsequent chapters contain in-depth discussions into the
data, methods, and results supporting this thesis.
1.2 A primer on molecules
Molecules form the basic unit of any chemical compound or ligand that take part in
a chemical reaction. A molecule is a group of two or more atoms that form the smallest
identifiable unit into which a pure substance can be divided and still retain the composition
and chemical properties of that substance [10]. Figure 1.1 visually illustrates the caffeine
molecule.
As is evident from Figure 1.1, molecules have two or more atoms held together by chemical
bonds. These bonds that hold atoms together themselves can be of two kinds: covalent or
ionic. A covalent bond is a chemical bond that involves the sharing of electron pairs between
atoms. The ionic on the other hand is formed by the complete transfer of some electrons from
one atom to another resulting in an electrostatic attraction between the two ions of opposite
charge. The molecules are dynamic entities; The atoms that make up the molecules are in a
constant state of motion relative to one another thereby causing their relative positions and
lengths of the bonds to be changing frequently. This consequently yields multiple “molecule
conformations,” which refer to any one of the infinite number of possible spatial arrangements
of atoms in a molecule. To make things more complex, the molecules can also exhibit a
property of chirality, implying that a mirror image of a molecule is not the same as itself.
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Figure 1.1: A sample molecule : Illustration of Caffeine molecule with its constituent atoms
and bonds.
That is, the molecules can come in two different forms that are intuitively mirror images
of each other (like our hands, a right hand and a left hand). While the physical forms are
similar, they may exhibit different behaviour in practice. The biological and pharmaceutical
activity of many molecules is often directly related to their chirality.
1.3 Ligand based Virtual Screening
Ligand based Virtual Screening refers to computational techniques used in drug discovery
to search libraries of molecules to identify those structures which are most likely to bind to a
drug target [11]. The target in this context is usually a biological organism against which the
drugs are directed—thereby resulting in a change in the said target’s behavior or function.
The ligand is a molecule that produces a signal by binding to a site on a target protein.
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Figure 1.2: Ligand Based Virtual Screening Methods :Several classes of algorithms exist
for performing ligand based virtual screening. As illustrated, the classes algorithms can be
categorized by the usage of known active ligands v/s both known active and inactive ligands.
The categorization of our method, utilizing collaborative filtering is also illustrated in the
figure.
Ligand-based virtual screening techniques attempt to exploit prior knowledge of the abil-
ities of ligands to bind to the protein targets to predict the effect of the candidate ligand on
the said protein target. The prior knowledge of the abilities of the ligands to bind with the
targets are recorded via Assays. Assays in our context are investigative procedures that qual-
itatively analyze a ligand’s effects on identified protein targets and are typically conducted
in laboratory settings.
Several variations of the ligand based virtual screening techniques exists. The various
categories of ligand based virtual screening approaches, along with the classification our
method is illustrated in Figure 1.2. The technique called Pharmacophore models, begin with
a known set of structurally diverse ligands that binds to a receptor, to construct a model
of the receptor by deciphering the collective information contained in such set of ligands.
The candidate ligand is compared to the receptor model thus constructed to then predict
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binding affinities. In the molecular similarity based technique, molecular similarity is assessed
between the candidate ligand and the set of ligands with known prior affinities. Alternately,
there exist a class of algorithms that utilize the ligands that exhibit both known active and
inactive ligands. Typically the knowledge of the prior affinities between a ligand and protein
target is recorded in Assays. Within the class of such methods, approaches can be further
distinguished based on how the models are trained. In the per target mode, one model per
target is trained, while in the across target mode one machine learning model is trained
using all targets and ligands. In summary, all virtual screening techniques can be viewed as
automated computational methods of filtering candidate ligands based upon their inferred
relationship with a given target. Screening virtually has a number of cost-saving advantages.
However, these advantages must be reconciled with the ability to accurately represent these
ligands in a form that computer programs can understand and, then, find binding ligands
from relatively few training examples. We discuss the nuances around accurately representing
the ligands in the next section.
1.3.1 Ligand Fingerprints
The numeric representation of a ligand is often referred to as a “fingerprint.” The ligand
fingerprints attempt to represent the molecular structural and physicochemical features in
a format comprehensible by a computer program, such as a binary vector of predetermined
length. Featurizing or “fingerprinting” molecules are a necessary precondition for ligand
based virtual screening. As is evident from our primer (section 1.2) above, several features
describe the molecules. To begin with, this includes the atoms that make up the molecule,
their counts, and the types of bonds that exist. The molecular conformation referring to any
one of the infinite number of possible spatial arrangements of atoms in a molecule also form
key aspects of describing the molecules. As described earlier, many molecules also exist in
‘left-’ and ‘right-handed’ forms (chirality). While the physical forms are similar, they may
exhibit different behaviour in practice when attempting to bind with protein targets.
Given these complexities, it comes as no surprise that the process of fingerprinting ligands
is an involved research area, with several seminal works [12–18]. Typically the aim of the
ligand fingerprint methods are to represent the following:
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• Molecular descriptors such as its constituents, counts, or structural fragments.
• Types of pharmacophores, which represent the features of the molecules that are neces-
sary for interactions with protein targets. Examples include hydrogen bond acceptors
or donors, positively or negatively charged groups, etc.
• Connectivity pathways, which represent a series of actions that can occur in molecules
to result in a change to the protein target with which they interact
The SMILES (Simplified Molecular Line Entry System) [12] is the most popular method
of representing ligands. In this representation the molecules are represented using ASCII
strings with specific rules governing the encoding of the constituent atoms, bonds, simple
chains, rings, and branches that may exist in a ligand. Alternately, dictionary-based fin-
gerprints, where the ligand is inspected for presence(1s) or absence(0s) of certain structural
fragments are also used for representing ligands. Other forms such as topological fingerprints,
encoding the types of atoms and the paths between them, and circular or radial fingerprints,
constructed by iterating through all atoms and picking an atom and including its atomic
surroundings within N bonds, are also in use.
However, all existing works employ the use of explicit structure featurization in order to
“fit” the problem into the workflow of traditional computer based modeling. Prior knowledge
of the ligand’s physical structure and its chemical formula is a necessary condition for featur-
ization. While knowing the ligand structure is not overly burdensome, especially given the
three-dimensional nature of ligands, there also exists a reliance on traditional machine learn-
ing algorithms to map from these explicit features to a desired outcome that requires many
training examples. More reliable mapping comes at the expense of needing more training
assays so that the machine learning model can learn the relevant portions of the features for
the desired task. Many state-of-the-art protein-ligand interaction (PLI) models use machine
learning that relies on abstract descriptors of compounds/proteins as input features [19–24].
1.3.2 Fingerprints and Virtual Screening
Virtual screening in drug discovery relies on the ligand fingerprints to perform any mean-
ingful similarity search among ligands. However the virtual screening techniques that use
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these models, while high performing, are not free of deficiencies: the limitations of rep-
resenting drug compounds and targets abstractly limits our ability to infer their binding
properties [25, 26]. We argue that a critical barrier is the lack of a universal fingerprinting
model that can amass knowledge about drug compounds, protein targets, and assay charac-
teristics in a shared latent space that can be used by a variety of machine learning models,
visualization tools, and compound design tools. We further argue that if the representation is
completely abstract, even if it performs well at PLI (Protein Ligand Interaction) prediction,
it is fundamentally limited because researchers cannot systematically create candidate com-
pounds based on the featurization of the target ( [27–29]). In this research, we propose and
evaluate an alternate fingerprinting technique based on collaborative filtering and methods
to generate new ligand based upon shared representations. This is further discussed in the
section Dissertation Objectives. Next, we present a short overview of computer aided drug
design, which forms the basis of Dissertation Objective 2.
1.3.3 Computer Aided Drug Design
While representing ligands and targets effectively for predicting PLI is an active research
area, an equally influential usage of this representation is to design new drugs. Computer-
aided drug design uses computational approaches to discover, develop, and analyze drugs
with similar biologically active molecules. This facilitates the process by which new candi-
date medications are discovered [30]. Modern drug discovery involves the identification of
screening hits, medicinal chemistry and optimization of those hits to increase the affinity,
selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to
increase the half-life), and oral bio availability. Once a compound that fulfills all of these re-
quirements has been identified, the process of drug development can continue. If successful,
clinical trials are developed [31]. The recent years have seen an uptick in research related
to applying generative deep learning algorithms to create new drug like ligands [2, 32–34].
Deep learning based drug design techniques attempt produce novel molecular structures with
desired pharmacological properties from scratch. This process has evolved to be an effec-
tive method for lead identification in the hit- and lead-finding stages of the drug discovery
process.
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In our research, we investigate the usefulness of our methods in facilitating the drug
discovery process. Our research objective and contributions to the specific area of drug
design are described in the subsequent sections.
1.4 Dissertation Objectives
In this section, we describe the three related but specific research objectives of this
dissertation. First, we aim to discover implicit ligand fingerprints via collaborative filtering,
with emphasis on their ability to predict binding. Second, we aim to develop generative
methods that allow the creation of new ligands based on their implicit representation. Third
and finally, we aim to employ our methods outside of the virtual screening application
domain.
1.4.1 Aim 1: Implicit fingerprint discovery by means of collaborative filtering, for applica-
tion to virtual screening
In this thesis, we investigated the use of “implicit fingerprints” that do not rely on any
prior knowledge of the ligand structure for the purposes of ligand based virtual screening.
Using collaborative filtering, we generated fingerprints for ligands and targets, deriving dense
numeric vectors that implicitly encode important characteristics of the ligand-target pair as
well as the assay experimental conditions.
Aim 1 attempts to answer the following questions with respect to ligand based virtual
screening
• Can we perform ligand based virtual screening without depending on fingerprints that
are explicitly featurized based on known molecular descriptors?
• Using these fingerprints, can we predict ligand protein interactions with relatively fewer
training examples per protein target?
While some previous works have investigated this approach [35], our evaluation shows that
our results are superior. Chapters 3 and 4 of this thesis describes in detail the experiments
conducted to answer the aforementioned questions. That is, to mitigate the need for large
data sets of dense assay examples by adopting an “implicit” structure model of the ligands.
That is, for a given ligand, we use the assay results of other implicitly similar ligands to
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help predict if a particular ligand binds to a target. The measure of similarity is only based
on the results of the recorded assays, not featurized descriptors of the ligand. By using this
implicit similarity, we can more readily predict if a ligand will bind to a target with far fewer
training examples per target.
1.4.2 Aim 2: Generative deep learning based drug design using Implicit Ligand fingerprints
As described, Deep learning based de novo drug design techniques refers to the process of
producing novel molecular structures with desired pharmacological properties from scratch
using generative deep learning networks. This process has evolved to be an effective method
for lead identification in the hit- and lead-finding stages of the drug discovery process.
Several recent works have investigated the use of neural embedding on compound struc-
ture representations such as SMILES codes, showing this embedding is effective for exploring
the chemical properties [36] and generating novel compounds. [37] refer to these embedded
fingerprints as implicit representations. However, their methods work upon the raw SMILES
textual representation and are therefore limited in their ability to discern more complicated
relationships encoded by graphical fingerprints. Recent years have seen a plethora of deep
learning based generative models for de-novo drug generation [37–42]. The common theme
in these techniques is to provide as input to the deep learning model the molecules only
to produce the same or similar molecules as output. The continuous vector representations
of the input molecules in the intermediate layers produce a larger chemical property space,
which is then sampled to produce novel molecules.
Given this context of de novo drug design and building on the successful results from our
previous aim, Aim 2 attempts to answer the following questions:
• Can we design and train deep learning methods that leverage the implicit compound
fingerprints to map back to the known physical structure of compounds (i.e, decoding)?
• If this decoding is possible, can we leverage the implicit fingerprints and decoder to
generate novel ligands?
The implicit encoding of compounds are a continuous vector-valued representation and
thus lend itself to the use of continuous optimization to generate novel compounds. We
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further assess the properties of the novel ligands generated in terms of the drug-like physical
properties of molecules, chemical complexity, and biological activity in Chapters 5, 6, 7, and
8.
1.4.3 Aim 3: Cross domain applicability of Implicit Fingerprints for Image Generation
Finally, as a part of this research, we also wish to investigate the cross domain applicabil-
ity of the said methods to an alternate domain, on a different dataset. We aim to investigate
the applicability of the implicit fingerprints in generating images from the corresponding
implicit image fingerprints from collaborative filtering. Our dataset for this exercise is com-
prised of images with meta data tags identifying the objects contained within the image.
The data is represented in a matrix form, with the meta data forming the columns of the
matrix and the images represented in the individual rows and the value of the data cell
indicating the applicability of corresponding tag to the image. The dataset in this form is
likened to the user-movie matrix or the ligand-target binding affinity matrix over which the
collaborative filtering algorithm can then be applied. It is to be noted that the collaborative
filtering algorithm is utilized to generate the latent vectors of the images and meta-data tags
as opposed to the traditional purpose of imputing a missing data cell values.
Given this context of evaluating CFGenNets across different domains, Aim 3 attempts
to answer the following questions
• Can we leverage the latent features generated for images using Collaborative Filtering
as an alternate encoded representation of images?
• Can we design and train deep learning methods that leverage the implicit image fin-
gerprints to map back to the original images?
1.5 Dissertation Contributions
In this section, we present the contributions stemming out of our work. The section is
organized by the corresponding research aim that resulted in the contribution.
1.5.1 Contributions from Research Aim 1
Our contributions resulting from our work on Research Aim 1 [43] are as follows:
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1. An investigation into how collaborative filtering methods can be used to predict bind-
ing affinity of ligand-target pairs. We compare collaborative filtering methods to tra-
ditional machine learning methods that use explicit fingerprinting from the RDKit
package, showing collaborative filtering performs on-par with other methods in terms
of all evaluation criteria, including enrichment factor even without the knowledge of a
ligand’s explicit physical structure.
2. An evaluation of collaborative filtering categorized by the amount of required training
assays needed for a target of interest, showing that collaborative filtering has a signif-
icant performance advantage when the number of training assays for a given target is
relatively low.
3. An introduction of “Implicit Target and Ligand Fingerprints”, a new type of ligand
fingerprinting and target fingerprinting derived from the latent factors employed by
the collaborative filtering method.
1.5.2 Contributions from Research Aim 2
In particular, our contributions resulting from our work on Research Aim 2 [1] are enu-
merated below. Additionally, we also note that domain specific semantic evaluation of the
novel compounds generated by our methods were done in collaboration with another re-
searcher(Niraj Verma, co-author on [1]. The details of the areas contributed by the collabo-
rator are described in Chapter 8.
• CFGenNet: A novel class of generative deep learning algorithms based on the implicit
fingerprints obtained from collaborative filtering.
• An evaluation of how the implicit ligand fingerprints from collaborative filtering trans-
late into discrete representations of molecules (SMILES).
• The design of new compounds based upon the latent representation without explic-
itly optimizing for chemical properties, thereby encoding drug-like properties including
binding affinities to known proteins. We evaluate the uniqueness of generated com-
pounds from CFGenNet and if novel compounds have similar binding properties to
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closely related compounds. Binding properties are evaluated using multiple computa-
tional models.
1.5.3 Contributions from Research Aim 3
Our contributions resulting from our work on Research Aim 3 are as follows:
• CFGenNets for Images : A successful investigation into the viability of leveraging the
concepts of CFGenNets into the domain of Image processing
• Composite CFGenNets : Successful design and development of methods that com-
bine the powers of Variational Autoencoders and CFGenNets by creating an enhanced
version of CFGenNets called Composite CFGenNets.
• Image Manipulation using Composite CFGenNets : Introduction of a novel mechanism
to manipulate images by levering Composite CFGenNets




Molecules Basic unit of any chemical compound or ligand,with 2or more atoms that take part in a chemical reaction.
Molecular Bonds Forces that hold atoms together within molecules.Can be of type covalent or ionic.
Target / Biological Target
/ Protein Target
Biological organism against which the drugs are
directed thereby resulting in a change in the
target’s behavior or function
Ligand Molecule that produces a signal by binding toa site on a target protein
Assays
Investigative procedures that qualitatively
analyze a ligand’s effects on identified protein targets
and are typically conducted in laboratory settings
Virtual Screening
Computational techniques used in drug discovery
to search libraries of molecules to identify those
structures which are most likely to bind to a drug target
Ligand Fingerprints
Representation of molecular structural and
physicochemical features in a format comprehensible
by a computer program, such as a binary vector
of predetermined length




In this chapter, we provide an overview of collaborative filtering. It is to be noted that
portions of the subsequent sections have been published as a part of our journal article [43],
where I am the first author of the publication.
2.1 Overview of Collaborative Filtering
As described in Chapter 1, collaborative filtering algorithms have been historically used
in the context of designing recommendation systems such as movie recommendation engines,
as well as up-sell and cross-sell recommendation engines for e-commerce sites. In general,
collaborative filtering is a method for making automatic predictions (filtering) about the
interests of a user by collecting preferences or taste information from other users (collabo-
rating) [8]. In general, collaborative filtering methods can be categorized into two groups of
methods: the neighborhood methods [44] and matrix factorization methods [45], also known
as latent factor models. Neighborhood methods compute the relationship between items
and/or users to identify similar items or like minded users to help predict ratings. Latent
factor methods try to explain the ratings by characterizing the items and users on 20 to 100
factors, derived entirely from past rating patterns.
2.1.1 Neighborhood-based Collaborative Filtering
Neighborhood methods (also called memory-based methods) evaluate the relationships
between items and users by approximating the relative distance between users. In this
scenario, there is a large user-item matrix, A, with users in the rows and items in the
columns. A particular rating between a user, u, and item, i, is denoted as au,i. This matrix
is typically sparse, with only a handful of ratings for each item per user. The general concept
is to find similar users by taking the similarity among each row of A. In this method the
system evaluates a user’s preference for an item based on ratings of similar users that have
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also rated that particular item [44]. More formally, we define this process for a particular







where U is the set of all similar users that have also rated item i and |U | is the total number
of similar users. Variants of this measure also exist where the au,i measure is weighted,
for example, by the relative similarity of users. Similarity of users can be calculated using
various distances. Common measures of distance include Euclidean, Cosine, and Pearson
Dissimilarity. Variants also exist on the “rules” for judging similar users. Some methods
look for the top-N similar users, whereas other methods employ a distance threshold for
discerning which users are similar. In general, neighborhood methods tend to work well for
a number of different applications, but suffer from computational issues when the user item
matrix A is large or very dense.
2.1.2 Matrix Factorization Method
Matrix factorization methods [8] have been one of the most popular implementation
techniques of latent factor recommendation systems. These methods find lower dimensional
representations of the full user-item matrix. The dimensions of the lower dimensional rep-
resentations are often called factors. In the context of movie recommendation engines, the
discovered factors from matrix factorization methods have been studied extensively. While
there is no guarantee that the factors found represent an interpretable quantity, many times
the factors can be identified as representing a number of interesting item and user prop-
erties (even though the modeling does not explicitly use any features of the user or item).
For example, in movie recommendations these factors often “encode” obvious factors such
as comedy versus drama, amount of action, or orientation to children. They can also rep-
resent less well-defined dimensions such as depth of character development, quirkiness, or
they might be completely uninterpretable dimensions. For users, each factor represents how
much the user likes movies that score high on the corresponding movie factor [8]. For the
target-ligand application, then the factors might encode properties of the binding sites for
the target or chemical properties of the ligands. We illustrate the metaphor in Figure 2.1.
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Figure 2.1: Latent Factor Embedding : Sub Figure a illustrates the concept of latent factor
the latent factor recommendation for a movie recommendation engine. The latent factor
method relies on learning hidden factors from the user-movie ratings alone. In this simplified
example the system learns two dimensions from the ratings and places the movies and users
in this 2D space. The users predicted rating of the movie would be a dot product of the user’s
and movie’s location in the 2D space. Figure b illustrates the same concept for a target-ligand
embedding. Here the latent factors correspond to properties that the ligands and protein
targets can be jointly modeled with. The properties may correspond to a distinct chemical
property, but might also pertain to a factor not well described by traditional cheminformatics.
When applied to the domain of virtual screening, this method involves representing the
ligands and targets as vectors of factors with dimensionality f , to represent the latent factor
space, where A ≈ Â = P ·Q. Here the affinity predictions are modeled using the well estab-
lished singular value decomposition method [46] and optimization procedures to minimize
the reconstruction error between A and Â. That is, we model each known affinity at,l ∈ A
between ligand l and target t as the following dot product of vectors pt and ql
at,l = pt · ql
where each known ligand l is associated with vector ql and each target associated with vector
pt. Both ql and pt contain f elements. This operation is often represented in matrix form
when there are L unique ligands and T unique targets in the database:
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The optimization step involves learning the factor vectors ql and pt by minimizing the regu-
larized square error on the set of known affinities, at,l, using standard optimization techniques





(at,l − pt · ql)2︸ ︷︷ ︸
mean square error
+λ · (||pt||2 + ||ql||2)︸ ︷︷ ︸
regularization
where Λ is set of t, l for which the affinities at,l is known. The optimization function also
includes the regularization term with the regularization parameter λ to help minimize over-
fitting. Figure 2.2 illustrates the method with an example. The highlighted cells in the matrix
At,l represents the known affinities between a hypothetical set of 6 ligands and 12 targets. The
matrix factorization involves employing single value decomposition [46] method to construct
matrices Q and P with f = 3 factors in this example. The optimization method involves
reducing the square error between the known affinities and the predicted values of the known
affinities resulting from P ·Q. Variants of the factorization methods also exist where the dot
product is approximated in a larger dimensional space using kernels, κ(p, q) = φ(pt) · φ(ql),
where φ is a transformation of the vectors into a higher dimensional space. However, it
has been previously shown that this is typically poor performing for target-ligand binding
affinity prediction [35].
2.1.3 Conclusion
In this chapter, we discussed the concepts of collaborative filtering and its applicability
to ligand based virtual screening. In the subsequent chapter, we provide the details of the
experiments conducted.
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Figure 2.2: Illustration of the matrix factorization method :In this example the highlighted
cells represent the known affinities. The SVD method generates the matrices P and Q.




Ligand based Virtual Screening using Collaborative Filtering
In this chapter, we provide extensive details of our investigation into utilizing collabora-
tive filtering for performing ligand based virtual screening. It is to be noted that parts of
the subsequent sections have been published as a part of our journal article [43], where I am
the first author.
3.1 Data Preparation
Evaluating the applicability of collaborative filtering for performing virtual screening re-
quires exhaustive dataset to work with. For this purpose, We use ligand-target bioactivity
data from the ChEMBL database (Version 23). In an effort to keep the evaluations con-
sistent with previous studies [48],we focus exclusively on human targets and three types of
binding affinity measures: half maximal inhibitory concentration (IC50), half maximal effec-
tive concentration (EC50), and the inhibitory constant (Ki). When more than one binding
concentration measure was present in the database, we use the Ki measure. When Ki is
not present we look at IC50 and then EC50 to categorize the ligand-target pair as active or
inactive. To convert data into the binary active-inactive format the following concentration
thresholds were applied: < 100 nM for “actives” and > 1000 nM as “inactives.” We note
that many other works apply two thresholds to the dataset and the interactions between the
two ranges are discarded, as their classification is subjective [48, 49]. We also note that the
thresholds selected in our study are consistent with the standardized activity values of the
CHEMBL database.
The data selection methods described above resulted in a bioactivity matrix of size
241,260 (ligands) by 2,739 (targets), with about 0.15% of the matrix containing a real value.
The mean inactive:active ligand ratio across targets in the dataset was approximately 7:3.
Figure 3.1 illustrates the distribution of the targets by the number of recorded assays
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available for predictions. It was observed that more than half of the targets in the data set
had less than 200 recorded assays (including actives and inactives).
We note that there have been recent reports in the literature [49, 50] stressing that the
overall model performance is highly dependent on threshold selection for inactive/active
as well as the ratio of inactive to active examples. Also, many ligand-target databases
are biased in that the experimental data they are comprised of represents only a small,
nonuniform portion of the chemical space. This leads to the over representation of certain
types of ligand-target patterns. Furthermore, experimental binding affinity measures are
often difficult to reproduce [51], which means there is inherent noise in the datasets such
that perfect classification of any test set should not be possible (unless models are over-fitted
to the problem). Although this has been a common knowledge within the community [52],
it nevertheless remains largely un-addressed.
Following recommendations from [50], we computed the bias of our training and test
selection to provide an estimate on how trustworthy our evaluation metrics are.
3.1.1 Evaluation Criteria
In this study three evaluation criteria are employed: the area under the receiver operating
characteristic (AUC), the enrichment factor (EF), and the Boltzmann-enhanced discrimina-
tion of the receiver operating characteristic (BEDROC). We briefly describe our rationale
in selecting these criteria, as well as an overview of the strengths and weaknesses of each
criterion.
Our first evaluation criterion is the area under the receiver operating characteristic curve
(ROC [53,54], the curve that results when the true positive rate is plotted as a function of the
false positive rate). This measure ranks ligands based on their predicted probability of being
active. An AUC value greater than 0.5 suggests that the classifier is better than chance
at assigning an active/inactive target-ligand pair. While widely reported in a number of
papers that use machine learning for target-ligand classification, the AUC does not capture
important aspects of the virtual screening problem. Specifically, the challenge is to rank
active ligands for a given target from the entire dataset. A superior classification model
would have a high true positive rate for the highest ranked ligands, which are the ones that
21
Figure 3.1: Number of targets by known assay counts : Illustration of the distribution of
the number of targets by the known assay counts for each target. More than half of the
targets have less than about 200 recorded assays. Therefore, it is imperative that the virtual
screening methods perform well when the number of assays is relatively sparse.
would be assayed first (the so-called early recognition problem). The AUC does not take into
account this early recognition, so it can incorrectly judge a classification model superior if it
has an overall high true positive rate, even though the true positives may not occur “early” in
the ranking of ligands. Such a model would result in many needless assays before becoming
sufficiently accurate. Therefore, more suitable metrics are often sought after that do take
into account early recognition – the two popular choices being Enrichment Factor (EF) and
Boltzmann-Enhanced Discrimination of Receiver Operating Characteristic (BEDROC).
Enrichment Factor [55, 56] is defined as the ratio of correctly classified active ligands
within a predefined early recognition threshold compared to the total ligands selected by the




where NX% is the number of ligands in the top X% of the ranked ligands. EF1%, then, is
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the ratio of true actives found in the top 1% of ranked ligands from a model normalized
by the total number of actives for a specific target. In other words, it gives an estimate on
how many more actives can be found within the early recognition threshold compared to a
random distribution. While this criterion closely matches the virtual screening problem, it is
not appropriate to compare the EF values obtained for different datasets when their number
of actives differ. Another disadvantage of the criterion is that it assigns equal weights to
the actives within the threshold, without any knowledge that some actives bind extremely
well and others have higher Ki concentrations. Robust Initial Enhancement (RIE) [57] helps
mitigate this by comparing two scenarios, (1) when the most active ligands are ranked at the
beginning of the threshold and (2) when the most active ligands are ranked closer to the end
of the threshold. This is achieved by applying continuously decreasing exponential weight
when ranking ligands. The RIE metric is similar in meaning to EF in that it quantifies
the superiority (to random) of the exponential average of the distribution generated by the
ranking method. Its minimum and maximum value dependance on (apart from the pre-
exponent factor α) the number of actives and the dataset size contributes to the metric
disadvantages. Nevertheless, RIE’s desirable property of differentiating actives within the
ordered list serves as a driving force for the development of the BEDROC metric, discussed
next.
Bound between 0 and 1, the BEDROC metric [58] is interpreted as the probability that
an active in the ordered list will be ranked before a ligand that is drawn from a random
probability distribution function. The shape of the distribution is governed by the pre-
exponent factor α, that must be selected by the user. In the words of the original authors:
“It is to be noted that α should not be chosen in such a way that it represents the best
performance expected by a ranking method, but rather it should be considered as a useful
standard to discriminate better or worse performance in a real problem to which the ranking
method will be applied.” [58]. Our study chose an α = 20 based on the previous study by
Riniker et al. [17] in their benchmarking of fingerprints for ligand-based virtual screening.
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Figure 3.2: AVE Bias : The image to the left visualizes the comparison of AVE Bias across 4
sets of training and validation data. The figure shows that the 4 training and validation sets
are randomly split with similar bias measures across the sets, thereby minimizing the impact
of variance across our study. The image to the right shows the spread of the AVE Bias for
each target in the dataset. The distribution of the AVE Bias from -0.5 to 1.5 (where closer
to 0 indicates no bias) across targets facilitates the study of the resilience of the collaborative
filtering algorithm to the impact of such a bias.
3.1.2 Variance and Bias in Validation Set Selection
The performance of machine learning models can be impacted by variance. A model
with high variance performs inconsistently on different validation sets. A model with high
bias is one that is well fitted to the training data but fails to generalize well. Building
machine learning models by using cross validation to separate training and validation can
aid in quantifying variance. In our experiments, the train and the test split was randomly
generated by stratifying on the targets, generating a random split with the ratio of 70%:30%
of associated ligands by target between the training and the validation sets.
In order to minimize the effects of variance influencing the claims in our study, we use
four iterations of our tests including generating four sets of training and validation data and
building the above mentioned models using implicit and explicit methods for each set of
training and validation data. Modeling bias is another design consideration while building
machine learning models to ensure the ability of the models to generalize beyond the training
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and validation datasets. In the field of computational chemistry the accuracy in practice is
not as good as the benchmark results from previous virtual screening results [8].
Wallach and Heifets [50] introduced a new measure of evaluating the redundancies in the
training - validation sets called the Asymmetric Validation Embedding Bias (AVE Bias).
The AVE Bias measures the quality of the training and validation sets by measuring the
similarities between the actives and inactives in the validation sets with the actives and
inactives in the training sets. The Bias is mathematically defined as [50]:
B =
H(Va,Ta) −H(Va,Ti)︸ ︷︷ ︸
AA−AI
+
H(Vi,Ti) −H(Vi,Ta)︸ ︷︷ ︸
II−IA

where, Va, Vi represent the validation sets with active and inactive ligands, Ta, Ti represent the
training sets with active and inactive ligands respectively, and H(·) represents a measure of
cluster similarity between the sets. The leftAA−AI term of the AVE Bias is a measure of how
clumped the validation actives are among the training actives. The right II − IA measures
the degree of clumping among the inactives. The study showed that the performance of
the ligand based screening methods strongly and positively correlated with the AVE Bias.
Intuitively, it means that an algorithm might perform well because there is an inherent
difference in the training and validation sets employed that makes the problem more easily
separable for the validation set. Positive values indicate a bias, whereas negative values
indicate that the problem is increasingly difficult because the training and validation sets
differ in a way that makes the classification problem even more difficult. The AVE Bias can
be measured for every target in the dataset. Therefore, it is appropriate to present the AVE
Bias results as a histogram or boxplot of the values.
As described, we use four stratified shuffle splits of the data. We computed the AVE
Bias for all targets in each of the four iterations of train-validation sets. In our calculations,
we employed Tanimoto similarity [13] to compute H(·) . Figure 3.2 illustrates the AVE Bias
scores using a boxplot to summarize the AVE Bias per target (a separate boxplot is used for
each iteration of the shuffle split). All four sets of train and validation sets have similar AVE
Bias measures. The imbalanced natured of our data set (inactives to actives, 7:3) in addition
to the method of classifying molecules as active or inactive based on the 100nM and 1000nM
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concentration thresholds and the randomized selection of training and validation set resulted
in a good distribution of targets with varying AVE Biases across targets. In addition, it was
also observed the data set also contained a subset of targets with a negative bias, thus makes
the classification of actives and inactives challenging for these sets [50]. Separate plots are
shown for each iteration of the validation split. Each box plot represents distribution of the
AVE Bias calculated per Target for each iteration of Training and validation sets. Figure
3.2 also illustrates the AVE Bias for each target in the dataset.
3.2 Collaborative Filtering Model Selection
In order to identify the best performing collaborative filtering model, we employ two
randomized grid searches. The first grid search investigates parameters for neighborhood
CF methods. The second grid search investigates parameters for using matrix factorization
CF methods. We separate the grid searches because the parameters in each algorithms
are quite different. We use collaborative filtering algorithms implemented in the GraphLab
API [59].
For the neighborhood CF methods we investigate three separate distance metrics: Jac-
card, Cosine, and Pearson. We also investigate a number of threshold values to determine
neighborhood size, logarithmically spaced from 10−7 up to 10−1. For each combination of hy-
per parameters, we calculate the mean for each of our evaluation criteria: AUC, BEDROC20,
and EF1% scores. The best performing neighborhood CF method utilized the Pearson simi-
larity metric with a threshold of 10−2. The mean AUC, BEDROC20, and EF1% scores were
0.79, 0.72, and 4.22%, respectively.
Table 3.1 summarizes additional results for the top 5 models, sorted by the EF1% score.
For the matrix factorization-based CF models, we investigated the number of latent factors,
ranging from 5 to 60 in increments of 5. We also investigated the value of the regularization
constant, C, used in the stochastic gradient descent method [47], with values logarithmically
spaced from 10−7 up to 10−1. Finally, we swept the values of the step size used for updates
in the stochastic gradient descent (SGD) optimization, spaced logarithmically from 10−3 up
to 10−1. We remind that the factorization CF method learns latent factors for each ligand
and for each target and uses them to rank ligands according to the likelihood of observing
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Table 3.1: Collaborative Filtering hyper-parameter tuning : Tabulated top 5 results from
training multiple collaborative filtering models using neighborhood methods and matrix
factorization methods.
Neighborhood-Based Collaborative Filtering
Distance N. Threshold AUC BEDROC20 EF1%
[0.3pt](r0.25em)1-2[0.3pt](r0.25em)3-5Pearson 10−2 0.791 0.723 4.225
Pearson 10−5 0.792 0.723 4.225
Pearson 10−4 0.791 0.723 4.225
Jaccard 10−2 0.648 0.647 3.670
Cosine 10−5 0.644 0.647 3.670
Matrix Factorization-Based Collaborative Filtering
Num. Factors SGD Step Size AUC BEDROC20 EF1%
[0.3pt](r0.25em)1-2[0.3pt](r0.25em)3-550 10−3 0.891 0.929 5.476
32 10−4 0.860 0.889 5.028
32 10−2 0.899 0.872 4.994
25 10−4 0.868 0.867 4.765
25 10−2 0.892 0.847 4.547
those (target, ligand) pairs. The stochastic gradient descent algorithm was used as the
optimization function to minimize the mean square error between the known affinities and
their predictions. Table 3.1 summarizes the results of the factorization CF method, sorted by
EF5% (SGD step size not shown for brevity). From the table, it is clear that the performance
of the factorization CF method exceeds that of the neighborhood recommender. The best
model was found with 50 latent factors, a value of C = 10−3 for regularization, and 10−3 for
the SGD step size. The best model had a mean AUC, BEDROC20, and EF1% as 0.89, 0.92,
and 5.47, respectively.
To more clearly understand how the hyper-parameters change the performance of the
factorization CF algorithm, we plot the BEDROC20 values as each hyper-parameter value
changes.Figure 3.3 illustrates the effect of the number of latent factors on the performance of
the model. It was observed that the performance plateaus near 50 factors. Similarly Figure
3.3 illustrates the performance of the regularization parameter of the SGD optimizer [47]
on the model performance. It is noticed that there is no consistent effect of the value of
regularization on the performance of the model.
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Figure 3.3: Hyperparameter tuning for matrix factorization collaborative filtering : Illustra-
tion of the effects of the number of factors, f , and regularization parameter, λ, on model
performance. While model performance improves with more factors, it may lead to over
fitting. The regularization parameter does not have a consistent performance, revealing that
performance is not sensitive to λ.The error bars represent the standard error of the mean
across the BEDROC20 scores for each Target at the specified parameter value
3.2.1 Conclusion
In this chapter, we provided exhaustive details on the methods utilized to train col-
laborative filtering model on ligand assay data. In the subsequent chapters, we provide
an in-depth analysis of the relative advantages of collaborative filtering compared to the
traditional virtual screening methods employing explicit featurization.
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Chapter 4
Performance Analysis of Collaborative Filtering for ligand based virtual screening
In this chapter we provide an in depth analysis of the outcomes observed with collab-
orative filtering methods when utilized for performing ligand based virtual screening. Fur-
thermore, we compare the outcomes of collaborative filtering with the traditional virtual
screening methods that employ explicit featurization.
4.1 Overall Performance of Collaborative Filtering
In the following section, we analyze the comparative performance of the collaborative
filtering model (which uses implicit featurization) and the baseline models (which use explicit
featurization from structure modeling). We use the evaluation criteria explained previously:
AUC, BEDROC20, and EF1%. Figure 4.1 shows boxplots of performance per target across
all the algorithms and all evaluation criteria. That is, a performance criterion is calculated
for each target and then all values are displayed in each boxplot. Results from all cross
validation iterations are combined in each boxplot.
Figure 4.1: Comparison of AUC, BEDROC20, and EF1% scores across all algorithms : The
collaborative filtering based implicit structure method, based only on assay outcomes per-
forms on par with the other methods across the three evaluation criteria. The across target
Random Forest model is the next best performer. All other models perform about the same
and poorer than collaborative filtering.
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Figure 4.2: Comparison of AUC, BEDROC20, and EF1% scores by number of known ac-
tivities : Illustration of the comparative performance of the algorithms by the number of
known affinities per target in the training data. Error bars correspond to standard error.
The collaborative filtering based implicit structure methods significantly outperform other
algorithms when the training data has 100 or fewer activities. Beyond 100 activities the
performance of all algorithms converge.
Across all evaluation criteria collaborative filtering performs similar to the baseline meth-
ods, despite the absence of known structural information of the ligands. In general, collab-
orative filtering is a slightly superior performer, followed by the across target RF model,
followed by per target RF, and KNN for across target and per target rounding out the
bottom. When taking the AVE Bias into account, the average AUC scores of the models
generated by RF and KNN are consistent with the performance of the same algorithms on
the unbiased training and validation tests for the J and J Benchmark reported by Wallach
and Heifets [50].
Although we have shown performance for all cross validation iterations combined, similar
performance was observed individually for each validation set.
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Figure 4.3: Distribution of AUC, BEDROC20, and EF1% : Distribution of AUC, BEDROC20,
and EF1% scores across all algorithms when the number of known affinities per target is less
than or equal to 100 activities. Based on a two-tailed t-test of the scores (p < 0.01), the
difference in scores for collaborative filtering with other methods is statistically significant.
4.2 Performance Comparisons by Number of known Actives
While the overall performance of collaborative filtering is encouraging, it is still unclear
if the implicit features employed help to mitigate the need for large numbers of training
assays for each target. To help delineate this, we now focus our attention on grouping the
results by how many training assays were used to model a given target. We remind from
Figure 3.1 that the number of training assays per target is typically less than 200, which
comprises the majority of targets in the ChEMBL database. As such, it is desirable for an
algorithm to perform well even when the number of training assays is relatively low. Figure
4.2 shows the performance of the algorithms on the validation sets with results grouped by
the number of available training assays. That is, each performance criteria is calculated for
each target and, then, the results are grouped by the number of assays used in the training
of that target. For example, targets with less than 100 training assays are in the first bin,
100-200 in the second bin, and so on until targets contain more than 500 training assays.
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We then clumped together all targets with more than 500 assays into the last bin. This
approach enables us to compare the relative performance of the algorithms based on the
the amount of available training assays. A consistent pattern was observed across all the
three evaluation criteria. The predictions from collaborative filtering on the validation set
significantly outperform the baseline methods when there were 100 or fewer assays in the
training set based on a two tailed t-test (p < 0.01). Between 100 - 500 training assays, the
implicit feature modeling methods perform statistically no different than the baseline models
(p > 0.5). Beyond 500 training assays, the traditional baseline method using the Random
Forest algorithm outperforms collaborative filtering.
It is interesting to note that the average enrichment factor in the top 1% is the high-
est across all methods when there are not many training assays available per target. We
hypothesize that collaborative filtering becomes less effective (in terms of EF1%) when the
number of ligands already tested is relatively numerous because the most likely candidates
have already been assayed by chance.
To further evaluate the differences between algorithms when the training assays are rel-
atively sparse, we expand on the performances of the AUC, BEDROC20, and EF1% scores
for targets with less than or equal to 100 training assays. Figure 4.3 represents the kernel
density plots for the distribution of the three aforementioned evaluation criteria. Kernel
density estimation is a means of estimating a smooth distribution from a finite set of points,
similar in spirit to a histogram. Below each density estimate is a “rug plot” of the values for
each machine learning method, with one “tick” for each observed value (this makes outliers
easier to see as they can easily be hidden in kernel density estimates). The distribution of the
scores from the implicit structure methods using collaborative filtering has a clear and visual
separation from the other baseline methods using explicit structures. With the exception of
across target RF, no other model has overlap in the performance for any evaluation criteria.
Even so, based on a two-tailed t-test of the distributions, collaborative filtering is the sig-
nificantly best performing algorithm in terms of all evaluation criteria when the number of
training assays is less than 100.
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4.2.1 Conclusion
In this chapter we provided an indepth look into the performance of collaborative filtering
algorithm for the problem at hand . In addition we also analysed the relative differences
between our methods with the known traditional methods utilizing the explicit ligand fin-
gerprinting methods. Because of the clear performance separation of collaborative filtering,
we conclude that the implicit structure methods demonstrate a consistent and significantly
increased performance when the number of known assays is limited to about 100 assays.
We also conclude that when the number of training assays is greater than about 500, tradi-
tional methods provide an increased performance. Unlike these baseline methods that use
molecular fingerprinting, collaborative filtering methods can “learn” about the ligands based
on their affinities with other targets and vice-versa, even with fewer numbers of known as-
says per target. This aspect of the collaborative filtering method contributes to the better
performance even with relatively sparse assay counts.
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Chapter 5
Introducing Implicit Target and Ligand Fingerprints
5.1 Overview
In this chapter, we turn our attention to an initial analysis of how the latent factors
computed by collaborative filtering, by virtue of the information encoded within them, can
be used to complement the traditional molecular and target fingerprints.
We introduce a new type of fingerprinting technique called Implicit Fingerprints,which
are the latent factors determined by the collaborative filtering method on the known affinities.
From our grid search, we found that 50 latent factors for each ligand and target was the most
optimal performing number of factors for the matrix factorization. We further evaluate the
applicability of the 50 latent factors to identify and cluster known cancer and thyroid related
protein targets. Greater than 20% of industrial cancer drug development programs focus on a
small subset of proteins when approximately 20,000 possible proteins are known [60] . While
there have been studies investigating the pharmaceutical vulnerabilities of these proteins, the
challenges with costs and off-target effects have been a limiting factor in realizing the proteins’
clinical potential. We investigated the inherent properties of the implicit fingerprints to
identify targets with similar binding affinities based on prior assays results. For the purposes
of the tests, we re-trained a collaborative filtering model without discarding the assays with
concentration levels 100nM and 1000nM. The experiment was rerun as a multi-label affinity
classification problem with the following labels to indicate binding affinities : < 1nM was
associated with the affinity label of 1, between 1nM and 100nM was labeled as 2, 100nM
and 1000nM labeled as 3 and greater than 1000nM labeled as 4.
To visually elucidate the power of Implicit Target Fingerprints, we mapped the dimen-
sions of the 50 latent factors of the targets into a 2-dimensional space using t-distributed
stochastic neighbor embedding (t-SNE) [61], a powerful method for reducing dimensionality
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Figure 5.1: Implicit Target Fingerprints : t-SNE plot reducing the dimensions of the 50-
dimensional implicit fingerprints into two dimensions for a subset of targets in the ChEMBL
database, highlighting known cancer and thyroid related protein targets. The method suc-
cessfully clusters related targets close to each other,as indicated in the zoomed version of
the largest cluster of cancer targets. Interestingly the clusters also contain other targets
which are found to have expressions with known cancer/thyroid targets as in the example of
Vascular Endothelial Growth Factor Receptor-2 Expression in breast cancer 1 protein.
of high dimensional datasets by minimizing the Kullback-Liebler divergence of distributions
in the higher and lower dimensional space. Figure 5.1 illustrates the distribution of the pro-
tein targets when mapped into a 2-dimensional space, with the cancer related target proteins
highlighted in blue ,and thyroid related in red. Interestingly, the graph demonstrates the
presence of three potential clusters of known cancer related targets appearing close to each
other. Similarly three potential clusters of thyroid related targets also appear close together.
These cancer-related targets are visually separated from other biological targets in the la-
tent space. The clusters also contain other targets which are found to have expressions with
known cancer/thyroid targets. For example, consider the target clusters containing Vascular
Endothelial Growth Factor Receptor-2 Expression (CHEMBL1878) with breast cancer 1 pro-
tein(CHEMBL1615382) or Thyroid peroxidase (CHEMBL1839) with PHD13 ovarian cancer
1(CHEMBL1764945). In the 2D implicit target fingerprints space, the close distances among
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Figure 5.2: t-SNE Plots of Implicit Ligand Fingerprints : Plots for three cancer targets
are shown where each point represents a compound assayed from the ChEMBL database.
The concentration results of the assays are color-coded. t-SNE plots of the 50-dimensional
implicit representations, reduced to 2 dimensions preserving distance.
these targets corresponds to known observations of similarity from prior research [62, 63] .
This also engenders a potential for identifying other unexplored relations between the protein
targets that appear close to each other in the implicit fingerprint space.
Similar to the biological targets, the the ligands can also be mapped in this latent space,
as illustrated next.
To help intuit the compound-protein binding affinity prediction capabilities of the implicit
latent space, we randomly selected three cancer related targets from the ChEMBL database.
We selected target with IDs CHEMBL4899, CHEMBL3774295 and CHEMBL2150837 as
shown in Figure 5.2. Again, the 50-dimensional implicit fingerprints of the compounds are
reduced into a 2-dimensional space using the aforementioned t-SNE method. We visual-
ize all compounds with known assays for the three selected cancer related protein targets.
The compounds are color-coded on the basis of their standardized concentration levels in
the assays, where a decreasing concentration level indicates stronger binding affinity. For
the t-SNE plots, the ideal result would be perfect clustering for each concentration level.
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The implicit fingerprints from the figure demonstrate a very clear separation between the
compounds based on the concentration levels required to trigger binding affinities with the
respective targets. This visual separation is striking for assays with excellent binding affinity
(standard value below 100nM), indicating that the implicit representation is excellent in its
ability to capture properties of similar compounds using Euclidean distance.
From the above evaluations, we conclude that the baseline modeling methods tradition-
ally can be enhanced by the use of Implicit Target and Ligand Fingerprints. The models
generated by the Implicit Fingerprints have better predictive power than their explicit coun-
terparts when the number of known assays for training is less than 100. For the remaining
targets, Implicit Fingerprints performs about equally to explicit molecular fingerprinting up
to about 500 assays. When the number of assays is above 500, traditional methods have a
slight, but significant advantage over collaborative filtering.
5.2 Limitations
While we conclude our research objective 1 that implicit-descriptor modeling is a promis-
ing method for virtual screening, we also point out that our analysis was completed on a
large subset of the ChEMBL database, Version 23. That said ,we also highlight some of
the limitations of the current work and opportunities within the domain.We acknoweledge
Further studies need to be conducted on the cumulative predictive powers of the traditional
ligand fingerprinting techniques and the implicit fingerprints generated from collaborative
filtering in order to understand if the implicit fingerprints are consistent with other groups
of targets and ligands. We also note that a limitation of our approach is that we require
ligands to be assayed upon more than one target in order to evaluate them. That is, a
ligand must be paired with a target in the training set and paired with another target in
the testing set for our method to be able to evaluate binding affinities. We also point out
that our implementation of across target training mode is not widely used in the chem-
informatics community. We only investigated one method of fingerprinting targets using the
ProFeat feature generation tool. Other target methods could provide superior performance.
Moreover, we note that the Random Forest method trained using combined target and lig-
and fingerprinting through RDKit was typically a strong performer compared to traditional
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per target training (which is most often employed in the virtual screening literature). While
the performance of Random Forests was inferior to collaborative filtering, this result does
warrant further investigation into techniques for featurizing protein targets. Such an inves-
tigation may prove to uncover models that can perform superior to collaborative filtering
methods.
5.3 Conclusion of Research Objective 1
We have thus far discussed our research pertaining to our research objective 1 : Implicit
Fingerprint based virtual screening by means of collaborative filtering. In the current chapter
and preceding chapters, we discussed the approach, algorithms, results and concluded with
our novel contribution to this domain, namely Implicit Ligand Fingerprint. In the subsequent
chapters, we describe the research methods into our Research Objective 2: Deeplearning
based drug design using Implicit Ligand fingerprints.
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Chapter 6
Introduction to CFGenNet, Collaborative Filtering based Generative Networks
Overview
In the previous chapters, we have shown that implicit fingerprints capture ligands and
proteins in a shared latent space, typically for the purposes of virtual screening with col-
laborative filtering models applied on known bio activity data. We extend this further in
our research objective 2, where we extend these implicit fingerprints/descriptors using deep
learning techniques to translate latent descriptors into discrete representations of molecules
(SMILES), without explicitly optimizing for chemical properties . This allows the design of
new compounds based upon the latent representation of nearby proteins, thereby encoding
drug-like properties including binding affinities to known proteins. The implicit descriptor
method does not require any fingerprint similarity search, which makes the method free of
any bias arising from the empirical nature of the fingerprint models [43]. We evaluate the
properties of the novel drugs generated by CFGenNet using physical properties of drug-like
molecules and chemical complexity. Additionally, we analyze the reliability of the biological
activity of the new compounds generated using this method by employing models of protein
ligand interaction, which assists in assessing the potential binding affinity of the designed
compounds. We find that the generated compounds exhibit properties of chemically feasible
compounds and are likely to be excellent binders to known proteins. Furthermore, we also
analyze the diversity of compounds created using the Tanimoto distance and conclude that
there is a wide diversity in the generated compounds. The rest of this chapter and the subse-
quent chapters will cover the methods investigated and the results obtained. It is to be noted
that some portions of the subsequent sections have already appeared our publication [1] for
which I am the first author.
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6.1 Decoders to generate SMILES code
The implicit fingerprints from collaborative filtering is an implicit mathematical repre-
sentation that allows for a more accurate characterization of the drug compound and protein
target in the same numeric latent space, thus narrowing the model-associated bias down to
that of the assay, i.e., real clinical (albeit in vitro) environment. [64]. Additionally, to facili-
tate the ability to discover the physical structure of new compounds, in this work we propose
decoding methods that map from the implicit representation of the candidate compounds
to their physical structure. We believe this expanded capacity of the fingerprinting model
will have significant impact on virtual screening and, consequently, drug discovery, as it will
render drug discovery less dependent on costly clinical facilities and services. Moreover, the
representation will provide new methods for creating and testing candidate drug compounds.
6.1.1 Related Works
The application of deep learning into ChemInformatics has shown tremendous impact
in the both replacing traditional ML methods such as QSAR modeling and in the space of
de-novo drug design using generative networks. The generative methods of de-novo drug
design do not rely on predefined rules of structure generation but generalize the probability
of generation process using databases of known structures. These methods rely on sampling
within the learned probability distributions. Several recent works in generative drug dis-
covery have borrowed key principles and architectures from the field of image synthesis and
natural language processing and successfully applied it to the the domain of de novo drug
design. Recurrent Neural and their variants have in the recent past been the mainstays of
NLP based applications. The sequential nature of the SMILES code make RNNs a natural
choice for adoption in the field of de novo drug design [65]. Additionally, reinforcement learn-
ing has also been popular, with special mention of REINVENT [32] , which combines RNNs
with reinforcement learning. [66] demonstrated that RNNs trained with a set of molecules
represented as SMILES strings is able to generate a much bigger chemical space than the
training set.
Several recent works have investigated the use of neural embedding on compound struc-
ture representations such as SMILES codes, showing this embedding is effective for exploring
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the chemical properties [36] and generating novel compounds. The Variational Autoencoder
architecture [67] has also shown to generate novel chemicals using courtesy, the latent encod-
ing generated in VAEs. [2] refer to these embedded fingerprints as implicit representations.
Another variation was introduced with the Randomized SMILES. [68] leveraged the condi-
tional variational autoencoders by controlling multiple molecular properties simultaneously
and imposing them on a latent space. They demonstrated the abilities to generate novel
chemical constrained to 5 specific properties. [69] introduced Grammar Variational Autoen-
coders, where they married the concepts of parse trees from context free grammar with VAEs
to mitigate the number of invalid SMILES strings generated from the generative models. [42]
introduced a concept of Junction tree Autoencoders, which constructs molecular graphs in
two phases, by first generating a tree structured scaffold over chemical substructures, and
then combining them into a molecule with a graph message passing network. This approach
allows us to incrementally expand molecules while maintaining chemical validity at every
step. With their novel method, [42] reported improvements over the state of the art methods
at the time of their writing. Additionally ArusPose et al [70] demonstrated the advantages
of using different representations of SMILEs are every stage of training as opposed to using
a unique SMILE representation for each molecule. They successfully demonstrated that the
quality of the chemical space generated was much higher with this approach. Besides the
SMILES representations, the graph based representations of molecules have also been used
in the domain successfully. [71] utilized the graph neural networks to express probabilistic de-
pendencies among a graph’s nodes and edges to learn distributions over any arbitrary graph.
Compared to baselines that do not use graph-structured representations, they were able to
produce models that often performed far better. [41] proposed a framework based on a type
of sequential graph generators that do not use atom level recurrent units. They successfully
demonstrated abilities of their approach to generate compounds containing a given scaffold,
compounds with specific drug-likeness and synthetic accessibility requirements.
In addition to Variational Autoencoders, Generative adversarial neural (GAN) networks
[72] are also a very popular architecture for generating realistic data.A GAN has two compo-
nents, a generator and a discriminator, that compete against each other during training. e
generator generates artificial data and the discriminator attempts to distinguish it from real
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data. e model is trained until the discriminator is unable to distinguish the artificial data
from the real data [72]. ORGAN [39] and ORGANIC [73] where some of the first demon-
strations of the application of GANs for drug discovery. [74] and [75] further combined the
concepts of GANs and Reinforcement learning to the application of de novo drug design. [40]
introduced LatentGAN, which combined VAEs and GANs for de novo molecular design.
They successfully demonstrated the abilities of Latent GAN to generate novel compounds in
two scenarios: one to generate random drug[U+2010]like compounds and another to gener-
ate target[U+2010]biased compounds. Additionally, IBM also demonstrated the viability of
deep generative models for antimicrobial discovery [76]. They leveraged classifiers trained on
an informative latent space of molecules modelled using a deep generative autoencoder, and
screened the generated molecules using deep-learning classifiers along with physicochemical
features derived from high-throughput molecular dynamics simulations. With the power of
generative learning methods combined with molecular dynamics simulations, they were able
to synthesize and experimental test 28 candidate antimicrobial peptides in record short time
frame.
While the list of interesting research in the field of deep learning for de novo drug design
is constantly growing , we also note that [77] provides a comprehensive review of research in
the advances for the generation of novel molecules with desired properties with a focus on
the applications of GANs, RL, and related techniques.
However, to the best of our knowledge all the prior methods,including their variants
[38–42,78] work upon a known representation of the ligands , either the raw SMILES textual
representation or graph based representations and are therefore limited in their ability to
discern more complicated relationships encoded by fingerprints. The common theme in these
techniques is to provide as input to the deep learning model, the molecules only to produce
the same or similar molecules as output. The continuous vector representations of the input
molecules in the intermediate layers produce a larger chemical property space, which is then
sampled to produce novel molecules.
In this work, we design and train deep learning methods that leverage the implicit com-
pound fingerprints obtained from collaborative filtering based on the past bioactivity/assay
data to map back to the physical structure of compounds. The implicit encoding of com-
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pounds are a continuous vector-valued representation and thus lend itself to the use of
continuous optimization to generate novel compounds. We further assess the properties of
the novel ligands generated in terms of the drug-like physical properties of molecules, chem-
ical complexity and biological activity. We observed that our compounds exhibit properties
similar to the known ligands even though CFGenNet does not explicitly train the neural
network for optimizing specific properties. Additionally, we compare our work to the prior
work of [37] on a set of chemical compounds with known binding affinities to cancer targets
from the ChEMBL23 database [79]. This comparative analysis investigates not only the
potential binding affinity of the generated compounds to selected protein targets, but also
the diversity of compounds generated. We provide evidence that our method is superior
in both binding affinity and compound diversity. In the rest of this chapter, we describe
the details of the neural network based decoder that attempts to translate a given ligand’s
implicit fingerprints into its corresponding SMILES representation.
6.2 Neural Network Architecture
Our method to generate novel ligands is comprised of two steps. (1) We generate implicit
ligand and protein fingerprints using collaborative filtering and (2) train a neural network to
generate the SMILES string from the implicit representation (i.e., a decoder that can map to
a conventional representation from the implicit space). The first step involves generating the
implicit fingerprints using known assays by applying the collaborative filtering algorithm [43].
This step yields the implicit fingerprint representations for both ligands and protein targets,
as described above. The implicit fingerprints are continuous vectors that represent a point
in 50 dimensional space.
The Implicit fingerprints of the ligands are then fed into a Gated Recurrent Unit (GRU)
[80] neural network to map the corresponding SMILES string encoding. The neural network
is trained to minimize the error in reproducing the relevant SMILES string for each input
implicit fingerprints of the ligands. The key aspect of the neural network is to learn the
function to map the fixed-length continuous vector representation to the SMILES string.
This architecture is illustrated in Figure 6.1. Additional details of the neural network design
are discussed in subsequent sections.
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As with other methodologies utilizing generative deep learning algorithms, [37] the neural
network should ensure that the points in the latent space decode to valid SMILES strings.
In order to avoid the latent space from being sparse and resolve to large “dead-areas” (areas
in the space that are never trained to decode from and therefore behave unpredictably), we
performed input data augmentation. The data augmentation involved adding randomness
to the input layer of the neural network (i.e., adding random perturbations to the implicit
vector). The data augmentation incentivizes the decoder to more fully represent the areas
in the implicit latent space of the ligands, such that they can successfully resolve to the
corresponding SMILES string. The intuition is that adding noise to the encoded molecules
forces the decoder to learn how to decode a wider variety of latent points and find more robust
representations. This approach follows the intuitions made popular by the variational auto-
encoders(VAEs) [81] by Bowman et al. The VAEs, instead of decoding from a single point
in the latent space, sample from a location centered around the mean value and with spread
corresponding to the standard deviation, before decoding. This ensures that a sample from
anywhere in the area is treated similar to the original input. Even so, there are differences
between the VAE approach and ours. In CFGenNet, the latent space if fixed from the
collaborative filtering; it is not trainable like in the VAE. Importantly, this means that the
sampling incentivizes the decoder to reconstruct similar SMILES scores from given set of
similar points. It does not incentivize the collaborative filtering algorithm to change its
implicit representation.
The sequential nature of the output SMILES string required us to consider neural network
architectures that are adept at handling such data. The application of neural network
architectures such as recurrent neural networks and their enhanced variations such as gated
recurrent neural networks (GRUs) for problems involving sequential data such as speech
recognition, language translation have been very successful. [80, 82–84] The GRU neural
networks, with their innate abilities of learning long-term dependencies in sequences, are
especially useful for handling SMILES strings.
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Figure 6.1: Deep learning based Ligand Design using Implicit Fingerprints from Collabora-
tive Filtering - Architecture
6.3 Dataset Description
Our method involves translating the implicit ligand fingerprints into its corresponding
SMILES string. The implicit fingerprints, however are derived from the ligand - target bioac-
tivity data from the ChEMBL database (Version 23). The bioactivity data, keeping in line
with previous studies [85, 86] was focused only on human targets. We restricted bioactivi-
ties to three types of binding affinities. The included half maximal inhibitory concentration
IC50, maximal effective concentration (EC50), and inhibitory constant(ki). Following the
precedence with previous works [43, 85, 86], we converted the data into the binary active-
inactive using the following conversation thresholds: lesser than 100 nM for “actives” and
greater than 1000 nM as “inactives.” Furthermore, in order to be consistent with research
objective 1, we retained only ligands which have at least two prior assays. This resulted
in a bioactivity matrix of size 241,260 (ligands) by 2,739 (targets). The bioactivity matrix
was subjected to the collaborative filtering method as described in research objective 1. The
resultant implicit fingerprints were then used as inputs to our deep learning model, with the
goal to produce the respective canonical SMILES string as the output. Figure 6.2 illustrates
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the data distribution of the number of ligands against the known number of prior assays and
known number of prior assays with known positive affinities. As evident from the plots, close
to 50% of the ligands have only 2 prior assays. Additionally close to 62% of the ligands have
only 1 prior assay with positive affinity. We also wish to note that the number of ligands
( 241k) used to model the deep learning model is comparable to previous works [78].
Considering that CFGenNet relies on the prior assay history to determine the implicit
ligand fingerprints, having more numerous examples of prior assays for each ligand may
also result in better quality implicit fingerprints. This statement is further evidenced by
results from the next section: (1) the ability of the decoder to accurately translate implicit
fingerprints into the corresponding SMILES and (2) the abilities of the ligands to yield more
novel ligands are both influenced by the number of available assays per ligand, as described
next.
Figure 6.2: Data Distribution : The first figure illustrates the number of molecules against
number of assays, binned at specified values or ranges. Close to 50% of the molecules have
only 2 prior assays. The second figure illustrates the number of ligands against the number
of known assays with positive affinities. It can be observed that 62% of the ligands with only
one assay with positive binding affinity.
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6.4 Construction of the Neural Network
In CFGenNet we use the implicit ligand fingerprints obtained from the prior assay in-
formation (collaborative filtering) as inputs to a deep learning model, with the objective of
producing the corresponding canonical SMILES representation as the output. This implicit
representation can have a number of advantages because it is based solely on the observed
behavior of the compound, rather than inherent measures of physical properties. Thus,
formulating a decoding procedure from this implicit representation may have distinct advan-
tages over previous methods. The implicit fingerprint, because it is a continuous vector of
fixed length (50), also lends itself well to statistical sampling with simple procedures. We
employ data augmentation of the input vector by employing a vector of means µ and another
vector of standard deviations, σ. The input vector (implicit fingerprint vector) serves as the
vector of means, which is then added to another vector,which is a random normal distribution
centered at 0 with standard deviation σ, to yield a statistically sampled point around the
implicit fingerprint. The stochastic sampling process ensures that the actual vector will vary
on every single iteration due to sampling, while keeping the mean and standard deviations
the same. Intuitively, the mean vector controls where the implicit fingerprint of a ligand is
centered around, while the standard deviation controls the “area,” how much from the mean
the encoding can vary. The decoder, hence learns that not only is a single point in latent
space referring to ligand, but all nearby points refer to the same ligand. The decoder is
exposed to a range of variations of the encoding of the same input during training. This pro-
cess is illustrated in the decoder architecture, as shown in figure 6.3. The approach adopted
here is similar to the data augmentation employed with Variational auto-encoders [67].
6.4.1 Gated Recurrent Neural Networks
In order to generate the SMILES string from the implicit fingerprint, we are motivated
to use recurrent neural networks (RNNs) because of their success in modeling sequential
data such as natural language. The SMILES strings lend themselves well to this model
considering the sequential nature of the notation. Each unit in the RNN attempts to capture
state information of the sequence by transforming all the elements that appeared before it.
It does so by encapsulating this information in a hidden state vector, that is passed from
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Figure 6.3: Implicit Fingerprints to SMILES Decoder : The deeplearning network learns
ligand representations by employing data augmentation technique at the input layer.The
continuous representation obtained is then fed into a series of dense layers followed by a
Gated Recurrent Unit Neural Network to obtain the corresponding SMILES string.






where xt represents the input at timestep t, wxh represents the weight from input node
to the hidden node, whh represents the weight on the feedback loop from the hidden node
to itself, and ht−1 represents the previous hidden state. As evident from the equation,the
hidden states from the earlier time steps get diluted over long sequences. This problem
gets compounded with SMILES considering the long term dependencies (such as matching
brackets etc.) that need to be maintained in order to resolve to a valid chemical compound.
The Gated Recurrent Neural Network attempts to address this problem by introducing two
gates called the “update” gate and a “reset” gate along with a memory which governs how
much of the previous state is retained. Each of these units (update gates, reset gate, and
memory) have their own trainable weights. The Update Gate at each unit decides the amount
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of new information to be added to the hidden states. The reset gate determines the past





where σ represents a logistic or sigmoid function. These sigmoid values of the reset gate
range from 0 to 1 and determine how much of the previous hidden node value is retained. A
value of r = 0 implies the none of the previous node value is retained and a r = 1 ensures the




xtwxm + (r  ht−1)whm
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where  represents the Hadamard (or element-wise) multiplication of two vectors. Addi-





The update gate, with values ranging from 0 to 1, determines if the new hidden state should
use the previous value or the new value. Tying all these together, hidden state is governed
by the equation:
ht = um+ (1− u) ht−1
Intuitively, the GRUs are better suited than the RNNS to our problem considering the
long term dependencies between symbols that must be maintained in the SMILES string.
The Ring structures, for example, are represented by matching numeric symbols typically
separated by two or more atoms within the SMILES string. The neural network should be
able to remember these long term dependencies for effectively decoding to a valid SMILES
string. Figure 6.3 illustrates multiple GRU layers that make up the decoder in order to
effectively map to the SMILES code. These “layers” shown in the figure are visualized
compactly—that is, they are actually two stacked sequences of GRU nodes .
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We performed extensive training and validation of the vanilla RNN and GRU models
with the continuous implicit fingerprint vector as the input and the one hot encoded SMILES
string as the output. We measured the outcome of the models by evaluating the categorical
cross entropy loss and the accuracy. As a part of training, we explored a variety of architec-
ture options with respect to the depth and the width of the deep learning models. We also
trained with different composition of the training sets based on ligands with varying counts
of past assay data. Across all training iterations, we noticed that the GRU based model
performed better with,lower cross entropy and higher accuracy. We also noticed that the
training loss converged faster compared to the validation loss. Our architecture comprised
of a series of dense layers followed which consume the 50 vector wide implicit fingerprint
representation of the ligands, followed by the GRU layers returning sequential information
to map to the SMILEs representations. The exact makeup of the deeplearning architecture
with the trainable parameters are provided in the supporting information.
Figure 6.4 illustrates the performance of the 3 different models trained with different
datasets. The first dataset comprised of all the 241K ligands from the dataset. We addition-
ally trained with training set comprised only of ligands with atleast 1 positive binding affinity
(121k ligands) and another iteration comprising of ligands with atleast 5 positive binding
affinities (8.5k ligands). As evident from the figure, the training and the corresponding
validation loss was lower when trained with the filtered data sets as opposed to the entire
population of 241k ligands. This can be attributed to the fact that the implicit fingerprints
of the ligands that exhibited positive binding affinities in prior assays tend to encode more
information on the ligands, and hence decodable into the explicit SMILES representations.
While this implies that approximately half the ligands in our dataset do not resolve back to
its corresponding SMILES representation, it does not however dent the utility of CFGenNet.
This is due to the fact CFGenNet is able to resolve the implicit fingerprints of the ligands
which have demonstrated bioactivities in the past, and hence such ligands are more desirable
to be used as anchor ligands from which to generate novel ligands.
The detailed architecture of the neural network is illustrated in figure 6.5. The number
of parameters at each layer is illustrated in the figure 6.6.
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Figure 6.4: Train and Validation Losses of the Neural Network : Training and validation
losses across multiple runs of the neural network.
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Figure 6.5: Neural network architecture of the deep learning model.
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Figure 6.6: Layers and parameters trained in the deep learning model.
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Chapter 7
Syntactic & Novelty Analysis of Generated Ligands
7.1 Introduction
In this chapter and the subsequent chapter, we present the results of our methods in
the context of its abilities to generate valid and novel molecules from the implicit latent
space. The ligands are validated in multiple folds. It is to be noted that some portions of
the subsequent sections have already appeared our publication [1] for which I am the first
author.
• Syntactic Analysis of generated molecules: We validate if the generated molecules are
syntactically correct and can indeed resolve to a valid molecule. The molecules (their
corresponding SMILES strings) are validated using the RDKIT library [16]. The details
are further described in the subsequent sections of this chapter.
• Novelty of the generated molecules : We validate of the generated molecules are novel.
We employ multiple criteria to assess novelty , as further described in this chapter.
• Semantic Analysis of generated molecules : We validate if the generated molecules are
meaningful and useful. We evaluate the properties of the molecules and further validate
its usefulness to be synthesized into a valid drug. The details are further described in
the subsequent sections of this chapter.
We wish to note that large parts of the subsequent sections have already been appeared
in a journal paper [1].
7.2 Syntactic Analysis of Generated Ligands
In this section, we discuss the outcomes of our method in the context of 5,000 randomly
selected ligands from the validation set. Additionally we also present the outcomes of a scaf-
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fold analysis from the potentially novel ligands generated from ligands with known affinities
to cancer targets from the ChEMBL23 database. To further analyze the practical applicabil-
ity of CFGenNet, the resulting ligands, specifically from approved cancer related drugs were
further evaluated for their viability to be valid compounds with enhanced biological activi-
ties. The complete list of ligands is made available as a part of the supporting information
of our journal paper [1](section 0.4).
Our method samples around the implicit latent space of the known ligands, or “anchor
ligands” to generate (potentially novel) compounds. In our testing, we randomly sampled
100 points across the 50 dimensions in the implicit space around our anchor ligands. Each
point was then processed through our neural network to obtain the corresponding SMILES
string. The SMILES string was then validated using the RDKIT library. This process is
discussed in more detail in the next chapter on the syntactic analysis of generated ligands.
We ran the aforementioned sampling and validation exercise on the 5,000 ligands (hence-
forth referred to as anchor ligands). A total of 4,632 out of the 5,000 (92.64%) anchor ligands
resolved to at least one valid ligand, although not all resolved ligands were (potentially) novel.
As mentioned earlier, 100 points are randomly sampled for each anchor ligand. Depending
on the information encoded in the continuous implicit vector space, multiple points around
a given anchor ligand may resolve to the same ligand. Only those ligands that are gener-
ated at least twice, and can be resolved to a valid compound using the RDKIT library, are
considered to be “valid” generated ligands. The frequency constraint of “at least twice ” is
enforced to help ensure that the generated ligand is not generated spuriously.
7.3 Novelty analysis of Generated Ligands
The practical applicability of the generative deep learning methods are typically measured
by the ability of the methods to generate novel ligands with desirable properties. However,
despite the plethora of works in the space, the concept of novelty is loosely defined. Several
popular recent works [2, 32, 33] just validate if the generated ligand was already present in
the training data set. If not found, the generated ligands are deemed as novel. Alternately,
Popova et al [34] assessed novelty by checking for the presence of the generated ligands in
the training set of 1.5m ligands from ChEMBL21. Additionally they also searched for the
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presence of the generated ligand in the ZINC database for 320M synthetically accessible
drug-like molecules. It is to be noted that a difference of even a single atom was deemed as
a sufficient condition to term a generated ligand as being novel. With the precedence in the
aforementioned prior works serving as a baseline, we adopted a series of multi-fold conditions
to assess the potential of the generated ligands to be deemed novel:
• Is the generated ligand already present in the training data set?
A total of 2917 generated from the validation set of 5k anchor ligands were not present
in the training set.
• Is there any other known ligand in the 1+B ZINC database with a similarity threshold
of .85 with the generated ligands.
We further ran the 2917 ligands against ZINC database to look for the most similar
known ligand from 1.3 billion compounds from the ZINC database, with a similarity
threshold of .85. The similarity between compounds were measured by the Tanimoto
Coefficient (TC) which measures a distance between fingerprints resulting in a score
ranging from [0,1] (0 corresponds to least similar and 1 to exactly same). [87] We
obtained the TC based on Morgan Fingerprints [88] of radius 512 bits . This resulted
in a total of 2759 ligands from the previous step.
• Among the ligands from ZINC database with similarity <.85, are there differences in
the scaffolds and/or the number of functional groups between the anchor and generated
ligands.
In order to further verify that the generated ligands were meaningfully different from
their closest hits from ZINC database, we further compared the scaffolds and functional
groups between the generated ligands and their closest hit from ZINC database. Of
the 2759 ligands from previous step,only 322( 12%) of ligands had the same functional
groups and only 618 ligands (22%) had similar scaffolds as their closest hit from ZINC
database. These numbers are summarized in table 7.1 for easier readability. Addition-
ally, Figure 7.1 plots the distribution of the ligands over the differences in the number
of functional groups between each pair of potentially novel ligand and their closest hit
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from ZINC database. It is seen that 67% (1831 ligands) of the ligands generated had
a difference of at least 2 or more functional groups with their closest hit. The figure
also illustrates the TC similarity scores between the potentially novel ligands & their
closest ZINC database hits. It is observed that 20% of the potentially novel ligands
have similarity of .5 or less.
We wish to note that the references of "novel ligands" in the rest of the sections should be
read as being potentially novel and in conjunction with the aforementioned set of conditions.
Figure 7.1: Novelty of generated ligands : Distribution of the number potentially novel ligand
and their closest hit pairs v/s differences in the functional groups & TC similarity ranges.
The figure demonstrates that A degree of novelty could be associated with the generated
ligands when compared with the 1.3Billion known ligands from ZINC DB. The differences
in the number of functional groups between the anchor and generated ligands range from 0
to 9,with at least 67% ligands with 2 or more differing functional groups. The TC similarity
bins help gauge the distribution of the TC similarities between the pairs. It is seen that the
lower the similarity,more likely it is for the pair having varying functional groups.
It was also observed that sampling around certain anchor ligands resulted in numerous
potentially novel ligands being generated, while sampling around other anchors did not yield
any novel ligands. To further investigate this phenomenon, we analyzed the abilities of the
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Table 7.1: Summary of Generated Ligands
Number of anchor ligands from validation set : 5,000
Number of anchor ligands yielding at least 1 valid ligand : 4,632
Number of generated ligands not present in the training data : 2,917
Number of generated ligands with a difference of 2 or more functional groups: 1,831
Number of anchor ligands yielding at least 1 ligand outside training data : 1,332
associated anchor ligands to yield potentially novel compounds by grouping according to
known prior assays. Figure 7.2 (left) illustrates the relationship between the presence of
assays of the anchor ligands and their ability to generate potentially novel ligands. As can
be seen, anchors that generated novel ligands tended to have a greater number of known
assays. In Figure 7.2 (right), we can also observe that this relationship holds for the number
of anchor ligands with positive affinities. Anchors with a more numerous positive assays also
tended to generate potentially novel ligands.
This observation is perhaps not surprising considering that the implicit fingerprints are
derived from the known assays. This provides evidence that the implicit fingerprints for
anchor ligands encode more meaningful information when there are more numerous assays.
One potential explanation for this is that the implicit representation can encode many desired
properties that are difficult to measure as the number of assays increases, thereby giving a
better blueprint for the decoder to generate potentially novel ligands. However, because the
implicit representation does not explicitly model chemical or experimental parameters, this
hypothesis must be investigated through observation of known ligand properties, as discussed
next.
7.3.1 Conclusion
In this chapter , we reviewed the methods adopted to validate the syntax and novelty of
the molecules generated by CFGenNet. We further evaluated in detail the results from the
aforementioned methods. We further evaluated these ligands for their usefulness in being
synthesized as drugs. We refer to this as the semantic analysis of the generated results,
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Figure 7.2: Ligand generation v/s total assays : Correlation of the ability to generate poten-
tially novel ligands with prior assays: Box plots show the co-relation between the two sets
of anchor ligands - one set from 1 or more potentially novel ligands were generated and the
second set which yielded no ligands when sampled in the implicit fingerprint latent space.
The first figure visualizes the total number of known assays that exists for each set. The
second box-plot visualizes the total number of positive binding affinities already recorded for
each assay.
whose details are covered in the next chapter.
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Chapter 8
Semantic Analysis of Generated Ligands
In this chapter, we provide details of the evaluation conducted to validate the quality of
the generated ligands.We term this as the semantic analysis of the generated ligands. As
a part of this analysis, we evaluated the some of the commonly used physical properties
to validate the usefulness of generated ligands from prior works. Additionally , we also
evaluated the scaffolds exhibited by the generated ligands along with the abilities of the
generated ligands to bind with known protein targets. We wish to note that large parts
of the subsequent sections are already published in our journal article (under review) [1]
for which I am lead author. It is also to be noted that the analysis of binding affinities,
scaffolds, and relative performance comparisons with FDA approved drugs was led by a
co-author (Niraj Verma) of the aforementioned paper [1]. However I contributed in the
interpretation of these analyses.
8.1 Physical Properties of Generated and Anchor Ligands
In order to explore the similarity of potentially novel and anchor ligands, we evaluated the
properties of the compounds using a number of scoring measures. More specifically, we used
the quantitative estimation of drug-likeness (QED), n-octanol water partition coefficient
(LogP), synthetic accessibility score (SAS), and used the number of benzene rings as an
indicator of the chemical complexity. Our approach to ascertain the similarities in the
physical properties between the anchor ligands and its corresponding novel ligands considered
the following approaches
• Compare the distribution of the populations of property values of the anchor ligands
with the distribution of the generated ligands. This comparison is standard practice
when evaluating the quality of generated ligands [34,36].
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Table 8.1: Properties of anchor and potentially novel ligands.
Anchor Ligands Novel Ligands t-test
QED Mean 0.69 0.57 t-stat = .99p-value = .35
Stddev 0.20 .22
LogP Mean 3.41 3.43 t-stat = 0.33p-value = .74
Stddev 1.69 1.95
Benzene Rings Mean 3.45 3.12 MW stat = 2.1e7p-value = 4.76e-18
Stddev 1.24 1.33
SAS Scores Mean 2.67 3.18 t - stat = 21.62p-value. = 6.7e-99
Stddev 0.55 0.85
• Additionally, to investigate similarity of generated ligands with their respective anchor
ligand, we evaluated the magnitude of the difference in the values between the ligands
for each of the 4 aforementioned properties. A residual value, which is the difference
between the property values is calculated for each pair of anchor ligand and its corre-
sponding generated ligand. A mean residual is then obtained for each anchor ligand
as described in equation 8.1. The magnitude of the mean residual value was used as a









Rm:mean residual property value for each anchor ligand
N :number unique potentially novel ligands generated for each anchor ligand
pa : property value (QED,LogP,SAS and NumRings) for the anchor ligand
pn : property value (QED,LogP,SAS and NumRings) for nth novel ligand for the cor-
responding anchor ligand.
The QED ranges between 0 and 1. The ligands with higher value indicate that the
molecule is more drug-like. Additionally, the method also claims to capture the abstract
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Figure 8.1: Property Distribution between anchor ligands and generated ligands : (A) Quan-
titative Estimate of DrugLikeness(QED) (B) Partition Coefficient (LogP) (C) Synthetic
Accessability Score (SAS) (D) Number of Benzene rings. The figure demonstrates that
the property distributions of the anchor ligands is similar to the potentially novel ligands
generated from the corresponding anchors across all 4 properties.
notion of aesthetics in medicinal chemistry [89]. We leveraged the python based RDKit
library to determine the QED scores of the generated novel compounds. As illustrated in
Table 8.1, the average QED score of the novel ligands was found to be 0.57. Figure 8.1-
A(i) illustrates the comparison of the distributions of the QED scores from the potentially
novel ligands with their anchors. It can be observed that the two distributions are very
similar. The 2 sample student t-test statistic of 0.99 with a p-value of 0.35 also confirms
that there exists no statistical difference between the two distributions. Table 8.1 tabulates
the mean, standard deviations and t-test scores of all the properties calculated as a part of
our experiments. Additionally, figure 8.1-A(ii) illustrates the similarities of the QED scores
between the anchor ligands and their respective generated ligands by measuring the mean
residual value as described in equation 8.1 . It is evident from the plot that a large number
of mean residuals are less than .1 units. This indicates the QED scores of close to 80% of
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the anchor ligands are within .1 units of their generated novel ligands, and close to 96% of
the anchor ligands have QED scores within .2 units of their generated ligands.
The water–octanal partition coefficient (LogP) was an other property used to quantify
the physical properties of the potentially novel ligands. LogP describes the propensity of
ligand to dissolve in an immiscible biphasic system of lipid (fats, oils, organic solvents)
and water [90]. A negative value for logP means the ligand has a higher affinity for the
aqueous phase(hydrophilic);when logP = 0 the ligand is equally partitioned between the
lipid and aqueous phases; a positive value for logP denotes a higher concentration in the
lipid phase(lipophilic). The potentially novel ligands tended to be more lipophilic with a
mean LogP value of 3.43 with a standard deviation of 1.94. Figure 8.1-B(i) illustrates that
distributions of LogP scores between the novel and anchor ligands. The two distributions
appear to be visually similar and the 2 sample student t-test score of .33 with p-value = .74
also confirms the same. Additionally figure 8.1-B(ii) illustrates the similarities of the LogP
scores between the anchor ligands and their respective generated ligands by measuring the
mean residual score as described in equation 8.1. It is observed that close to 87% of the
anchor ligands have their LogP scores within 1 unit of their generated ligands.
The synthetic accessibility score (SAS), a method that is able to characterize molecule
synthetic accessibility as a score between 1 (easy to make) and 10 (very difficult to make) [91]
was another property that was evaluated for the potentially novel drugs generated by our
method. The mean score was found to be at 3.17 with a standard deviation of .85. While the
SAS scores between anchors and their novel ligands appear to be similar visually (8.1-C(i)),
the t-statistic score of 21.62 with p-value=6.7e-99 indicate that the two distributions are
statistically different. Nevertheless the mean score of 3.17 of the potentially novel ligands
indicate that the potentially novel ligands are synthesizable to generate valid drugs. Fig-
ure 8.1-C(ii) further compares the individual SAS Scores between the generated ligands and
their respective anchor ligands. It is observed that 87.3% anchor ligands have SAS Scores
within 1 unit of the generated ligands. This indicates that an overwhelming majority of
the anchor ligands share similar SAS Scores with their generated novel counterparts. Ad-
ditionally the number of Benzene rings was evaluated as a measure of chemical complexity
of the potentially novel ligands. Figure 8.1-D(i) demonstrates that the complexities of the
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potentially novel drugs are comparable to the complexities of their corresponding anchor
ligands. Figure 8.1-D(ii) compares the similarities in the number of benzene rings between
the anchor ligands with their respective generated novel ligands. From the figure, it is evi-
dent that the distribution of the number of rings do not follow a normal distribution. For
this reason, we conducted the Mann Whitneyu non parametric test [92] to compare the two
distributions. The test yielded a statistically significant difference in the 2 distributions .
however it was observed that approximately 83% of the anchor ligands had the exact same
number of benzene rings as their respective generated novel ligands.
Figure 8.2: Lipinski’s Rule of 5 : Lipinski’s Rule of 5 valuated on the potentially novel
ligands generated from implicit fingerprints. The figure demonstrates that 80% out of the
1,831 potentially novel ligands satisfy 3 or more rules, signifying that the generated ligands
have properties to be an effective drug.
We further evaluated the Lipinski’s rule of 5 (LR5) for all the generated ligands. [93]
The LR5 describes critical properties of a ligand in the human body such as absorption,
distribution, metabolism, and excretion. The rule states that a ligand to be effective for
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therapeutics should have less than 5 hydrogen bond donors, less than 10 hydrogen bond
acceptors, a molecular mass of less than 500 daltons and the LogP less than 5. The LR5 score
was computed for all generated ligands based on [94]. We observed that 68% of generated
ligands completely satisfies the LR5 rule and 22% of generated potentially novel ligands
satisfy at least 3 out of the 4 rules. This is further illustrated in figure 8.2. The percentage
of matches to Lipinski’s rule of 5 signifies that the generated ligands have properties to be
an effective drug.
Now that it is established that the potentially novel and anchor ligands are likely to have
similar and comparable physical properties, we turn our attention to answering whether the
novel ligands are also likely to similarly bind to known targets.
8.2 Binding Affinity predictions of the potentially novel ligands
The biological activities of the potentially novel ligands were evaluated by inferring their
predicted binding affinities with 102 DUD-E protein targets. [95] The DUD-E targets consist
of a variety of proteins exhibiting different mechanism of protein-ligand interactions. The
relationship of bioactivities within the anchor ligand and generated ligands over the DUD-E
targets will highlight the versatility of our model. Thus we used the anchor ligands to test
their binding affinities with the DUD-E targets.
In order to validate the similarities of the binding affinity properties of the novel ligands
with their respective anchors, the binding affinity scores were determined from SSnet and
Smina for the anchor ligands with the 102 DUD-E proteins. Each ligand (anchor and novel
ligands) yielded a distribution of binding affinity scores against each target from the set of
102 DUD-E protein targets. The similarities in the binding affinities of the novel and their
respective anchor ligands were evaluated by comparing the aforementioned binding affinity
distributions. Out of the total 1,332 unique combinations of novel and respective anchor
ligands, approximately 84% demonstrated similar binding affinity behaviors. The similarity
score or the measure of Intersection over Union (IOU) [96], in this exercise is calculated by
evaluating the proportion of DUD-E targets to which both the ligands demonstrate binding or
lack of binding. An SSnet score of 0.5 or less is considered lack of binding, and a score greater
than 0.5 as binding. Figure 8.3 illustrates this for 1,332 unique pairs of novel ligands and
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their anchor ligands. Each data point on the x - axis in figure 8.3 represents a unique anchor-
novel ligand combination. The y-axis represents the Intersection over Union score calculated
between the 2 distributions of binding affinity scores, the first distribution being binding
affinity indicator of anchor ligand with 102 DUD-E proteins and the second distribution, the
binding affinity indicator of the novel ligand with 102 DUD-E proteins. The figure further
illustrates that a large majority of the anchor-ligand pairs exhibit similar binding affinities. A
similar observation was made for Smina shown as Figure S1 by considering ligand similarity
based on -7.5 kcal/mol as a threshold for ploting IOU.
Figure 8.3: Pairwise binding affinity scores : The plot illustrates the similarities in the bio-
activity between each pair of anchor ligands and their corresponding generated ligands to the
102 DUDE protein targets. The large regions of dark blue hue in the heat map demonstrate
a strong co-relation between the binding affinities for most pairs with the DUDE targets.
The scatter plot illustrates two sample pairs, with the top right plot representing a pair with
very similar affinity scores, with the bottom right plot illustrating a pair where the affinities
differ between the anchor and generated ligand.
While there is a high coherence of the scores obtained from SSnet, we further evaluated
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Figure 8.4: IoU scores and the Tanimoto coefficient scores : A) Comparison of the IoU scores
and the Tanimoto coefficient scores between the anchor and generated ligands. : The figure
illustrates that there is no strong correlation between the anchor and generated ligands.
B)Histogram of TC scores across all the pairs : Illustrates the distribution of the similarity
scores between the pairs.
the similarities between the anchor and generated ligands. We calculated the Tanimoto
Coefficient based similarity scores between each pair of anchor and generated ligands. Figure
8.4 plots the IoU scores and the TC similarity scores for each pair. It is evident from the
plot that there is no correlation between the IoU scores and the TC similarities. Despite
the lack of correlation, the high coherence in the binding affinities could be explained by the
scaffold similarities between the anchor and generated ligands. This is further evidenced by
the scaffold analysis using the pseudo-hilbert curve as described in the subsequent section.
The analysis on QED, LogP, and SAS provided an intuitive relationship of generated
ligands and drug-likeliness. However, for a drug to be effective for specific target and show
selectivity among other targets, should preserve the scaffold (core structure of a molecule
[97–99]). To analyze if the generated ligands have similar scaffolds, we sorted all the anchor
ligands by Tanimoto Coefficient (TC). The sorting was performed by recursively finding
next most similar ligand from the anchor ligands starting from a random anchor ligand. The
sorted list was then mapped to a pseudo-Hilbert space filling curve. The pseudo-Hilbert
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Figure 8.5: Scaffold analysis : A pseudohilbert curve is plotted for anchor ligands and
generated ligands. The color denotes SSnet scores. Similarity between anchor and generated
pseudohilbert curves and the low difference among them, signifies that our method retains
scaffolds from the anchor ligands while also predicting similar bioactivities.
curve was used to observe molecular scaffolds directly from the map as pseudo-Hilbert curve
preserves the spatial proximity of the sorted list. The pseudo-Hilbert map for the generated
ligands were made similarly. Each anchor ligands were repeated to the same number of
generated ligands in order to match one-to-one when comparing pseudo-Hilbert curve for
generated ligands and anchor ligands. Figure 8.5a and 8.5b shows the pseudo-Hilbert map
for anchor ligands and generated ligands respectively. The pseudo-Hilbert map is colored
based on the SSnet scores obtained by docking the ligands with the DUD-E targets with
PDB ID 1B9V and 3KBA.
We observe that the clusters are majorly retained for the generated ligands when com-
pared to the anchor ligands. This is further highlighted in Figure 8.5c, that shows the
difference in SSnet scores for generated and anchor ligands. The map is mostly blue which
represents a mere difference of SSnet scores in generated and anchor ligand of less than
0.1. The results highlight that the novel molecules generated preserves the scaffold that is
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essential in protein ligand binding.
8.3 Comparison with FDA Approved Drugs
In order to further hone in on the practical applicability of our methods and the poten-
tially novel drugs generated, we conducted analysis on novel drugs generated on known cancer
related ligands. For this exercise we shortlisted 10 drugs approved for treating various forms
of cancer also available in the ChEMBL23 database. We present detailed analysis of the
potentially novel ligands generated around a known cancer drug, DASATINIB. Sampling
around the implicit fingerprint space of this anchor ligand yielded 10 novel ligands. Fig-
ure 8.6 illustrates the 10 novel ligands. The novelty of the compounds were tested from the
ChEMBL23 dataset (1.4 million compounds) and the ZINC dataset (1.3 billion compounds).
Across the 10 novel compounds, the maximum similarity score were 0.88 for ligands in the
ChEMBL23 dataset and 0.92 for ligands in the ZINC dataset. Table 3(in supporting in-
formation [1]) shows the largest TC obtained for each novel compounds. Interestingly, in
this particular case, we observe that the scaffold for the anchor ligand is retained in most of
the generated ligands. The results are in line with the scaffold analysis performed for the
DUD-E protein targets provided in the previous section (Figure 8.5). Retention of scaffold
is crucial for ligand binding as the protein pocket in general has confined space for docking.
The scaffold provides both size and imperative interactions such as hydrogen bonding, π
interactions etc. that contributes to the stability of the protein-ligand complex.
To test the bioactivities for the novel ligands generated, we sorted 9 known targets for
the anchor ligand, the details of which is provided in Table 2(in supporting information [1]).
We conducted a docking method Smina [100] and a deep neural network based model SS-
net [24] for bioactivity score prediction. Figure 8.7 shows the results obtained by the two
methods. The first five targets are labeled active and the remaining four as inactive for the
anchor ligand used in the ChEMBL dataset. We observe that the generated ligands have
similar Smina scores as the anchor ligands. A similar behaviour is observed when compar-
ing the SSnet scores for anchor and generated ligands. It is important to note that both
Smina and SSnet are sensitive to ligand and their complex interaction with a protein target.
Many factors such as functional group, size of the molecule, molecular weight etc. govern
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Figure 8.6: Novel ligands generated around known cancer drug, DATASINIB : It is observed
that the generated ligands have ring structures similar to the anchor drug compound. In or-
der to further validate if the rings are indeed realistic and ligands pragmatic,we investigated
synthesizability, and like-liness of the ring to bind a protein. Section 0.2.1 from Supporting
Information [1] enumerates information about the novelty and the binding affinities exhib-
hited by these generated ligands.
the bioactivity. The fact that all the 10 novel generated ligands have similar bioactivities
provides evidence that our ligand generation method produces ligands with similar binding
characteristics to the anchor ligand.
We further compared the bioactivities of 6 FDA approved drugs and their corresponding
generated ligands from the implicit fingerprint and latent space generated from the varia-
tional autoencoder (VAE) work from [36] respectively. Each of the 6 ligands were docked
towards their original intended target, the details of which is provided in Table 1(supporting
information [1]). We observe high similarity in predicted bioactivities for implicit finger-
prints compared to the latent space generated from VAE for both the Smina and SSnet
scores shown in Figure 8.8 (Table 5-10) (in supporting information [1], sections 0.2.2 - 0.2.7).
A visual inspection of the compounds generated from our method and the latent space from
VAE [2] shows that both the scaffold of the original anchor ligand (Figure 2-7, supporting
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Figure 8.7: SMINA scores for generated ligands around DATASINIB : Sample test on various
active/inactive targets for anchor ligands. The first 5 targets 2FO0, 1PKG, 1AVZ, 1GQ5
and 1MQB are active and the rest inactive. The red color denotes the anchor ligands and
the black denotes generated ligands respectively.
information [1] section 0.2) and generated ligands are similar. However, bioactivity is sensi-
tive to small changes in the chemical structure such as a functional group. Our method is
perceptive towards functional groups due to the way collaborative fingerprints was modeled,
i.e. by considering the bioactivities.
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Figure 8.8: Comparison with Variational Autoencoder based fingerprints : Comparison of
Implicit and latent fingerprints on FDA approved drugs and their corresponding targets. The
red color denotes the anchor ligand and the black color denotes generated ligands respectively.
The latent label and implicit label shows the binding affinities for generated ligands from
the method developed by [2] (in blue) and our method (in green).
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Chapter 9
CFGenNets for Image Generation
Introduction
Research Aim 1, outlined in the previous chapters demonstrated that implicit fingerprints
capture ligands and proteins in a shared latent space, typically for the purposes of virtual
screening with collaborative filtering models applied on known bioactivity data. Research
Aim 2 further extended this concept and introduced the concept of CFGenNets, a novel
generative deep learning algorithm that could not only reconstruct the original ligands but
also generate novel ligands from the implicit ligand fingerprint space. Our third and final
research objective as a part of this thesis involves evaluating the abilities of CFGenNets
to generate images with implicit image fingerprints derived from the corresponding image
meta data. That is, we seek to evaluate our generative methodology in a new application
area—images. The recent years have seen rapid advances in the domain of caption to image
generation [72,101–104]. These methods attempt to generate realistic images that match the
captions semantically. In this aim, we propose to generate images, however from a structured
set of attributes describing the images, as opposed to the unstructured natural language text.
Such a function could have meaningful applications in areas such as image manipulation and
gaming. For example, Open AI unveiled DALL-E [105], which was trained to generated im-
ages from unstructured text. DALL-E demonstrated the creation of novel objects in images
by combining unrelated concepts, e.g., an armchair shaped like an avocado. Going beyond
these, the creators of DALL-E also demonstrated more practical applications such as im-
age manipulation by generating shadows of objects within images, fashion design, and more
generally product design and conceptualization (e.g., conceptualization of spaces by merely
controlling the caption to generate relevant images). While we are focused on structured
sets of attributes as opposed to unstructured caption text, with this aim we investigate the
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applicability of CFGenNets to provide a framework where the user can manipulate synthetic
images by altering structured attributes (e.g., keywords). Hence, in theory some of the same
applications described above in the context of caption to image generated are applicable to
CFGenNets based image generation capabilities. In general, image understanding and rep-
resentation are thriving research communities and our methodology may have informative
and interesting contributions that complement existing theory.
9.1 Motivation for Image Synthesis
While the previous chapters described in detail the applications of CFGenNets in the
field of ChemInformatics to generated novel drug compounds, there is still a need to eval-
uate the cross domain applicability of CFGenNets. In this context, the domain of image
synthesis, which aims to generate images given a set of descriptors is naturally aligned to
the application of CFGenNets. The images with their shared descriptors can be described
in a tabular form, with the rows representing images and the columns representing the at-
tributes. Once in this form, the tabular data is conducive to the application of collaborative
filtering to generate latent representations of the images. While technically, the domain of
image synthesis is conducive to the application of CFGenNets, there also exists practical
applicability as evidenced by the recent research trends in the field of image synthesis.
9.1.1 A Primer on Related Work in Image Synthesis
The recent years have seen tremendous progress in the field of deep learning based im-
age synthesis and manipulation using generative neural networks. The Variational Autoen-
coders [67] (VAEs) are a class of generative models that attempt to learn the underlying
distribution of the data to decipher how the data is generated. It aims to identify the un-
derlying distribution of the data which allows for sampling to generate new data, or images
in our case. The traditional VAE uses and encoder and decoder pair of neural networks
(typically convolutional). The encoder reduces dimensionality and is designed such that the
reduced dimensionality space can be sampled from to produce images. In general, VAEs are
designed with a loss function that simultaneously reduces error between the image input and
the reconstructed image, while also keeping the latent space samples normally distributed.
This is typically achieved by placing a KL-divergence constraint for Gaussian samples in
74
the latent space through the loss function. Several works have attempted to deploy VAEs
and their variants to obtain neural embeddings on celebA datasets and manipulate the la-
tent spaces to generate novel synthetic images. [106] demonstrated the use of VAEs not
only to reconstruct the original images, but also to extract features correlated to binary
labels in the data. Their model, the Conditional Subspace VAE (CSVAE) [106], used mu-
tual information minimization to learn a low-dimensional latent subspace associated with
each image attribute, that could be easily interpreted and also used for image manipula-
tion. Li et al. [107], introduced Latent Space Adversarial Auto Encoders, where the latent
space from the autoencoders are mapped into a style space and an attribute space. The
former represents attribute-irrelevant factors, such as identity, position, illumination and
background, etc. The latter represents the attributes, such as hair color, gender, with or
without glasses, etc, of which each dimension represents one single attribute [107]. Yan et
al. [108] investigated the problem of image generation by modeling images as a composite
of foreground and background. They developed a model with disentangled latent variables
using VAEs called disentangled Attribute-Conditional generative models. Their model re-
lied on interpreting an image as a composite of a foreground image and background image
combined via a gating function with the model training process aimed at learning the latent
representations of the background and foreground images. Cai et al. [109] extended the
concepts of VAEs by producing Multi-Stage VAEs where the decoder is divided into 2 com-
ponents where the second component generates refined images based on the course images
generated by the first component. They decoupled the second component from the VAEs
which allows other loss functions beyond the MSE based loss function typically employed in
VAEs. Razavi et al. [110] introduced VQ-VAEs , or Vector Quantized VAEs which builds
on the ideas of lossy compression in techniques such as JPEGs [111]. Their argument stems
from the idea that it is possible to remove more than 80% of the data without noticeably
changing the perceived image quality. They compress images into a discrete latent space by
vector-quantizing intermediate representations of an autoencoder. In their version of VAEs,
the encoders output discrete encondings instead of continuous vectors using the concepts
of vector quantization [112]. Besides VAEs, the Generative Adverserial Networks (GANS)
have also been prominently used for image synthesis and generation in the recent past. As
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a framework of generative model, Generative Adversarial Net (GAN) [113] aimed to gen-
erate better synthetic images than previous generative models, and has become a popular
research area. A Generative Adversarial Net consists of two neural networks, a generator
and a discriminator, where the generator tries to produce realistic samples that fool the dis-
criminator, while the discriminator tries to distinguish real samples from generated ones [72].
This methodology has progressed dramatically in the past decade such that many generated
images are quite realistic. As mentioned earlier, the GANs leverage discriminator network is
trained to tell apart the synthetic data from the real examples. The difference between the
synthetic and the real examples determined during each step of the training process produces
a gradient that guides the learning of the two networks. The recent years have seen a number
of enhancements to the core idea proposed by Goodfellow et al. [72]. For example, Hjelm
et al. [114] proposed Boundary Seeking Generative Adversarial Networks, to handle discrete
settings by means of a policy gradient for training the generator which is informed from by
the estimated difference measure from the discriminator to compute importance weights for
generated samples. Mao et al. [115] proposed the adoption of L2 loss function as an effective
measure to overcome the saturation problem in GANs after exhaustive experiments on large
image datasets. Zhao et al. [116] proposed Dual-Agent GANs, where they employed an off
the shelf 3D face model as a simulator to generate profile face images with varying poses.
They specifically attempted to address the problems associated with the unbalanced distribu-
tion of poses in available face recognition datasets. They employed teo discriminators that
the generator played against — the real-fake discriminator and an identity discriminator.
Additionally, Mirza et al. [117] proposed the conditional version of GAN, with condition on
both the generator and discriminator for effective image tagging. Berthelot et al. [118] pro-
posed Boundary Equilibrium GAN (BE-GAN) framework where they leveraged Wasserstein
distance loss for controlling the trade-off between image diversity and visual quality.
Some of the more seminal works in the space of image synthesis is in the domain of
Neural Style Transfer. Gatys et al. [119] successfully demonstrated that the neural networks
can encode both the content and the style information of images and that it was possible to
separate them. Huang et al. [120] enhanced the optimization process to enable a real time
style transfers by introducing Adaptive Instance Normalization technique. They modified
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the concepts of Instance Normalization where they align the channel-wise mean and variance
of the content input to that of the style input. The Adaptive Instance Normalization involves
removing the style information from the content image by normalizing and performs style
transfer to the content image by transferring feature statistics, specifically the channel-wise
mean and variance from the style images to the content images. In this technique the affine
parameters are not learnt but adapts the affine parameters from the style input. Karras et al.
[121], motivated from style transfer literature redesigned the generator architecture to control
the image synthesis process. They introduced a nonlinear mapping network to generate an
intermediate latent space, which provides the style information to enable Adaptive Instance
Normalization. With GANs as their foundation, another notable advancement is Stack GAN
[122], which consisted of two stages of GANs, with Stage One producing the basic shapes for
images at relatively low resolution. This is further enhanced by Stage Two GANs, which add
realism and resolution to the base images. For this task, the latent space cannot simply be
random, but must be discovered from the image caption used to generate the image. To this
end, recent years have also seen the advent of Recurrent Adversarial networks to map natural
language input to visual images [123]. In this work, recurrent networks are used to transform
captions into a latent encoding and this encoding is used to reconstruct an image. This is
a similar process to adversarial auto encoding [124], except that the input is a sentence,
not an image. Further, alignDRAW [125] was another mechanism that leveraged Recurrent
neural networks in lieu of Convolutional Networks to generate images using soft attention
mechanisms. Similarly, Zhi et al. introduced PixelBrush [126], a tool to generate art from
text description from human written descriptions using Skip-thoughts text embedding (a
popular form of sentence embedding). PixelBrush used Generative adversarial networks to
produce artistic images conditioned on human-written descriptions. Skip-thoughts were used
for text embedding of 4800 dimension and conditional generator and discriminator network
for generating images [126].
The recent popularity in the field of image synthesis, as evidenced by the continuous
stream of novel research, and the natural alignment of the problem statement to Collabora-
tive filtering for generating the latent image vectors, serve as motivation for us to choose this
as an application to evaluate the cross domain applicability of CFGenNets. By illustrating
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the versatility of the CFGenNet algorithm to a popular research field, we hope to maximally
impact the research community of our peers. Our contribution, therefore, can be thought of
as the first work to investigate the use of collaborative filtering with generative deep learning
analysis. We hypothesize that the latent space learned by collaborative filtering offers unique
qualities that previous works have had difficulty achieving. We therefore explore the space
of image synthesis with our CFGenNet algorithm, and manipulate the algorithm to better
represent images.
9.2 Methodology
We adopted the following steps in order to investigate the applicability of CFGenNets
for Image synthesis:
• Constructing a matrix to represent the images from the data and their respective
attributes. Here the rows represent each image, while the columns represent the entire
set of distinct attributes that capture key aspects and/or objects contained within the
images.
• Performing collaborative filtering on the said matrix to derive the implicit image fin-
gerprints for each image. We hypothesize that this implicit latent space will have more
utility in synthesizing images, similar to our findings in virtual screening.
• Training a decoder with convolutional layers to generate the images from their corre-
sponding implicit image fingerprints.
This methodology is similar to that employed in CfGenNets for drug discovery, but using
images and image attributes to train the collaborative filtering algorithm. Later on, we will
show that using this base methodology produces good, but not great, image reconstructions.
Therefore, we combine our methodology with VAEs to produce more photo-realistic images
(discussed later).
9.2.1 Dataset details
We leveraged the CelebFaces Attribute Dataset (CelebA) [3] for our evaluation of CF-
GenNets for Image processing. CelebA is a large dataset with around 200k celebrity images
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with 40 attributes describing the facial features found in the images. The images in this
dataset cover large pose variations and background clutter. Figure 9.1, reproduced from
the original article [3] in this paper for easy reference, illustrates the a sample set of images
and the attributes associated with them. In order for us to be able to apply collaborative
filtering algorithm on the dataset, we recast the CelebA faces dataset in terms of a large
matrix consisting of 200k rows, each row representing one image and 40 columns, with each
column representing the facial attribute descriptors. Figure 9.2 illustrates the matrix with
two sample images.
Figure 9.1: Sample Images from CelebA dataset. Reproduced from the original article [3]
here for easy reference.
9.2.2 Collaborative Filtering on CelebA dataset
The next step in our process (once the matrix described in Figure 9.2 is constructed) is to
run the collaborative filtering algorithm. In our dataset, there are 200,000 rows (one for each
image) and 40 columns (one for each image attribute). We leveraged the same set of steps
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Figure 9.2: CelebA dataset recast as a matrix with each row representing one image from
the dataset and the columns representing the attributes described for the image.
as described in Chapter 3 to generate two sets of fingerprints. One set of fingerprints for the
images called Implicit Image Fingerprints and another set of 40 fingerprints representing the
40 attribute descriptors. We chose the latent representation to be 500 dimensional for the
collaborative filtering. Thus, the fingerprints are continuous vectors of size 500 dimensions.
9.3 Analysis of Implicit Fingerprint
As described in the previous section, our method generates implicit fingerprints for images
and the 40 features that describe the images. By definition of collaborative filtering, as
outlined in Chapter 2, the implicit image and the feature fingerprints share the same latent
space. For visualization, we reduced the dimensions of the implicit fingerprints from 500
dimensions to 2 dimensions using the t-SNE [61] algorithm. The t-SNE algorithm attempts
to retain the same mutual distances of the data points even in a lower dimensional space.
Figure 9.3 illustrates the images and the 40 features in a reduced 2 dimensional space. It
can be seen that the features and the images share the latent implicit fingerprint space with
the features interspersed amidst the images. In this way, one could reduce an image into this
latent space or construct a set of 40 attributes for an image and map into the same latent
space. This property is key to understanding why the collaborative filtering latent space
might be advantageous compared to other methods—the shared latent space might allow
for increased understanding because we can “probe” values from the image attributes or the
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image itself.
Figure 9.3: Representation of the implicit image and feature fingerprints in a 2 dimensional
space using t-SNE algorithm. The images and the features both share the same latent space,
with the features interspersed amidst the images.
We further evaluated the predictive powers of the implicit image fingerprints for the
task of Facial Attribute Recognition, ie facial attribute prediction. We trained a multi-class
classifier using a neural network with fully connected layers. The input to the network
was the continuous implicit image fingerprints and the network was trained to predict the
presence or absence of 40 facial attributes contained in the respective images. We used 160k
images for training the network with 40k images as the validation set. The results of the
training is illustrated in Figure 9.4. One can think of this classifier as a “reverse encoder” for
the latent space. That is, it maps from the latent space back to the 40 dimensional image
attributes. By performing this classification, we can further understand if the latent space
is converged and reliable at separating images with similar attributes.
The classifier was trained to minimize the binary cross entropy loss and we measured
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Figure 9.4: Performance Metrics of facial attribute prediction classifier trained on the implicit
image fingerprints.
the accuracy and the precision of the predictions. We see the classifier performing with very
high accuracy and precision, both hovering around 99%. This indicates that the implicit
image fingerprints indeed encode the information on the distinct facial attributes contained
in the images. We hypothesis that these patterns encoded in the implicit fingerprint space
would enable the CFGenNet decoders for images learn the patterns in order to reconstruct
the original images.
9.3.1 Implicit Feature Fingerprints
As we described earlier, the collaborative filtering exercise produces latent encoding for
both the images and the 40 facial features/attributes that describe the images. The latent
space encoding of the facial features or the Implicit Feature Fingerprints also share the same
latent space as the images. This is property is also captured in the figure 9.3, where we see
the features interspersed with the images in the reduced 2-dimensional implicit fingerprint
space.
We further analyzed the abilities of the Implicit Feature Fingerprints to be able to suc-
cessfully predict the corresponding facial attribute. We used the classifier trained on the
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Figure 9.5: The hash map illustrates the abilities of the Implicit Feature Fingerprints to
predict the presence of respective facial descriptor attributes in the images.The Implicit
feature fingerprints generate accurate predictions even though they are fed into the classifier
trained solely on the Implicit Image Fingerprints. This is possible because the features and
images share the same latent fingerprint space when generated via Collaborative Filtering.
Implicit Image Fingerprints, described in the previous section, to generate the predictions
using the Implicit Feature fingerprints. The implicit features were able to predict with close
to a 100% accuracy. Figure 9.5 further illustrates the predictions from the implicit feature
fingerprints. The rows in the figure represent the fingerprint vectors for each of feature and
the columns represent each facial attribute. The cell at the intersection of the rows and
columns is representative of the prediction generated from the Facial Attribute classifier.
As is evident from the hash map, the implicit feature fingerprints encode information about
the attributes they represent. In addition, they also encode information on other correlated
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attributes. For example, we notice that the fingerprint for ’Wearing Makeup’ predicts with
high confidence the presence of other facial attributes such as attractive, wearing lipstick,
arched eyebrows, and female. While wearing makeup does not necessarily indicate these
other attributes, the CelebA dataset clearly has correlations that reflect these similarities.
As illustrated in Figure 9.5, the Implicit Feature Fingerprints predict the presence of respec-
tive facial descriptor attributes in the images with very high accuracy. The Implicit feature
fingerprints generate accurate predictions even though they are fed into the classifier trained
trained solely on the Implicit Image Fingerprints. This is possible because the features and
images share the same latent fingerprint space when generated via Collaborative Filtering.
9.3.2 Conclusion
In this chapter, we introduced the concept of CFGenNets for image processing and de-
scribed in detail the data set used and the methods applied to generate the implicit finger-
prints. We also presented the analysis conducted on the predictive powers of the Implicit
Image and Feature fingerprints. Given the predictive capability of the implicit fingerprints,
we are comfortable moving forward with additional analyses to produce images from the
implicit fingerprints. We describe our experiments to around building CFGenNets for image
generation in the subsequent chapter.
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Chapter 10
CFGenNets for Image Generation : Architecture
In this chapter, we extend the utility of CFGenNets to the domain of image generation.
We explore the abilities of CFGenNets to reconstruct images from their implicit fingerprint
space. The previous chapter described the methods adopted to generate the implicit image
fingerprints. In this chapter, we describe in detail the experiments conducted on CFGenNets
for image generation and synthesis.
10.1 Decoders to generate images
While it is observed that the implicit fingerprints for Images encode attributes and fea-
tures of the images in the latent space, we propose the usage of the fingerprints to reconstruct
the corresponding images. We believe this can form the foundation for enhanced applications
such as generation of synthetic images and image manipulation by manipulating the corre-
sponding implicit fingerprint space. Unlike the previous related works described in Chapter
9, in our research, we start from the latent space obtained from collaborative filtering instead
of generating the latent space from a network that has processed images in some form. The
subsequent sections describe our network architecture and the results. Additionally, we also
demonstrate in subsequent chapters that the Implicit Feature Fingerprints obtained from
Collaborative Filtering itself encodes the style information along with the Implicit Image
Vector encoding the content information, thereby providing a framework for image manipu-
lation.
10.2 Decoder Architecture
From our experiments outlined in the previous chapter, it is evident that the implicit
fingerprints from collaborative filtering encapsulate certain aspects of the underlying images
and the features that describe the images. Here, we design deep neural networks to decode
the implicit image fingerprints and map back to the original image. Recall that the implicit
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Figure 10.1: CFGenNets architecture for generating images from implicit image fingerprints
generated from collaborative filtering.
fingerprints of the images are continuous vectors that represent the images in a space with
500 dimensions. This is fed as an input to our custom decoder which consists of a series of
fully connected layers followed by a variant of two dimensional convolution layers. These
layers up-sample the image and provide details based upon the latent space representation.
Ideally, the images would look perceptually similar to their original forms.
As outlined in the CFGenNets for drug discovery in the preceding chapters describing
Aim 2, we adopt a mechanism of input data augmentation. Similar to our previous work
in ChemInformatics, this is done to avoid the latent space from being sparse. We perform
data augmentation by adding randomness to the input layer of the neural network. This
stochastic noise added to the decoder input ensures that the decoders learn to decode from
a wider variety of latent points to find more robust representations. This is similar to
the process by which Variational Autoencoders (VAEs) sample in the latent space before
reconstruction. Our network consists a series of fully connected layers processing the input
implicit image vector followed by convolution layers to upscale the dense representations
and map to valid images. The up-sampling operation performed was evaluated with two
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competing convolutional techniques that are each common in generative deep learning with
images (discussed more in the next section). The general flow of the process is shown in
Figure 10.1.
Figure 10.2: CFGenNets for Images : Network design using transpose convolution operations
and bi-linear upsampling.
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10.2.1 Convolution Layer Design
Convolution layers are standard components of neural networks that deal with images.
The convolutional layers facilitate representational learning, a method that aims to learn
relevant features for a given task without manual feature engineering. In the context of image
related tasks, convolutional networks exploit the facts that nearby pixels in any given image
are likely to be strongly related compared to farther pixels, and that objects represented in an
image are made up of smaller parts. The convolutional network uses filters, which are moved
from the top left of the image to bottom right using a standard two-dimensional convolution
operation. Each point on the image is represented in the filter by a value calculated by the
convolutional operation. The convolutional operation typically results in down-sampling,
i.e., the spatial dimensions of the output layer is lesser from the input layer. However,
for our purposes of producing an output image of dimensions 128x128 from a dense input
vector of 500 dimensions, we apply the filters as a means of up-sampling operations in the
neural networks. That is, the learned filters in the network function as image interpolating
filters. The up-sampling operations can either be conducted via interpolation such as bi-
linear interpolation or transposed convolution [127] methods. In bi-linear interpolation, the
input to the convolutional layer is doubled in size using bi-linear interpolation and then filters
are learned that smooth out this interpolation process and add detail. Bi-linear interpolation
also is one of the re-sampling techniques used in computer vision and image processing
applications [128]. The bi-linear interpolation extends the concepts of linear interpolation
in the 2 dimensions. It is basically a method of curve fitting using linear polynomials to
construct new data points within the range of a discrete set of known data points. Several
recent works in the realm of deep-learning based image processing applications [129–132]
have successfully demonstrated the viability of simple interpolation techniques as opposed
to parameter learning methods for up-scaling images.
In the transposed convolution methods [127], the network attempts to learn the most op-
timal method of up sampling by parameters that are learnt during the training process. This
is similar to adding “zeros” on the rows and columns of the input and then the convolutional
filter learns to interpolate these “zeros” to add detail to the image. The deep convolutional
generative adversarial networks (DCGAN) [102] successfully employed the transpose convo-
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lutional operations to generate images from random sampled values, following which several
variants of generative adversarial networks employed similar approach. The application of
transpose convolution can also be found in the image based variational auto encoders [109],
where convolutional layers are deployed to extract features in the encoder and then decoders
restore the original image size by applying transpose convolution operation.
We experimented using both variants (bi-linear and transpose convolution) in our de-
coder. We present the details of the experiments conducted and the results obtained. Figure
10.2 shows the architecture employed for each convolutional layer type investigated.
10.3 Results
We performed extensive training and validation of the CFGenNets with the continuous
implicit image fingerprint vector as the input and corresponding image as the output. We
measured the outcome of the models by evaluating the mean square error loss and the
reconstruction accuracy. For images, reconstruction accuracy is the percentage of pixels that
match exactly with the original image, which is a commonly reported evaluation metric. As
a part of training, we explored a variety of architecture options with respect to the depth and
the width of the deep learning model, include the two variants of up-sampling - transpose
convolutional operations and bi-linear interpolation up-sampling. In order to compare the
performance of CFGenNets across the 2 up sampling methods, we trained the two variants of
the neural networks as illustrated in Figure 10.2 on a sample set of randomly selected 10,000
images and their corresponding implicit fingerprints. Figure 10.3 illustrates the performance
metrics from the two models after training for 300 epochs. As is evident, the MSE loss of the
2 networks are quite comparable, hovering around .01. The reconstruction accuracy of the
networks the end of 300 epochs is a 76% and 75.5% for network with transpose convolutions
and bi-linear interpolation, respectively.
While the quantitative metrics of the two variants were very comparable, we also qualita-
tively evaluated the output of the models with visual inspection. A sample of output images
is presented in Figure 10.4 for illustrating the nature of outcomes from the two networks in
comparison with the original images. We observe that both pairs of images, from transpose
convolutions and up-sampling methods can generate clean images that are clearly human
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Figure 10.3: Performance metrics across the 2 networks trained on celebA dataset. After
100 epochs, the network encompassing transpose convolution layers has a lower mean square
error and higher reconstruction accuracy.
faces. The images have preserved the overall face and object structures, however we also
notice that the images are blurry and not sharp. As discussed above, our network aims to
minimize the per pixel reconstruction loss between the input and output images. We hy-
pothesize this effect to be similar to prior works with generative image models [133], where
the images tend to get sharper when trained to minimize the feature reconstruction loss as
opposed to the pixel reconstruction loss. However, we observe that CFGenNets for Images
are indeed able to generate output images consistent with their respective inputs with reason-
able and perceivable facial features and backgrounds. For some images, the reconstructions
appear “more generic” than the input image. That is, the output appears to have lost some
of the distinct facial structures and the head pose appears straighter toward the camera.
Mouth shape sometimes appears distorted, but eyes tend to take the same position as in the
original images. Both the networks were able to map the implicit image fingerprints obtained
from collaborative filtering back to the original image with approximately 75% accuracy and
little difference between each method can be observed. In summary, blurring appears to be
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the most noticeable artifact, as well some replacement of specific facial features with more
“general” facial features—however, the essential aspects of the images like face shape, mouth
and eye position, are captured observably well.
An additional set of images are presented in Appendix A12.3.
Figure 10.4: A small sample of generated images in comparison with the original images.
Appendix A12.3 contains a larger sample of images generated from CFGenNets.
In order to evaluate if the models are indeed generalizable, we trained the CFGenNet
variant with transpose convolution layers on the entire dataset of 200k images, with 80%-20%
train and test split for 100 epochs. Figure 10.5 illustrates the performance of the network in
terms of the mean square error loss and the reconstruction accuracy. The mean square error
for this network was found to be hovering around .03 with image reconstruction accuracy
around 75%. We note that there is some flattening of the performance on this large dataset,
but the y-axes are considerably Zoomed, so performance remains relatively constant. As
for the computational time, the models were built using the Keras library with Tensorflow
91
backend. It took approximately 24 hours to train models for 100 epochs. During testing, it
took approximately .01 seconds to process a single image of dimensions 128X128 thru the
network. These training and test times are benchmarked on the standard compute nodes
on the SMU Maneware systems,consisting of 36 cores, 256 GB of memory, and 100 Gb/s
networking.These nodes contain dual Intel Xeon E5-2695v4 2.1 GHz 18-core “Broadwell”
processors with 45 MB of cache.
Figure 10.5: CFGenNets for Image generation : Performance metrics at the end of 100
epochs on the final model trained on 160k images and evaluated on 40k images.
10.3.1 Limitations and Next Steps
In this chapter, we demonstrated the abilities of CFGenNets to be able to generate images
from the implicit fingerprints obtained from collaborative filtering. We observed that the
network was indeed to able to reconstruct the images with 75% accuracy and low mean
squared error. The manual inspection also demonstrated the ability to visually perceive
the output when compared with the original image. While the outcomes affirm the original
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research objective, i.e., to evaluate the applicability of CFGenNets in image generation, we
also note that the output quality of the images could be better, potentially with additional
hyper parameter tuning and tweaks to model architecture. In the next chapter, we explore
this further, conducting additional experiments to evaluate how the CFGenNets trained
on implicit fingerprints compares with traditional variational autoencoders using a similar
architecture and trained on the same dataset splits. The details of the experiments conducted
and results obtained are outlined in the subsequent chapter.
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Chapter 11
CFGenNets and Variational Autoencoders
We demonstrated the abilities of CFGenNets to reconstruct original images from Implicit
image fingerprints obtained from collaborative filtering in the previous chapter. We observed
that the reconstruction accuracy was approximately 75%. The outcomes validate the hy-
pothesis that the implicit fingerprints indeed capture large aspects of the underlying images
which allow for image reconstruction,—however there is still considerable room for improving
the quality of reconstructed images. In particular, the implicit fingerprints exhibited strong
blurring and other image artifacts. In comparison with other popular generative frame-
works, we note that CFGenNets are different from Variational Autoencoders(VAEs) [67] or
Generative Adversarial Networks (GANs) [72] where the original images are leveraged in
the generative process. In this chapter, we compared the outcomes from CFGenNets with
another generative network, Variational AutoEncoders [67]. We describe the details of the
experiments conducted and the reasoning behind our choice of networks for comparision with
CFGenNets in the next section.
11.1 CFGenNets and Variational Autoencoders
Typically generative models such as Variational Autoencoders [67,134] are trained with a
given dataset, and are used to generate data having similar properties as the samples in the
dataset. VAEs learn the internal essence of the dataset and “store” all the information in the
limited parameters(latent features) that are significantly smaller than the training dataset.
Notwithstanding the inputs, we deem VAEs to be comparable to CFGenNets due to some
commonalities. For instance the CFGenNet is essentially the same as the decoders in VAEs.
The only difference being, in VAEs, the latent space is learnt from training and is constrained
to resemble a standard normal distribution with mean of 0 and standard deviation of 1.
While there are several variants of variational autoencoders introduced by researchers in the
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field in the recent past, we limit our study to comparing the latent space encoded by “plain
variational autoencoders” or often referred to as “vanilla variational autoencoders.” In the
context of image reconstruction via plain VAEs, the network aims to minimize pixel-by-pixel
mean square loss between the original image and the reconstructed image. We deem this
as appropriate for comparative studies considering the same loss is leveraged for training
CFGenNets, as described in the previous chapter. We note that all references to VAEs
in the context of the experiments we describe in this thesis refer to the VAEs trained to
minimize the per pixel reconstruction loss. In our experiments, we investigate a composite
neural network that uses the VAE representation and implicit representation to construct
an image. We theorize that the composite network can better use the implicit fingerprints
for image attributes, while using the image representation to fine tune the generated images
with information that is not captured by the implicit fingerprint.
Additionally we also trained a composite CFGenNet decoder that intakes the implicit
image fingerprint from Collaborative filtering and the latent image vector obtained from
variational autoencoders. Figure 11.1 illustrates the network architecture for composite
CFGenNet decoders. As illustrated in the figure 11.1, the composite CFGenNet decoder
takes two vector inputs, the latent vector obtained from Variational autoencoder (trained
on the image data) and the Implicit image fingerprints obtained from collaborative filtering.
These inputs feed in parallel to a series of fully connected layers and are averaged to obtain
an “aggregated latent space” encoding information. The network is trained to minimize the
mean square with the original images. The intuition behind the network is to augment
the latent space obtained from variational autoencoders with the implicit image fingerprints
from collaborative filtering to improve the reconstruction accuracy of the images. We also
hypothesize that the network can separate its usage of the latent spaces in a way that general
attributes are more influenced by the implicit fingerprints and other variables that are not
encoded in the image attributes are “offloaded” to the VAE encoding. This dichotomy of
latent representation encourages the model to learn disentangled latent variables. However,
there is some redundancy between the implicit fingerprints and the VAE, so its unclear
exactly how the latent space will be represented.
Figure 11.2 illustrates the technical metrics obtained by training the Variational autoen-
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Figure 11.1: Composite CFGenNet decoders Architecture: These decoders consume the la-
tent fingerprints from Variational Autoencoders and Collaborative Filtering as inputs. These
are eventually averaged in the network to obtain the corresponding image.
coder and the composite CFGenNet decoders. The figure also plots metrics obtained by
training the CFGenNets for purposes of comparison. As evidenced in the plot, the com-
posite model trained with the encoding obtained from VAEs and collaborative filtering has
the best performance out of the three models. We observe that the reconstruction accuracy
for the CFGenNet model is at 75% and the plain VAE model at 81% while the composite
CFGenNet decoder model demonstrated a reconstruction accuracy of 84%.
While the technical metrics indicate better outcomes in the composite CFGenNet de-
coder, we also visually inspected the outcomes to validate the results. Figure 11.3 illustrates
a set of random images generated from each of the 3 networks presented side by side. We
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Figure 11.2: VAEs v/s vanilla CFGenNets v/s Composite CFGenNets: a random sample of
images processed via 3 different types of networks. The reconstruction accuracy is highest
for the Composite CFGenNet Decoders. They take advantage of the information encoded
within the latent spaces generated by Variational Autoencoders and Collaborative Filtering
notice that the images generated by the composite decoder are a better quality compared
with the other two models. While both VAEs and Vanilla CFGenNets generate clean images,
the image details are blurred and in some cases slightly distorted, as similarly described in
the previous chapter for CFGenNets. While the details and structures of images are pre-
served, the images are not as sharp as their input counterparts. However, we notice that in
the case of the composite CFGenNet decoders, the images are comparatively sharper and
more consistent. The faces also have much clearer noses, eyes, and other features, besides
maintaining the background and foregrounds. As observed in figure 11.3, the images, we
note that the VAEs maintain the image structures and the backgrounds reasonably well.
This can be especially well perceived in the 2nd and the 5th images in the set of images on
the left side. For example, the red background in 2nd image is well maintained in the VAE
ouput, while the details of the red color are not fully captured by CFGenNets. However we
notice that the details of the facial features considerable sharper in CFGenNets as opposed to
VAEs. This phenomenon can again be observed in the 2nd image on the left most section in
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Figure 11.3: VAEs v/s vanilla CFGenNets v/s Composite CFGenNet Decoders : a random
sample of images processed via 3 different types of networks. Visually, it is evident that the
outcomes from the Composite CFGenNet Decoders are more aligned to the original image
then the other 2.
Figure 11.3. We notice that the output from the Composite CFGenNets takes advantage of
both these qualities from the VAEs and Vanilla CFGenNets to produce better quality images
than their individual counterparts. In summary, visual inspection reveals that combining
the two latent representations is helpful and reduces many of the “generic” artifacts caused
by the CFGenNet model. Moreover, compared with the Vanilla VAEs, the combined model
reduces many ringing artifacts around edges that would typically be observed in wavelet
compression.
11.1.1 Visualization of latent vectors
The results presented in figure 11.3 indicate better reconstruction in the images gener-
ated by the Composite CFGenNet decoder. We further analyzed the latent representations
from VAEs and Implicit fingerprints to validate if the better outcomes of the Composite
Decoders is truly because of the complementary nature of the information contained in the
two encodings. In this analysis, we visualized the images based on the similarity of their
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latent representations. Here we define similarity by their L2-Distance in the latent space. We
randomly chose 400 images from the data set and reduced both their latent encoding from
VAEs and Implicit fingerprints into two dimensional space using the t-SNE [61] algorithm.
The t-SNE method preserves higher dimensional space distances such that images having
similar encoding in the higher dimensions are similar to one other in the two dimensional
t-SNE space as well.
Figure 11.4 and Figure 11.5 illustrate the two sets of images. In each Figure, “more
similar” images are positioned closely on a 2-D plane. We observe that in Figure 11.4,
images having similar backgrounds (dark or light) tend to appear together. This is evident
in the contrast in the images appearing the top left of Figure 11.4 versus the images appearing
in the bottom right. Similarly images with similar poses appear together in smaller clusters.
For example, the series of images in Figure 11.4 in the red box all contain images that are
looking to the right, while the set of images in the purple box are all looking to the left.
We can also see a presence of many images with raised hands among the images contained
inside the purple box. From this perspective, the VAE encodings tend to be overpowered by
background color and head pose.
We can contrast this representation with the images in Figure 11.5, where the images
with similar descriptor properties appear together (due to the implicit fingerprints). These
features tend to be more semantic to the face, rather than to the background and head
pose. For example, the series of images under the red box in the first row contain images
of older males with glasses, while the cluster of images enclosed in the green box contain
an overwhelming majority of images with older looking males wearing ties. Similarly the
images under the purple box contain images of females with blonde and straight hair. The
contrast between the two fingerprints in terms of the images that appear together indicate
that the VAE based encodings focus for a large part on the global features of the images
such as backgrounds, poses, etc., while the implicit fingerprints encode attributes describing
the features of the face contained in the image. This further supports our hypothesis that
the two encoding methods are complementary with each other and, therefore, when com-
bined help enhance the output image quality. Thus, we observe that Composite CFGenNet
decoders might be a popular method of image understanding that bridges the advantages of
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collaborative filtering with the less structured attributes in VAEs.
11.1.2 Conclusion
In this chapter, we introduced the concept of Composite CFGenNets Decoder which
leveraged the latent encoding from Variational Autoencoders and Implicit Fingerprints from
Collaborative Filtering. We observed the benefits in terms of better image reconstruction on
Composite CFGenNet decoders. We also analyzed the two latent encodings to help explain
the improved results from Composite CFGenNets. In the next chapter, we extend the Com-
posite CFGenNets to perform image manipulation based on Implicit Feature Fingerprints.
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Figure 11.4: Visualization of 20 x 20 face images based on VAE latent vectors by t-SNE
algorithm
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Image Attribute Manipulations using CFGenNets
One of the more interesting applications demonstrated with latent encoding both in
the domain of image and language is the semantic manipulations performed in the latent
space. For example [135] shows that vector(“King”) - vector(“Man”) + vector(“Woman”)
generates a vector whose nearest neighbor is the vector(“Queen”) when evaluating learned
representation of words. On similar lines (in the domain of image processing), Radford et al.
[102] demonstrated that visual concepts such as face pose and gender could be manipulated
by vector arithmetic. Hou et al. [136] also demonstrated the abilities to perform linear
interpolation between two latent vectors. They also demonstrated how the interpolation
could yield effects of image manipulation. For example transitioning from an image with
short hair to an image with long hair, “without glasses” to “with glasses”. While the results
can be compelling, these dimensions must be found through manual exploration of the latent
space. That is, the dimensions of the VAE representation are uncontrolled and therefore
two different optimizations of the same VAE architecture can result in completely different
structured latent spaces. There have been several recent style based generative models that
have demonstrated abilities to generate realistic yet synthetic images. For instance, recent
result allow for the use of freeform text to manipulate the images. We discuss in detail some
of the recent works in Neural style transfers under the Related Work section in Chapter 9.
In our work, we attempt to perform image feature manipulation using the Implicit Feature
Fingerprints. The subsequent sections describe in detail the steps undertaken.
12.1 Attribute Manipulation using Composite CFGenNet Decoders
We further conducted analyses on the latent implicit fingerprints to evaluate the pres-
ence image manipulation properties. In Chapter 9, we evaluated the shared latent implicit
fingerprint space, where we saw that our method produces two sets of implicit encodings
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- the implicit Image fingerprints that encode the images and the Implicit Feature finger-
prints that encode the 40 individual properties that describe each image. Chapter 9 Figure
9.5 further demonstrated the abilities of the implicit feature fingerprints could accurately
predict the presence of the respective facial descriptor attributes when fed into the "facial
attribute recognition classifier" trained on implicit image fingerprints. Given this context, we
hypothesize that the Implicit Feature Fingerprints encode attribute information that could
be visually perceived when fed into CFGenNets decoders. This sort of an operation could
provide a mechanism to control the specific attribute of the facial images. We describe in
the details of the experiments conducted as an algorithm for easy readability (Algorithm 1
below), in addition to discussing in detail the steps and the results.
Algorithm 1: Attribute Manipulation using Composite CFGenNets Decoder
Step 1 : Function TrainCompositeCFGenNetsDecoder;
CompositeDecoder = model.train(inputs=[LatentVAEFingerprints,
ImplicitImageFingerprints], output = OriginalImages);
Step 2 : Manipulate an image to show ‘Wearing Lipstick’ ;
r = random_image_index;
LV AE = LatentVAEFingerprints[r];
Limp = ImplicitImageFingerprints[r];
feature_index = get_index_of(’Wearing Lipstick’);
Lwearing_lipstick = ImplicitFeatureFingerprints[feature_index];
reconstructedImage = CompositeDecoder.predict(inputs=[LV AE, Limp ]);
manipulatedImage = CompositeDecoder.predict(inputs=[LV AE, Lwearing_lipstick
]);
We hypothesize that the Composite CFGenNet Decoder, described in Chapter 11 pro-
vides a framework to affect such manipulations. In our experiment, we fed as inputs to
the Composite CFGenNet, the latent encoding obtained from VAEs and the desired feature
specific fingerprint to obtain manipulated images as the output. For example, we attempted
to manipulate images to have the facial images “wearing lipstick”— i.e., we utilized the latent
VAE fingerprints of the sample image and the Implicit Feature Fingerprint for the attribute
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Figure 12.1: Image manipulation via Composite CFGenNet decoders : Images are generated
by feeding the latent encoding obtained by VAEs and Implicit Feature fingerprint obtained
from Collaborative Filtering. The first set of images are fused with the feature vector rep-
resenting the attribute ’Wearing Lipstick’ and the second set of images with the vector
representing the attribute ’Smiling’.
“Wearing Lipstick” as the inputs to the Composite CFGenNet Decoder (Figure 11.1). This
results in the input images undergoing the said manipulations. This is demonstrated in
the samples presented in Figure 12.1. The first row in figure 12.1 represents the original
image, while the second row represents the reconstructed image, without applying attribute
manipulations. The third row represents the out images after having undergone the said
manipulations. In Figure 12.1, we observe qualitatively that the output images from Com-
posite CFGenNets are indeed manipulated when the Implicit Feature fingerprints are input
along with the latent encodings from VAEs. We also observe that the degree of manipulation
varies by the feature and the underlying image. Figure 12.1 illustrates a sample of images
that have undergone feature manipulation based on our approach of using the Composite
CFGenNet decoders. The two sets of images are contained in 12.1, the first set of images
are fused with the implicit feature fingerprints representing the attribute “Wearing Lipstick”.
We observe that the presence of lipstick is perceivable in the output images. In fact, we also
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notice that the faces in the first 2 images begin to show feminine features along with the lip-
stick being perceivable. Additionally, we also observe that the faces seem to exhibit presence
of makeup as well. These manipulations of the images to indicate presence of Makeup and
Feminine features are consistent with the facial attribute recognition predictions obtained
from Implicit Feature Fingerprints for the attribute “Wearing Lipstick” in Figure 9.5. Figure
9.5 shows that the attribute recognition classifier for the implicit feature fingerprints for
“Wearing Lipstick”, also recognized the presence of the attribute “Heavy Makeup” and the
absence of attribute “Male.” This is attributed to the fact that these features are highly
correlated in the CelebA dataset. This follows some of the common conceptual relationships
that exist between different facial attributes. As an example, we would assume bald and gray
hair are associated to old people. Additionally, The technical correlated metrics measuring
the correlated in CelebA the dataset have been evaluated and reported by Hou et al. [136].
It is not surprising that we do see effects of such correlated features in the first set of output
images in figure 12.1. The second set of images in figure 12.1 have been fused with the
fingerprints representing the attribute “Smiling.” We notice that the manipulated images in
the second set have pronounced expressions indicating smiles. We also see that these images
retained many attributes from their original counterparts. It could be explained by the fact
that smiling seems to have no correlation with most of other attributes and is a very common
human facial expression, especially in photographs. While we present limited examples in
this section, Appendix 12.3 lists many more examples of image manipulations attempted
via Composite CFGenNet decoders. In general, we observe that the manipulations result in
changed images related to the attribute, but that some combinations of images and attribute
manipulations results in visually anomalous artifacts that are difficult to describe. We there-
fore propose a competing architecture for attribute manipulation in the next section that
also employs VAEs and implicit fingerprints.
12.2 Selective Attributes Manipulation using CFGenNets
The results obtained from the previous section validate that the Implicit Feature Fin-
gerprints indeed contain visually perceivable encoding which, when processed via Composite
CFGenNets, can be used to manipulate the images attributes. We akin each Implicit Feature
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Fingerprint to a ‘style vector,’ encoding specific attribute properties. The composite CF-
GenNets, however, only allow for attribute manipulations of one dimension at a time—i.e.,
the Composite CFGenNets decoder, as described in Figure 11.1, consumes a given image’s
latent VAE fingerprint and an Implicit Image/Feature fingerprint obtained from Collabora-
tive Filtering as its input. In the previous section, we demonstrated the outcomes of fusing
the latent VAE fingerprints and the Implicit feature fingerprints to affect image attribute
manipulations. However, the architecture supported manipulations at only one dimension
at time, as in the case of fusing the image’s VAE fingerprint with either Implicit feature
fingerprint the attribute “Wearing Lipstick” or “Smiling”, but not both concurrently. We
note that it is possible to average the factors for “Wearing Lipstick” and “Smiling” but this
results in images with highly visual and unnatural distortions.
We also observed that the manipulation using the previously proposed method may in-
troduce competing representations. That is, when we manipulate the implicit fingerprint, the
VAE fingerprint remains unchanged. Therefore, encodings that are redundantly described
in the VAE and implicit fingerprint may cause unexpected artifacts. We attempt to ad-
dress this constraint by introducing the Feature Gated Composite CFGenNets architecture,
shown in Figure 12.2. The gating mechanism in the Gated Composite CFGenNets refers to
the mechanism of controlling the exact features that can be fed into the CFGenNets at any
given point in time. In this way, we can combine the VAE and original implicit fingerprints
into an aggregated vector. Then, we use the gating mechanism of the network to manip-
ulate the features. We hypothesize that this will mitigate competing representations when
redundancy is present.
Figure 12.2 describes the architecture of the Feature Gated Composite CFGenNets. This
is an enhancement over the Composite CFGenNets, where, in addition to the Latent VAE
encodings and Implicit Image Fingerprints, the decoder also received a gated input from the
Image Feature Maps and the Implicit Feature Fingerprints. The Image Feature Maps here
refers to a binary vector of size 40, with one flag for each facial attribute that is contained
in the image. The flag, when set, indicates that the attribute feature is present in the image
and when unset indicates it is absent. The matrix multiplication operation between the
implicit feature map and Implicit Feature Fingerprints serves as the gating mechanism. At
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Figure 12.2: Feature Gated Composite CFGenNets : Architecture.
the time of training, the gating mechanism ensures that the Implicit Feature fingerprints of
only the features present on the images are being leveraged to reconstruct the original image.
Once trained, the gating mechanism provides a framework for controlling any set of features
that can be concurrently manipulated on a given image. The pseudo code describing the
manipulations using Gated Composite CFGenNets is described in Algorithm 2 below.
Figure 12.3 illustrates a sample set of images that have undergone image manipulation
via Gated Composite CFGenNets. The single dimensional manipulation is achieved by
setting only the desired feature to TRUE in the Image Feature Map input to the decoder.
In Figure 12.3, three different input images have undergone various manipulations. In the
first image, we apply the Implicit Fingerprint for “Wearing Hat.” We see that the output
image produces what resembles a blue headgear. The same image when manipulated with
the Implicit feature fingerprint for “Male” results in an image that has facial features with
a more blocked jaw and wider lips. We observe appropriate modifications occurring in all
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Figure 12.3: Feature Gated Composite CFGenNets: sample images with 1 dimensional
feature manipulations
the images represented in Figure 12.3.While the quality of the image could be improved,
we observe that the desired changes take effect on the output image in a visually consistent
manner. Appendix 12.3 illustrates a other example images which have undergone single
dimensional feature manipulations across all the 40 feature dimensions.
As mentioned previously, another advantage rendered by the Feature Gated Composite
CFGenNets is the ability to affect more than one desired feature manipulation at a given time.
This is illustrated in Figure 12.4, where multiple manipulations are performed concurrently.
The first row in figure 12.4 represents the original image, while the second row represents the
reconstructed image, without applying attribute manipulations. The third row represents
the out images after having undergone the said manipulations.
The first two images of female celebrities are manipulated by gating in the Implicit Fea-
ture Fingerprints of the features “Male” and “Bushy Eyebrows.” We can clearly perceive these
changes applied on the resultant images where the resultant faces in fact appear to have more
traditionally masculine features with straighter jawlines and reduced eye makeup. Similarly,
in the second set of images, the Implicit Feature Fingerprints corresponding to “Wearing Lip-
stick” and “Eye Glasses” are gated in. These features are evidently perceived in the resultant
images where facial hair is reduced and the rims of eye glasses are also perceivable—although
some ringing artifacts in the face and background are also introduced. While we are able
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Figure 12.4: Feature Gated Composite CFGenNets : sample images with 2 dimensional
feature manipulations
to perceive the desired manipulations on the resultant image, we acknowledge that there is
more work to be done to improve the image resolutions from Composite CFGenNet decoders.
We discuss these limitations in the subsequent section. Even so, these experiments support
our hypothesis that combined collaborative filtering and other encodings (such as the VAE)
are advantageous for research in image latent representations.
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Algorithm 2: Attribute Manipulation using Gated CFGenNets Decoder
Step 1 : Function PrepareImageFeatureFingerprint;
ImageFeatureFingerprints = ImageFeatureMap X
ImplicitFeatureFingerprints;
where
ImageFeatureMap ∈ RNumImagesX40 & ImplicitFeatureF ingerprint ∈ R40X500




Step 3 : Manipulate an image to show ‘Wearing Lipstick’ & ’With
Eyeglasses’;
r = random_image_index;






LManipFeatures =CustomImageFeatureMap X ImplicitFeatureFingerprints;
reconstructedImage = GatedDecoder.predict(inputs=[LV AE,
LImpImageFP,LImpImageFeatureFP ]);
manipulatedImage = GatedDecoder.predict(inputs=[LV AE,
LImpImageFP,LManipFeatures ]);
12.3 Conclusion & Future work
Aim 3 of our research demonstrated the abilities of CFGenNets to be applied to the
domain of Image Synthesis. The results discussed in Chapter 10 ascertain the fact that the
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implicit fingerprints indeed capture patterns that help in reconstructing the original images.
Chapter 11 further demonstrated the combined efficacy of latent encodings obtained from
Variational autoencoders and Implicit Image Fingerprints. From the results presented above,
it is evident that the combining the latent fingerprints obtained from VAEs and Collabora-
tive filtering has positively influenced the outcome. In the case of Variational Autoencoders,
the latent embeddings are obtained by learning to reconstruct the input image using an
encoder/decoder combination. In the case of CFGenNets, we leverage the metadata of the
images to obtain an encoding. This is different from VAEs in that the images are not used
in the training. The collaborative filtering method leverages only the descriptors of the im-
ages. The approach learns the encoding from all the images and mutually similar/dissimilar
properties represented in a matrix form. From the results presented above, we see that each
of the methods VAEs and CFGenNets encode certain nuances of the underlying images.
The enhanced performance of the Composite decoder indicates the advantages of combining
these two encodings of the underlying images.We further demonstrated the flexibility offered
by the Composite CFGenNet decoders to manipulate images by merely swapping the Im-
plicit Image fingerprints with the Implicit Feature Fingerprints obtained from Collaborative
Filtering.
While our work engenders the interpretability of the latent encodings obtained from col-
laborative filtering, we also acknowledge that there could be additional enhancements to
CFGenNets architecture to improve the reconstruction accuracy of the images. As an ex-
ample, in the current design, the process of generating implicit fingerprints via collaborative
filtering and the generative networks to affect reconstruction are conducted as 2 separate but
related steps. There is further scope to combine these 2 steps into a single multi-objective
based neural network. This could further refine the latent encodings produced to facilitate
improved reconstructions. We also note that the objective function of the CFGenNet de-
coders could be further enhanced on the lines of the advancements made in the objective
functions of other works , such as mutual information minimization from Conditional Sub-
space VAE [106] or feature perceptual loss leveraged by Deep Feature Consistent Variational
Autoencoder [136].
While we demonstrate a method of leveraging the Implicit Feature Fingerprints for in-
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fluencing image manipulation, we also acknowledge that the current results demonstrated in
this work could be further improved upon with better resolution decoders. We have largely
stayed independent of the advancements made around Neural Style Transfers. We believe
borrowing some of the underlying concepts driving style transfer literature such as Adaptive
Instance normalization, specifically evaluating applicability of leveraging Implicit Feature
Fingerprints as inputs for AdaIn, could provide further breakthroughs in image manipula-
tion.
Finally, we believe with this work we have only scratched the surface of the exciting
possibilities of leveraging the encoding generated by Collaborative Filtering by successfully
demonstrating the cross domain applicability of our methods. We believe we have contributed
a novel area of research to the community and believe the possibilities can be improved by
the research community, where countless additions can be investigated.
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APPENDIX A : Sample Images generated from CFGenNets
This appendix sample images generated from the 2 variants for CFGenNets , one with
Transpose Convolution layers and the one with Bi-linear Upsampling layers
Figure 12.5: Sample images generated from CFGenNets with Transpose Convolution layers
and Bi-linear Upsampling layers
114
APPENDIX B : Image Manipulation via Composite CFGenNet Decoders
This appendix contains 2 randomly selected images whose latent encoding from Varia-
tional Autoencoders were processed with the Implicit feature fingerprints for each of the 40
features from the CelebA dataset. The original image and the outcomes when fused with
each of the 40 features is illustrated in figure 12.6 and figure 12.7
Figure 12.6: Random Image 1 manipulated using Implicit Feature fingerprints via Composite
CFGenNet decoder
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Figure 12.7: Random Image 2 manipulated using Implicit Feature fingerprints via Composite
CFGenNet decoder
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APPENDIX C : Image Manipulation via Feature Gated Composite CFGenNet Decoders
This appendix contains 2 randomly selected images whose latent encoding from Varia-
tional Autoencoders were processed with the Implicit feature fingerprints for each of the 40
features from the CelebA dataset. The original image and the outcomes when fused with
each of the 40 features is illustrated in figure 12.8 and figure 12.9
Figure 12.8: Random Image 1 manipulated using Implicit Feature fingerprints via Feature
Gated Composite CFGenNet decoder
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Figure 12.9: Random Image 2 manipulated using Implicit Feature fingerprints via Feature
Gated Composite CFGenNet decoder
118
BIBLIOGRAPHY
[1] R. Srinivas, N. Verma, E. Kraka, and E. C. Larson, “Deep learning-based ligand
design using shared latent implicit fingerprints from collaborative filtering,” Journal
of Chemical Information and Modeling, vol. 61, no. 5, pp. 2159–2174, 2021. xiii, 12,
39, 54, 55, 60, 69, 70, 71
[2] R. Gómez-Bombarelli, J. N. Wei, D. Duvenaud, J. M. Hernández-Lobato,
B. Sánchez-Lengeling, D. Sheberla, J. Aguilera-Iparraguirre, T. D. Hirzel, R. P.
Adams, and A. Aspuru-Guzik, “Automatic chemical design using a data-driven
continuous representation of molecules,” ACS Cent. Sci., vol. 4, pp. 268–276, 2018.
xiii, 8, 41, 55, 70, 72
[3] Z. Liu, P. Luo, X. Wang, and X. Tang, “Deep learning face attributes in the wild,” in
Proceedings of International Conference on Computer Vision (ICCV), December
2015. xiii, 78, 79
[4] J. B. Schafer, D. Frankowski, J. Herlocker, and S. Sen, “Collaborative filtering
recommender systems,” in The adaptive web. Springer, 2007, pp. 291–324. 1
[5] P. Melville, R. J. Mooney, and R. Nagarajan, “Content-boosted collaborative filtering
for improved recommendations,” Aaai/iaai, vol. 23, pp. 187–192, 2002. 1
[6] B. Kitts, D. Freed, and M. Vrieze, “Cross-sell: a fast promotion-tunable
customer-item recommendation method based on conditionally independent
probabilities,” in Proceedings of the sixth ACM SIGKDD international conference on
Knowledge discovery and data mining, 2000, pp. 437–446. 1
[7] R. Khaleghi, K. Cannon, and R. Srinivas, “A comparative evaluation of recommender
systems for hotel reviews,” SMU Data Science Review, vol. 1, no. 4, p. 1, 2018. 1
[8] Y. Koren, R. Bell, and C. Volinsky, “Matrix factorization techniques for recommender
systems,” Computer, vol. 42, no. 8, pp. 30–37, Aug. 2009. [Online]. Available:
http://dx.doi.org/10.1109/MC.2009.263 1, 15, 16, 25
[9] “Simon Funk SVD,” https://sifter.org/simon/journal/20061211.html, []. 2
[10] “What is a molecule,” https://www.britannica.com/science/molecule, []. 3
[11] “What is Virtual Screening,” https://en.wikipedia.org/wiki/Virtual_screening, []. 4
[12] D. Weininger, “Smiles, a chemical language and information system. 1. introduction
to methodology and encoding rules,” Journal of chemical information and computer
sciences, vol. 28, no. 1, pp. 31–36, 1988. 6, 7
119
[13] D. Bajusz, A. Rácz, and K. Héberger, “Why is tanimoto index an appropriate choice
for fingerprint-based similarity calculations?” Journal of Cheminformatics, vol. 7,
no. 1, p. 20, May 2015. [Online]. Available:
https://doi.org/10.1186/s13321-015-0069-3 6, 25
[14] G. Maggiora, M. Vogt, D. Stumpfe, and J. Bajorath, “Molecular similarity in
medicinal chemistry,” Journal of Medicinal Chemistry, vol. 57, no. 8, pp. 3186–3204,
2014, pMID: 24151987. [Online]. Available: http://dx.doi.org/10.1021/jm401411z 6
[15] R. Todeschini, V. Consonni, H. Xiang, J. Holliday, M. Buscema, and P. Willett,
“Similarity coefficients for binary chemoinformatics data: Overview and extended
comparison using simulated and real data sets,” Journal of Chemical Information and
Modeling, vol. 52, no. 11, pp. 2884–2901, 2012, pMID: 23078167. [Online]. Available:
http://dx.doi.org/10.1021/ci300261r 6
[16] “RDKit: Open-source cheminformatics,” http://www.rdkit.org. 6, 54
[17] S. Riniker and G. A. Landrum, “Open-source platform to benchmark fingerprints for
ligand-based virtual screening,” Journal of Cheminformatics, vol. 5, no. 1, p. 26, May
2013. [Online]. Available: https://doi.org/10.1186/1758-2946-5-26 6, 23
[18] I. Muegge and P. Mukherjee, “An overview of molecular fingerprint similarity search
in virtual screening,” Expert Opinion on Drug Discovery, vol. 11, no. 2, pp. 137–148,
2016, pMID: 26558489. [Online]. Available:
http://dx.doi.org/10.1517/17460441.2016.1117070 6
[19] L. Jacob and J.-P. Vert, “Protein-ligand interaction prediction: An improved
chemogenomics approach,” Bioinformatics, vol. 24, pp. 2149–2156, 2008. 7
[20] Y. Yamanishi, M. Araki, A. Gutteridge, W. Honda, and M. Kanehisa, “Prediction of
drug-target interaction networks from the integration of chemical and genomic
spaces,” Bioinformatics, vol. 24, pp. i232–i240, 2008. 7
[21] I. Wallach, M. Dzamba, and A. Heifets, “Atomnet: A deep convolutional neural
network for bioactivity prediction in structure-based drug discovery,” 2015,
arXiv:1510.02855. 7
[22] M. Tsubaki, K. Tomii, and J. Sese, “Compound–protein interaction prediction with
end-to-end learning of neural networks for graphs and sequences,” Bioinformatics,
vol. 35, pp. 309–318, 2018. 7
[23] L. Li, C. C. Koh, D. Reker, J. B. Brown, H. Wang, N. K. Lee, H. haw Liow, H. Dai,
H.-M. Fan, L. Chen, and D.-Q. Wei, “Predicting protein-ligand interactions based on
bow-pharmacological space and bayesian additive regression trees,” Sci. Rep., vol. 9,
p. 7703, 2019. 7
[24] N. Verma, X. Qu, F. Trozzi, M. Elsaied, Y. Tao, E. C. Larson, and E. Kraka, “SSnet
- secondary structure based end-to-end learning model for protein-ligand interaction
prediction,” bioRxiv, 2019. 7, 69
120
[25] G. Schneider, “Virtual screening: an endless staircase?” Nature Reviews Drug
Discovery, vol. 9, no. 4, pp. 273–276, 2010. 8
[26] B. K. Shoichet, “Virtual screening of chemical libraries,” Nature, vol. 432, no. 7019,
pp. 862–865, 2004. 8
[27] A. Giordano, G. Forte, L. Massimo, R. Riccio, G. Bifulco, and S. Di Micco, “Discovery
of new erbb4 inhibitors: repositioning an orphan chemical library by inverse virtual
screening,” European journal of medicinal chemistry, vol. 152, pp. 253–263, 2018. 8
[28] G. Lauro, A. Romano, R. Riccio, and G. Bifulco, “Inverse virtual screening of
antitumor targets: pilot study on a small database of natural bioactive compounds,”
Journal of natural products, vol. 74, no. 6, pp. 1401–1407, 2011. 8
[29] X. Xu, M. Huang, and X. Zou, “Docking-based inverse virtual screening: methods,
applications, and challenges,” Biophysics reports, vol. 4, no. 1, pp. 1–16, 2018. 8





[32] M. Olivecrona, T. Blaschke, O. Engkvist, and H. Chen, “Molecular de-novo design
through deep reinforcement learning,” J. Cheminf., vol. 9, no. 1, pp. 1–14, 2017. 8,
40, 55
[33] J. Yasonik, “Multiobjective de novo drug design with recurrent neural networks and
nondominated sorting,” J. Cheminf., vol. 12, no. 1, pp. 1–9, 2020. 8, 55
[34] M. Popova, O. Isayev, and A. Tropsha, “Deep reinforcement learning for de novo
drug design,” Science advances, vol. 4, no. 7, p. eaap7885, 2018. 8, 55, 60
[35] D. Erhan, P.-J. L’Heureux, S. Y. Yue, and Y. Bengio, “Collaborative filtering on a
family of biological targets,” Journal of Chemical Information and Modeling, vol. 46,
no. 2, pp. 626–635, 2006, pMID: 16562992. [Online]. Available:
http://dx.doi.org/10.1021/ci050367t 9, 18
[36] R. Gómez-Bombarelli, J. N. Wei, D. Duvenaud, J. M. Hernández-Lobato,
B. Sánchez-Lengeling, D. Sheberla, J. Aguilera-Iparraguirre, T. D. Hirzel, R. P.
Adams, and A. Aspuru-Guzik, “Automatic chemical design using a data-driven
continuous representation of molecules,” ACS central science, vol. 4, no. 2, pp.
268–276, 2018. 10, 41, 60, 70
[37] ——, “Automatic chemical design using a data-driven continuous representation of
molecules,” ACS central science, vol. 4, no. 2, pp. 268–276, 2018. 10, 43, 44
121
[38] T. Blaschke, M. Olivecrona, O. Engkvist, J. Bajorath, and H. Chen, “Application of
generative autoencoder in de novo molecular design,” Molecular informatics, vol. 37,
no. 1-2, p. 1700123, 2018. 10, 42
[39] G. L. Guimaraes, B. Sanchez-Lengeling, C. Outeiral, P. L. C. Farias, and
A. Aspuru-Guzik, “Objective-reinforced generative adversarial networks (organ) for
sequence generation models,” arXiv preprint arXiv:1705.10843, 2017. 10, 42
[40] O. Prykhodko, S. V. Johansson, P.-C. Kotsias, J. Arús-Pous, E. J. Bjerrum,
O. Engkvist, and H. Chen, “A de novo molecular generation method using latent
vector based generative adversarial network,” Journal of Cheminformatics, vol. 11,
no. 1, p. 74, 2019. 10, 42
[41] Y. Li, L. Zhang, and Z. Liu, “Multi-objective de novo drug design with conditional
graph generative model,” Journal of cheminformatics, vol. 10, no. 1, p. 33, 2018. 10,
41, 42
[42] W. Jin, R. Barzilay, and T. Jaakkola, “Junction tree variational autoencoder for
molecular graph generation,” arXiv preprint arXiv:1802.04364, 2018. 10, 41, 42
[43] R. Srinivas, P. V. Klimovich, and E. C. Larson, “Implicit-descriptor ligand-based
virtual screening by means of collaborative filtering,” Journal of Cheminformatics,
vol. 10, no. 1, p. 56, 2018. 11, 15, 20, 39, 43, 45
[44] C. C. Aggarwal, Neighborhood-Based Collaborative Filtering. Cham: Springer
International Publishing, 2016, pp. 29–70. [Online]. Available:
https://doi.org/10.1007/978-3-319-29659-3_2 15, 16
[45] Y. Koren and R. Bell, Advances in Collaborative Filtering. Boston, MA: Springer
US, 2015, pp. 77–118. [Online]. Available:
https://doi.org/10.1007/978-1-4899-7637-6_3 15
[46] G. H. Golub and C. Reinsch, Singular Value Decomposition and Least Squares
Solutions. Berlin, Heidelberg: Springer Berlin Heidelberg, 1971, pp. 134–151.
[Online]. Available: https://doi.org/10.1007/BF02163027 17, 18
[47] L. Bottou, Large-Scale Machine Learning with Stochastic Gradient Descent.
Heidelberg: Physica-Verlag HD, 2010, pp. 177–186. [Online]. Available:
https://doi.org/10.1007/978-3-7908-2604-3_16 18, 26, 27
[48] D. Reker, P. Schneider, G. Schneider, and Brown, “Active learning for computational
chemogenomics,” Future Medicinal Chemistry, vol. 9, no. 4, pp. 381–402, 2017, pMID:
28263088. [Online]. Available: https://doi.org/10.4155/fmc-2016-0197 20
[49] E. B. Lenselink, N. ten Dijke, B. Bongers, G. Papadatos, H. W. T. van Vlijmen,
W. Kowalczyk, A. P. IJzerman, and G. J. P. van Westen, “Beyond the hype: deep
neural networks outperform established methods using a chembl bioactivity
benchmark set,” Journal of Cheminformatics, vol. 9, no. 1, p. 45, Aug 2017. [Online].
Available: https://doi.org/10.1186/s13321-017-0232-0 20, 21
122
[50] I. Wallach and A. Heifets, “Most Ligand-Based Benchmarks Measure Overfitting
Rather than Accuracy,” ArXiv e-prints, Jun. 2017. 21, 25, 26, 30
[51] D. Fourches, E. Muratov, and A. Tropsha, “Trust, but verify ii: A practical guide to
chemogenomics data curation,” Journal of Chemical Information and Modeling,
vol. 56, no. 7, pp. 1243–1252, 2016, pMID: 27280890. [Online]. Available:
http://dx.doi.org/10.1021/acs.jcim.6b00129 21
[52] R. P. Sheridan, “The relative importance of domain applicability metrics for
estimating prediction errors in qsar varies with training set diversity,” Journal of
Chemical Information and Modeling, vol. 55, no. 6, pp. 1098–1107, 2015, pMID:
25998559. [Online]. Available: http://dx.doi.org/10.1021/acs.jcim.5b00110 21
[53] T. M. Mitchell, Machine Learning, 1st ed. New York, NY, USA: McGraw-Hill, Inc.,
1997. 21
[54] N. Triballeau, F. Acher, I. Brabet, J.-P. Pin, and H.-O. Bertrand, “Virtual screening
workflow development guided by the “receiver operating characteristic” curve
approach. application to high-throughput docking on metabotropic glutamate
receptor subtype 4,” Journal of Medicinal Chemistry, vol. 48, no. 7, pp. 2534–2547,
2005, pMID: 15801843. [Online]. Available: http://dx.doi.org/10.1021/jm049092j 21
[55] D. A. Pearlman and P. S. Charifson, “Improved scoring of ligand-protein interactions
using owfeg free energy grids,” Journal of Medicinal Chemistry, vol. 44, no. 4, pp.
502–511, 2001, pMID: 11170640. [Online]. Available:
http://dx.doi.org/10.1021/jm000375v 22
[56] C. Empereur-mot, H. Guillemain, A. Latouche, J.-F. Zagury, V. Viallon, and
M. Montes, “Predictiveness curves in virtual screening,” Journal of Cheminformatics,
vol. 7, no. 1, p. 52, Nov 2015. [Online]. Available:
https://doi.org/10.1186/s13321-015-0100-8 22
[57] R. P. Sheridan, S. B. Singh, E. M. Fluder, and S. K. Kearsley, “Protocols for bridging
the peptide to nonpeptide gap in topological similarity searches,” Journal of
Chemical Information and Computer Sciences, vol. 41, no. 5, pp. 1395–1406, 2001,
pMID: 11604041. [Online]. Available: http://dx.doi.org/10.1021/ci0100144 23
[58] J.-F. Truchon and C. I. Bayly, “Evaluating virtual screening methods: Good and bad
metrics for the early recognition problem,” Journal of Chemical Information and
Modeling, vol. 47, no. 2, pp. 488–508, 2007, pMID: 17288412. [Online]. Available:
http://dx.doi.org/10.1021/ci600426e 23
[59] Y. Low, J. Gonzalez, A. Kyrola, D. Bickson, C. Guestrin, and J. Hellerstein,
“Graphlab: A new framework for parallel machine learning,” in Proceedings of the
Twenty-Sixth Conference on Uncertainty in Artificial Intelligence, ser. UAI’10.
Arlington, Virginia, United States: AUAI Press, 2010, pp. 340–349. [Online].
Available: http://dl.acm.org/citation.cfm?id=3023549.3023589 26
123
[60] S. C. Bull and A. J. Doig, “Properties of protein drug target classes,” PLoS One,
vol. 10, no. 3, p. e0117955, 2015. 34
[61] L. Maaten and G. Hinton, “Visualizing high-dimensional data using t-sne,” vol. 9, pp.
2579–2605, Nov 2008. 34, 80, 99
[62] K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P.
Metz, and S. Safe, “Vascular endothelial growth factor receptor-2 expression is
induced by 17β-estradiol in zr-75 breast cancer cells by estrogen receptor α/sp
proteins,” Endocrinology, vol. 147, no. 7, pp. 3285–3295, 2006. 36
[63] “Phf13 protein,” pHF13 PHD finger protein 13 [ Homo sapiens (human) ]. [Online].
Available: https://www.ncbi.nlm.nih.gov/gene/148479 36
[64] I. Wallach and A. Heifets, “Most ligand-based benchmarks measure overfitting rather
than accuracy,” arXiv preprint arXiv:1706.06619, vol. 20, 2017. 40
[65] C. Voss, “Modeling molecules with recurrent neural networks,” 2019. 40
[66] M. H. Segler, T. Kogej, C. Tyrchan, and M. P. Waller, “Generating focused molecule
libraries for drug discovery with recurrent neural networks,” ACS central science,
vol. 4, no. 1, pp. 120–131, 2018. 40
[67] D. P. Kingma and M. Welling, “Auto-encoding variational bayes,” arXiv preprint
arXiv:1312.6114, 2013. 41, 47, 74, 94
[68] J. Lim, S. Ryu, J. W. Kim, and W. Y. Kim, “Molecular generative model based on
conditional variational autoencoder for de novo molecular design,” Journal of
cheminformatics, vol. 10, no. 1, pp. 1–9, 2018. 41
[69] M. J. Kusner, B. Paige, and J. M. Hernández-Lobato, “Grammar variational
autoencoder,” in International Conference on Machine Learning. PMLR, 2017, pp.
1945–1954. 41
[70] J. Arús-Pous, T. Blaschke, S. Ulander, J.-L. Reymond, H. Chen, and O. Engkvist,
“Exploring the gdb-13 chemical space using deep generative models,” Journal of
cheminformatics, vol. 11, no. 1, pp. 1–14, 2019. 41
[71] Y. Li, O. Vinyals, C. Dyer, R. Pascanu, and P. Battaglia, “Learning deep generative
models of graphs,” arXiv preprint arXiv:1803.03324, 2018. 41
[72] I. J. Goodfellow, J. Pouget-Abadie, M. Mirza, B. Xu, D. Warde-Farley, S. Ozair,
A. Courville, and Y. Bengio, “Generative adversarial networks,” arXiv preprint
arXiv:1406.2661, 2014. 41, 42, 73, 76, 94
[73] B. Sanchez-Lengeling, C. Outeiral, G. L. Guimaraes, and A. Aspuru-Guzik,
“Optimizing distributions over molecular space. an objective-reinforced generative
adversarial network for inverse-design chemistry (organic),” ChemRxiv, vol. 2017,
2017. 42
124
[74] E. Putin, A. Asadulaev, Y. Ivanenkov, V. Aladinskiy, B. Sanchez-Lengeling,
A. Aspuru-Guzik, and A. Zhavoronkov, “Reinforced adversarial neural computer for
de novo molecular design,” Journal of chemical information and modeling, vol. 58,
no. 6, pp. 1194–1204, 2018. 42
[75] E. Putin, A. Asadulaev, Q. Vanhaelen, Y. Ivanenkov, A. V. Aladinskaya, A. Aliper,
and A. Zhavoronkov, “Adversarial threshold neural computer for molecular de novo
design,” Molecular pharmaceutics, vol. 15, no. 10, pp. 4386–4397, 2018. 42
[76] P. Das, T. Sercu, K. Wadhawan, I. Padhi, S. Gehrmann, F. Cipcigan,
V. Chenthamarakshan, H. Strobelt, C. Dos Santos, P.-Y. Chen et al., “Accelerated
antimicrobial discovery via deep generative models and molecular dynamics
simulations,” Nature Biomedical Engineering, pp. 1–11, 2021. 42
[77] Q. Vanhaelen, Y.-C. Lin, and A. Zhavoronkov, “The advent of generative chemistry,”
ACS Medicinal Chemistry Letters, vol. 11, no. 8, pp. 1496–1505, 2020. 42
[78] E. J. Bjerrum and B. Sattarov, “Improving chemical autoencoder latent space and
molecular de novo generation diversity with heteroencoders,” Biomolecules, vol. 8, p.
131, 2018. 42, 46
[79] “ChEMBL23,” https://www.ebi.ac.uk/chembl/, accessed: 2020-09-30. 43
[80] J. Chung, C. Gulcehre, K. Cho, and Y. Bengio, “Empirical evaluation of gated
recurrent neural networks on sequence modeling,” arXiv preprint arXiv:1412.3555,
2014. 43, 44
[81] S. R. Bowman, L. Vilnis, O. Vinyals, A. M. Dai, R. Jozefowicz, and S. Bengio,
“Generating sentences from a continuous space,” arXiv preprint arXiv:1511.06349,
2015. 44
[82] Z. Tang, Y. Shi, D. Wang, Y. Feng, and S. Zhang, “Memory visualization for gated
recurrent neural networks in speech recognition,” in 2017 IEEE International
Conference on Acoustics, Speech and Signal Processing (ICASSP). IEEE, 2017, pp.
2736–2740. 44
[83] Y. Santur, “Sentiment analysis based on gated recurrent unit,” in 2019 International
Artificial Intelligence and Data Processing Symposium (IDAP). IEEE, 2019, pp.
1–5. 44
[84] M. Zulqarnain, S. Ishak, R. Ghazali, N. M. Nawi, M. Aamir, and Y. M. M. Hassim,
“An improved deep learning approach based on variant two-state gated recurrent unit
and word embeddings for sentiment classification,” International Journal of Advanced
Computer Science and Applications, vol. 11, pp. 594–603, 2020. 44
[85] D. Reker, P. Schneider, G. Schneider, and J. Brown, “Active learning for
computational chemogenomics,” Future medicinal chemistry, vol. 9, no. 4, pp.
381–402, 2017. 45
125
[86] E. B. Lenselink, N. Dijke, B. Bongers, G. Papadatos, H. W. Vlijmen, W. Kowalczyk,
A. P. IJzerman, and G. J. Westen, “Beyond the hype: deep neural networks
outperform established methods using a chembl bioactivity benchmark set,” Journal
of Cheminformatics, vol. 9, no. 1, p. 45, 2017. 45
[87] G. Maggiora, M. Vogt, D. Stumpfe, and J. Bajorath, “Molecular similarity in
medicinal chemistry,” J. Med. Chem., vol. 57, pp. 3186–3204, 2013. 56
[88] D. Rogers and M. Hahn, “Extended-connectivity fingerprints,” J. Chem. Inf. Model,
vol. 50, pp. 742–754, 2010. 56
[89] G. R. Bickerton, G. V. Paolini, J. Besnard, S. Muresan, and A. L. Hopkins,
“Quantifying the chemical beauty of drugs,” Nature chemistry, vol. 4, no. 2, pp.
90–98, 2012. 62
[90] S. A. Wildman and G. M. Crippen, “Prediction of physicochemical parameters by
atomic contributions,” Journal of chemical information and computer sciences,
vol. 39, no. 5, pp. 868–873, 1999. 63
[91] P. Ertl and A. Schuffenhauer, “Estimation of synthetic accessibility score of drug-like
molecules based on molecular complexity and fragment contributions,” Journal of
cheminformatics, vol. 1, no. 1, p. 8, 2009. 63
[92] H. B. Mann and D. R. Whitney, “On a test of whether one of two random variables is
stochastically larger than the other,” The annals of mathematical statistics, pp.
50–60, 1947. 64
[93] C. A. Lipinski, “Lead- and drug-like compounds: the rule-of-five revolution,” Drug
Discov. Today Technol., vol. 1, pp. 337–341, 2004. 64
[94] Z.-J. Yao, J. Dong, Y.-J. Che, M.-F. Zhu, M. Wen, N.-N. Wang, S. Wang, A.-P. Lu,
and D.-S. Cao, “TargetNet: a web service for predicting potential drug–target
interaction profiling via multi-target SAR models,” J. Comput. Aided Mol. Des.,
vol. 30, pp. 413–424, 2016. 65
[95] M. M. Mysinger, M. Carchia, J. J. Irwin, and B. K. Shoichet, “Directory of useful
decoys, enhanced (DUD-e): Better ligands and decoys for better benchmarking,” J.
Med. Chem., vol. 55, pp. 6582–6594, 2012. 65
[96] S. Nowozin, “Optimal decisions from probabilistic models: the intersection-over-union
case,” in Proceedings of the IEEE conference on computer vision and pattern
recognition, 2014, pp. 548–555. 65
[97] G. W. Bemis and M. A. Murcko, “The properties of known drugs. 1. molecular
frameworks,” J. Med. Chem., vol. 39, no. 15, pp. 2887–2893, 1996. 67
[98] Y. Hu, D. Stumpfe, and J. Bajorath, “Lessons learned from molecular scaffold
analysis,” J. Chem. Inf. Model., vol. 51, no. 8, pp. 1742–1753, 2011. 67
126
[99] ——, “Computational exploration of molecular scaffolds in medicinal chemistry,” J.
Med. Chem., vol. 59, no. 9, pp. 4062–4076, 2016. 67
[100] D. R. Koes, M. P. Baumgartner, and C. J. Camacho, “Lessons learned in empirical
scoring with smina from the CSAR 2011 benchmarking exercise,” J. Chem. Inf.
Model., vol. 53, pp. 1893–1904, 2013. 69
[101] E. Denton, S. Chintala, A. Szlam, and R. Fergus, “Deep generative image models
using a laplacian pyramid of adversarial networks,” arXiv preprint arXiv:1506.05751,
2015. 73
[102] A. Radford, L. Metz, and S. Chintala, “Unsupervised representation learning with
deep convolutional generative adversarial networks,” arXiv preprint
arXiv:1511.06434, 2015. 73, 88, 103
[103] S. Reed, Z. Akata, X. Yan, L. Logeswaran, B. Schiele, and H. Lee, “Generative
adversarial text to image synthesis,” in International Conference on Machine
Learning. PMLR, 2016, pp. 1060–1069. 73
[104] S. Reed, Z. Akata, S. Mohan, S. Tenka, B. Schiele, and H. Lee, “Learning what and
where to draw,” arXiv preprint arXiv:1610.02454, 2016. 73
[105] A. Ramesh, M. Pavlov, G. Goh, S. Gray, C. Voss, A. Radford, M. Chen, and
I. Sutskever, “Zero-shot text-to-image generation,” arXiv preprint arXiv:2102.12092,
2021. 73
[106] J. Klys, J. Snell, and R. Zemel, “Learning latent subspaces in variational
autoencoders,” arXiv preprint arXiv:1812.06190, 2018. 75, 112
[107] D. Li, M. Zhang, W. Chen, and G. Feng, “Facial attribute editing by latent space
adversarial variational autoencoders,” in 2018 24th International Conference on
Pattern Recognition (ICPR). IEEE, 2018, pp. 1337–1342. 75
[108] X. Yan, J. Yang, K. Sohn, and H. Lee, “Attribute2image: Conditional image
generation from visual attributes,” in European Conference on Computer Vision.
Springer, 2016, pp. 776–791. 75
[109] L. Cai, H. Gao, and S. Ji, “Multi-stage variational auto-encoders for coarse-to-fine
image generation,” in Proceedings of the 2019 SIAM International Conference on
Data Mining. SIAM, 2019, pp. 630–638. 75, 89
[110] A. Razavi, A. v. d. Oord, and O. Vinyals, “Generating diverse high-fidelity images
with vq-vae-2,” arXiv preprint arXiv:1906.00446, 2019. 75
[111] G. K. Wallace, “The jpeg still picture compression standard,” IEEE transactions on
consumer electronics, vol. 38, no. 1, pp. xviii–xxxiv, 1992. 75
[112] A. Gersho and R. M. Gray, Vector quantization and signal compression. Springer
Science & Business Media, 2012, vol. 159. 75
127
[113] I. Goodfellow, “Nips 2016 tutorial: Generative adversarial networks,” arXiv preprint
arXiv:1701.00160, 2016. 76
[114] R. D. Hjelm, A. P. Jacob, T. Che, A. Trischler, K. Cho, and Y. Bengio,
“Boundary-seeking generative adversarial networks,” arXiv preprint
arXiv:1702.08431, 2017. 76
[115] X. Mao, Q. Li, H. Xie, R. Y. Lau, and Z. Wang, “Multi-class generative adversarial
networks with the l2 loss function,” arXiv preprint arXiv:1611.04076, vol. 5, p.
00102, 2016. 76
[116] J. Zhao, L. Xiong, J. Karlekar, J. Li, F. Zhao, Z. Wang, S. Pranata, S. Shen, S. Yan,
and J. Feng, “Dual-agent gans for photorealistic and identity preserving profile face
synthesis.” in NIPS, vol. 2, 2017, p. 3. 76
[117] M. Mirza and S. Osindero, “Conditional generative adversarial nets,” arXiv preprint
arXiv:1411.1784, 2014. 76
[118] D. Berthelot, T. Schumm, and L. Metz, “Began: Boundary equilibrium generative
adversarial networks,” arXiv preprint arXiv:1703.10717, 2017. 76
[119] L. A. Gatys, A. S. Ecker, and M. Bethge, “Image style transfer using convolutional
neural networks,” in Proceedings of the IEEE conference on computer vision and
pattern recognition, 2016, pp. 2414–2423. 76
[120] X. Huang and S. Belongie, “Arbitrary style transfer in real-time with adaptive
instance normalization,” in Proceedings of the IEEE International Conference on
Computer Vision, 2017, pp. 1501–1510. 76
[121] T. Karras, S. Laine, and T. Aila, “A style-based generator architecture for generative
adversarial networks,” in Proceedings of the IEEE/CVF Conference on Computer
Vision and Pattern Recognition, 2019, pp. 4401–4410. 77
[122] H. Zhang, T. Xu, H. Li, S. Zhang, X. Wang, X. Huang, and D. N. Metaxas,
“Stackgan: Text to photo-realistic image synthesis with stacked generative adversarial
networks,” in Proceedings of the IEEE international conference on computer vision,
2017, pp. 5907–5915. 77
[123] H. Wang, J. D. Williams, and S. Kang, “Learning to globally edit images with textual
description,” arXiv preprint arXiv:1810.05786, 2018. 77
[124] A. Makhzani, J. Shlens, N. Jaitly, I. Goodfellow, and B. Frey, “Adversarial
autoencoders,” arXiv preprint arXiv:1511.05644, 2015. 77
[125] E. Mansimov, E. Parisotto, J. L. Ba, and R. Salakhutdinov, “Generating images from
captions with attention,” arXiv preprint arXiv:1511.02793, 2015. 77
[126] J. Zhi, “Pixelbrush: Art generation from text with gans,” in Cl. Proj. Stanford
CS231N Convolutional Neural Networks Vis. Recognition, Sprint 2017, 2017, p. 256.
77
128
[127] V. Dumoulin and F. Visin, “A guide to convolution arithmetic for deep learning,”
arXiv preprint arXiv:1603.07285, 2016. 88
[128] “Bilinear Upsampling,” https://en.wikipedia.org/wiki/Bilinear_interpolation, []. 88
[129] T. Scherr, K. Streule, A. Bartschat, M. Böhland, J. Stegmaier, M. Reischl,
V. Orian-Rousseau, and R. Mikut, “Beadnet: deep learning-based bead detection and
counting in low-resolution microscopy images,” Bioinformatics, vol. 36, no. 17, pp.
4668–4670, 2020. 88
[130] C. W. Tseng, H.-R. Su, S.-H. Lai, and J. Liu, “Depth image super-resolution via
multi-frame registration and deep learning,” in 2016 Asia-Pacific Signal and
Information Processing Association Annual Summit and Conference (APSIPA).
IEEE, 2016, pp. 1–8. 88
[131] L. Fang, F. Monroe, S. W. Novak, L. Kirk, C. R. Schiavon, B. Y. Seungyoon,
T. Zhang, M. Wu, K. Kastner, Y. Kubota et al., “Deep learning-based point-scanning
super-resolution imaging,” BioRxiv, p. 740548, 2019. 88
[132] P. Wang, P. Chen, Y. Yuan, D. Liu, Z. Huang, X. Hou, and G. Cottrell,
“Understanding convolution for semantic segmentation,” in 2018 IEEE winter
conference on applications of computer vision (WACV). IEEE, 2018, pp. 1451–1460.
88
[133] X. Hou, K. Sun, L. Shen, and G. Qiu, “Improving variational autoencoder with deep
feature consistent and generative adversarial training,” Neurocomputing, vol. 341, pp.
183–194, 2019. 90
[134] J. C. Leachtenauer, W. Malila, J. Irvine, L. Colburn, and N. Salvaggio, “General
image-quality equation: Giqe,” Applied optics, vol. 36, no. 32, pp. 8322–8328, 1997. 94
[135] T. Mikolov, I. Sutskever, K. Chen, G. Corrado, and J. Dean, “Distributed
representations of words and phrases and their compositionality,” arXiv preprint
arXiv:1310.4546, 2013. 103
[136] X. Hou, L. Shen, K. Sun, and G. Qiu, “Deep feature consistent variational
autoencoder,” in 2017 IEEE Winter Conference on Applications of Computer Vision
(WACV). IEEE, 2017, pp. 1133–1141. 103, 106, 112
[137] R. E. Carhart, D. H. Smith, and R. Venkataraghavan, “Atom pairs as molecular
features in structure-activity studies: definition and applications,” Journal of
Chemical Information and Computer Sciences, vol. 25, no. 2, pp. 64–73, 1985.
[138] R. Nilakantan, N. Bauman, J. S. Dixon, and R. Venkataraghavan, “Topological
torsion: a new molecular descriptor for sar applications. comparison with other
descriptors,” Journal of Chemical Information and Computer Sciences, vol. 27, no. 2,
pp. 82–85, 1987. [Online]. Available:
http://pubs.acs.org/doi/abs/10.1021/ci00054a008
129
[139] M. Sastry, J. F. Lowrie, S. L. Dixon, and W. Sherman, “Large-scale systematic
analysis of 2d fingerprint methods and parameters to improve virtual screening
enrichments,” Journal of Chemical Information and Modeling, vol. 50, no. 5, pp.
771–784, 2010, pMID: 20450209. [Online]. Available:
http://dx.doi.org/10.1021/ci100062n
[140] N. M. O’Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, and G. R.
Hutchison, “Open babel: An open chemical toolbox,” J. Cheminformatics, vol. 3,
2011.
[141] “PubChem Substructure Fingerprint Description,”
ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem_fingerprints.txt, [].
[142] N. M. O’Boyle and R. A. Sayle, “Comparing structural fingerprints using a
literature-based similarity benchmark,” Journal of Cheminformatics, vol. 8, no. 1,
p. 36, Jul 2016. [Online]. Available: https://doi.org/10.1186/s13321-016-0148-0
[143] J. Hert, P. Willett, D. J. Wilton, P. Acklin, K. Azzaoui, E. Jacoby, and
A. Schuffenhauer, “Comparison of topological descriptors for similarity-based virtual
screening using multiple bioactive reference structures,” Org. Biomol. Chem., vol. 2,
pp. 3256–3266, 2004. [Online]. Available: http://dx.doi.org/10.1039/B409865J
[144] A. Bender, H. Y. Mussa, R. C. Glen, and S. Reiling, “Similarity searching of chemical
databases using atom environment descriptors (molprint 2d): evaluation of
performance,” Journal of chemical information and computer sciences, vol. 44, no. 5,
pp. 1708–1718, 2004.
[145] G. J. van Westen, J. K. Wegner, A. P. IJzerman, H. W. van Vlijmen, and A. Bender,
“Proteochemometric modeling as a tool to design selective compounds and for
extrapolating to novel targets,” MedChemComm, vol. 2, no. 1, pp. 16–30, 2011.
[146] H. Yuan, I. Paskov, H. Paskov, A. J. González, and C. S. Leslie, “Multitask learning
improves prediction of cancer drug sensitivity,” Scientific reports, vol. 6, 2016.
[147] G. E. Dahl, N. Jaitly, and R. Salakhutdinov, “Multi-task neural networks for qsar
predictions,” arXiv preprint arXiv:1406.1231, 2014.
[148] B. R. Beno and J. S. Mason, “The design of combinatorial libraries using properties
and 3d pharmacophore fingerprints,” Drug Discovery Today, vol. 6, no. 5, pp.
251–258, 2001.
[149] A. Bender, H. Y. Mussa, R. C. Glen, and S. Reiling, “Molecular similarity searching
using atom environments, information-based feature selection, and a naive bayesian
classifier,” Journal of chemical information and computer sciences, vol. 44, no. 1, pp.
170–178, 2004.
[150] E. E. Bolton, Y. Wang, P. A. Thiessen, and S. H. Bryant, “Pubchem: integrated
platform of small molecules and biological activities,” Annual reports in
computational chemistry, vol. 4, pp. 217–241, 2008.
130
[151] J. L. Durant, B. A. Leland, D. R. Henry, and J. G. Nourse, “Reoptimization of mdl
keys for use in drug discovery,” Journal of chemical information and computer
sciences, vol. 42, no. 6, pp. 1273–1280, 2002.
[152] J. L. Melville, E. K. Burke, and J. D. Hirst, “Machine learning in virtual screening,”
Combinatorial chemistry & high throughput screening, vol. 12, no. 4, pp. 332–343,
2009.
[153] D. Joseph-McCarthy, “Computational approaches to structure-based ligand design,”
Pharmacology & therapeutics, vol. 84, no. 2, pp. 179–191, 1999.
[154] T. Liu, Y. Lin, X. Wen, R. N. Jorissen, and M. K. Gilson, “Bindingdb: a
web-accessible database of experimentally determined protein–ligand binding
affinities,” Nucleic acids research, vol. 35, no. suppl_1, pp. D198–D201, 2006.
[155] P. D. Lyne, “Structure-based virtual screening: an overview,” Drug discovery today,
vol. 7, no. 20, pp. 1047–1055, 2002.
[156] S. Wold, K. Esbensen, and P. Geladi, “Principal component analysis,” Chemometrics
and Intelligent Laboratory Systems, vol. 2, no. 1, pp. 37 – 52, 1987, proceedings of the
Multivariate Statistical Workshop for Geologists and Geochemists. [Online].
Available: http://www.sciencedirect.com/science/article/pii/0169743987800849
[157] B. Merget, S. Turk, S. Eid, F. Rippmann, and S. Fulle, “Profiling prediction of kinase
inhibitors: Toward the virtual assay,” Journal of Medicinal Chemistry, vol. 60, no. 1,
pp. 474–485, 2017, pMID: 27966949. [Online]. Available:
http://dx.doi.org/10.1021/acs.jmedchem.6b01611
[158] A. M. Afzal, H. Y. Mussa, R. E. Turner, A. Bender, and R. C. Glen, “A multi-label
approach to target prediction taking ligand promiscuity into account,” Journal of
Cheminformatics, vol. 7, no. 1, p. 24, May 2015. [Online]. Available:
https://doi.org/10.1186/s13321-015-0071-9
[159] H. Y. Mussa, D. Marcus, J. B. O. Mitchell, and R. C. Glen, “Verifying the fully
“laplacianised” posterior naïve bayesian approach and more,” Journal of
Cheminformatics, vol. 7, no. 1, p. 27, Jun 2015. [Online]. Available:
https://doi.org/10.1186/s13321-015-0075-5
[160] J. Balfer and J. Bajorath, “Introduction of a methodology for visualization and
graphical interpretation of bayesian classification models,” Journal of Chemical
Information and Modeling, vol. 54, no. 9, pp. 2451–2468, 2014, pMID: 25137527.
[Online]. Available: http://dx.doi.org/10.1021/ci500410g
[161] B. Chen, R. P. Sheridan, V. Hornak, and J. H. Voigt, “Comparison of random forest
and pipeline pilot naïve bayes in prospective qsar predictions,” Journal of Chemical
Information and Modeling, vol. 52, no. 3, pp. 792–803, 2012, pMID: 22360769.
[Online]. Available: http://dx.doi.org/10.1021/ci200615h
131
[162] J. Ma, R. P. Sheridan, A. Liaw, G. E. Dahl, and V. Svetnik, “Deep neural nets as a
method for quantitative structure-activity relationships,” Journal of Chemical
Information and Modeling, vol. 55, no. 2, pp. 263–274, 2015, pMID: 25635324.
[Online]. Available: http://dx.doi.org/10.1021/ci500747n
[163] R. P. Sheridan, W. M. Wang, A. Liaw, J. Ma, and E. M. Gifford, “Extreme gradient
boosting as a method for quantitative structure-activity relationships,” Journal of
Chemical Information and Modeling, vol. 56, no. 12, pp. 2353–2360, 2016, pMID:
27958738. [Online]. Available: http://dx.doi.org/10.1021/acs.jcim.6b00591
[164] V. Svetnik, A. Liaw, C. Tong, J. C. Culberson, R. P. Sheridan, and B. P. Feuston,
“Random forest: A classification and regression tool for compound classification and
qsar modeling,” Journal of Chemical Information and Computer Sciences, vol. 43,
no. 6, pp. 1947–1958, 2003, pMID: 14632445. [Online]. Available:
http://dx.doi.org/10.1021/ci034160g
[165] R. L. Marchese Robinson, A. Palczewska, J. Palczewski, and N. Kidley, “Comparison
of the predictive performance and interpretability of random forest and linear models
on benchmark data sets,” Journal of Chemical Information and Modeling, vol. 57,
no. 8, pp. 1773–1792, 2017, pMID: 28715209. [Online]. Available:
http://dx.doi.org/10.1021/acs.jcim.6b00753
[166] K. Ullrich, M. Kamp, T. Gärtner, M. Vogt, and S. Wrobel, “Ligand-based virtual
screening with co-regularised support vector regression,” in 2016 IEEE 16th
International Conference on Data Mining Workshops (ICDMW), Dec 2016, pp.
261–268.
[167] N. Sugaya, “Ligand efficiency-based support vector regression models for predicting
bioactivities of ligands to drug target proteins,” Journal of Chemical Information and
Modeling, vol. 54, no. 10, pp. 2751–2763, 2014, pMID: 25220713. [Online]. Available:
http://dx.doi.org/10.1021/ci5003262
[168] S. E. Rensi and R. B. Altman, “Shallow representation learning via kernel pca
improves qsar modelability,” Journal of Chemical Information and Modeling, vol. 57,
no. 8, pp. 1859–1867, 2017, pMID: 28727421. [Online]. Available:
http://dx.doi.org/10.1021/acs.jcim.6b00694
[169] K. Heikamp and J. Bajorath, “Support vector machines for drug discovery,” Expert
Opinion on Drug Discovery, vol. 9, no. 1, pp. 93–104, 2014, pMID: 24304044.
[Online]. Available: http://dx.doi.org/10.1517/17460441.2014.866943
[170] M. Duran-Frigola, D. Rossell, and P. Aloy, “A chemo-centric view of human health
and disease,” vol. 5, p. 5676, Dec 2014, article. [Online]. Available:
http://dx.doi.org/10.1038/ncomms6676
[171] M. Luo, X. S. Wang, and A. Tropsha, “Comparative analysis of qsar-based vs.
chemical similarity based predictors of gpcrs binding affinity,” Molecular Informatics,
132
vol. 35, no. 1, pp. 36–41, 2016. [Online]. Available:
http://dx.doi.org/10.1002/minf.201500038
[172] Y. Wang, Y. Guo, Q. Kuang, X. Pu, Y. Ji, Z. Zhang, and M. Li, “A comparative
study of family-specific protein–ligand complex affinity prediction based on random
forest approach,” Journal of Computer-Aided Molecular Design, vol. 29, no. 4, pp.
349–360, Apr 2015. [Online]. Available: https://doi.org/10.1007/s10822-014-9827-y
[173] C. Bendtsen, A. Degasperi, E. Ahlberg, and L. Carlsson, “Improving machine
learning in early drug discovery,” Annals of Mathematics and Artificial Intelligence,
vol. 81, no. 1, pp. 155–166, Oct 2017. [Online]. Available:
https://doi.org/10.1007/s10472-017-9541-2
[174] F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel,
M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, J. Vanderplas, A. Passos,
D. Cournapeau, M. Brucher, M. Perrot, and E. Duchesnay, “Scikit-learn: Machine
learning in Python,” Journal of Machine Learning Research, vol. 12, pp. 2825–2830,
2011.
[175] F. Chollet et al., “Keras,” https://github.com/fchollet/keras, 2015.
[176] M. Abadi, A. Agarwal, P. Barham, E. Brevdo, Z. Chen, C. Citro, G. S. Corrado,
A. Davis, J. Dean, M. Devin, S. Ghemawat, I. Goodfellow, A. Harp, G. Irving,
M. Isard, Y. Jia, R. Jozefowicz, L. Kaiser, M. Kudlur, J. Levenberg, D. Mané,
R. Monga, S. Moore, D. Murray, C. Olah, M. Schuster, J. Shlens, B. Steiner,
I. Sutskever, K. Talwar, P. Tucker, V. Vanhoucke, V. Vasudevan, F. Viégas,
O. Vinyals, P. Warden, M. Wattenberg, M. Wicke, Y. Yu, and X. Zheng,
“TensorFlow: Large-scale machine learning on heterogeneous systems,” 2015, software
available from tensorflow.org. [Online]. Available: https://www.tensorflow.org/
[177] A. Gaulton, A. Hersey, M. Nowotka, A. P. Bento, J. Chambers, D. Mendez,
P. Mutowo, F. Atkinson, L. J. Bellis, E. Cibrián-Uhalte, M. Davies, N. Dedman,
A. Karlsson, M. P. Magariños, J. P. Overington, G. Papadatos, I. Smit, and A. R.
Leach, “The chembl database in 2017.” Nucleic Acids Research, vol. 45, no. 1, p. 10,
Jan 2017. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210557/
[178] B. Ramsundar, S. Kearnes, P. Riley, D. Webster, D. Konerding, and V. Pande,
“Massively Multitask Networks for Drug Discovery,” ArXiv e-prints, Feb. 2015.
[179] “Front matter,” in Artificial Neural Network for Drug Design, Delivery and
Disposition, M. Puri, Y. Pathak, V. K. Sutariya, S. Tipparaju, and W. Moreno, Eds.
Boston: Academic Press, 2016, pp. iii –. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/B9780128015599010012
[180] C. Empereur-Mot, J.-F. Zagury, and M. Montes, “Screening explorer–an interactive
tool for the analysis of screening results,” Journal of Chemical Information and
133
Modeling, vol. 56, no. 12, pp. 2281–2286, 2016, pMID: 27808512. [Online]. Available:
http://dx.doi.org/10.1021/acs.jcim.6b00283
[181] H. B. Rao, F. Zhu, G. B. Yang, Z. R. Li, and Y. Z. Chen, “Update of profeat: a web
server for computing structural and physicochemical features of proteins and peptides
from amino acid sequence,” Nucleic Acids Research, vol. 39, no. suppl2, pp.
W385–W390, 2011. [Online]. Available: +http://dx.doi.org/10.1093/nar/gkr284
[182] Z. R. Li, H. H. Lin, L. Y. Han, L. Jiang, X. Chen, and Y. Z. Chen, “Profeat: a web
server for computing structural and physicochemical features of proteins and peptides
from amino acid sequence,” Nucleic Acids Research, vol. 34, no. suppl2, pp.
W32–W37, 2006. [Online]. Available: +http://dx.doi.org/10.1093/nar/gkl305
[183] T. Unterthiner, A. Mayr, G. ünter Klambauer, M. Steijaert, J. Wenger,
H. Ceulemans, and S. Hochreiter, “Deep learning as an opportunity in virtual
screening,” in Deep Learning and Representation Learning Workshop (NIPS 2014),
2014.
[184] D. Rogers and M. Hahn, “Extended-connectivity fingerprints,” Journal of Chemical
Information and Modeling, vol. 50, no. 5, pp. 742–754, 2010, pMID: 20426451.
[Online]. Available: http://dx.doi.org/10.1021/ci100050t
[185] S. J. Swamidass, C.-A. Azencott, T.-W. Lin, H. Gramajo, S.-C. Tsai, and P. Baldi,
“Influence relevance voting: An accurate and interpretable virtual high throughput
screening method,” Journal of Chemical Information and Modeling, vol. 49, no. 4, pp.
756–766, 2009, pMID: 19391629. [Online]. Available:
http://dx.doi.org/10.1021/ci8004379
[186] P. Resnick, N. Iacovou, M. Suchak, P. Bergstrom, and J. Riedl, “Grouplens: An open
architecture for collaborative filtering of netnews,” in Proceedings of the 1994 ACM
Conference on Computer Supported Cooperative Work, ser. CSCW ’94. New York,
NY, USA: ACM, 1994, pp. 175–186. [Online]. Available:
http://doi.acm.org/10.1145/192844.192905
[187] D. Goldberg, D. Nichols, B. M. Oki, and D. Terry, “Using collaborative filtering to
weave an information tapestry,” Commun. ACM, vol. 35, no. 12, pp. 61–70, Dec.
1992. [Online]. Available: http://doi.acm.org/10.1145/138859.138867
[188] S. P. Leelananda and S. Lindert, “Computational methods in drug discovery,”
Beilstein Journal of Organic Chemistry, vol. 12, pp. 2694–2718, 2016.
[189] D. Rognan, “The impact of in silico screening in the discovery of novel and safer drug
candidates,” Pharmacology & Therapeutics, vol. 175, no. Supplement C, pp. 47 – 66,
2017. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S0163725817300487
[190] J. B. O. Mitchell, “Machine learning methods in chemoinformatics,” Wiley
Interdisciplinary Reviews: Computational Molecular Science, vol. 4, no. 5, pp.
468–481, 2014. [Online]. Available: http://dx.doi.org/10.1002/wcms.1183
134
[191] H. van Vlijmen, R. L. Desjarlais, and T. Mirzadegan, “Computational chemistry at
janssen,” Journal of Computer-Aided Molecular Design, vol. 31, no. 3, pp. 267–273,
Mar 2017. [Online]. Available: https://doi.org/10.1007/s10822-016-9998-9
[192] V. Tsui, D. F. Ortwine, and J. M. Blaney, “Enabling drug discovery project decisions
with integrated computational chemistry and informatics,” Journal of
Computer-Aided Molecular Design, vol. 31, no. 3, pp. 287–291, Mar 2017. [Online].
Available: https://doi.org/10.1007/s10822-016-9988-y
[193] J. Hughes, S. Rees, S. Kalindjian, and K. Philpott, “Principles of early drug
discovery,” British Journal of Pharmacology, vol. 162, no. 6, pp. 1239–1249, 2011.
[Online]. Available: http://dx.doi.org/10.1111/j.1476-5381.2010.01127.x
[194] I. Muegge, A. Bergner, and J. M. Kriegl, “Computer-aided drug design at boehringer
ingelheim,” Journal of Computer-Aided Molecular Design, vol. 31, no. 3, pp. 275–285,
Mar 2017. [Online]. Available: https://doi.org/10.1007/s10822-016-9975-3
[195] D. B. Kitchen, “Computer-aided drug discovery research at a global contract research
organization,” Journal of Computer-Aided Molecular Design, vol. 31, no. 3, pp.
309–318, Mar 2017. [Online]. Available: https://doi.org/10.1007/s10822-016-9991-3
[196] Z. Wu, B. Ramsundar, E. N. Feinberg, J. Gomes, C. Geniesse, A. S. Pappu,
K. Leswing, and V. Pande, “Moleculenet: a benchmark for molecular machine
learning,” Chemical science, vol. 9, no. 2, pp. 513–530, 2018.
[197] W. Zheng and A. Tropsha, “Novel variable selection quantitative structure- property
relationship approach based on the k-nearest-neighbor principle,” Journal of chemical
information and computer sciences, vol. 40, no. 1, pp. 185–194, 2000.
[198] P. M. Petrone, B. Simms, F. Nigsch, E. Lounkine, P. Kutchukian, A. Cornett,
Z. Deng, J. W. Davies, J. L. Jenkins, and M. Glick, “Rethinking molecular similarity:
comparing compounds on the basis of biological activity,” ACS chemical biology,
vol. 7, no. 8, pp. 1399–1409, 2012.
[199] D. Rognan, “The impact of in silico screening in the discovery of novel and safer drug
candidates,” Pharmacology & therapeutics, vol. 175, pp. 47–66, 2017.
[200] V. Tsui, D. F. Ortwine, and J. M. Blaney, “Enabling drug discovery project decisions
with integrated computational chemistry and informatics,” Journal of computer-aided
molecular design, vol. 31, no. 3, pp. 287–291, 2017.
[201] D. B. Kitchen, “Computer-aided drug discovery research at a global contract research
organization,” Journal of computer-aided molecular design, vol. 31, no. 3, pp.
309–318, 2017.
[202] I. Muegge, A. Bergner, and J. M. Kriegl, “Computer-aided drug design at boehringer
ingelheim,” Journal of computer-aided molecular design, vol. 31, no. 3, pp. 275–285,
2017.
135
[203] H. van Vlijmen, R. L. Desjarlais, and T. Mirzadegan, “Computational chemistry at
janssen,” Journal of computer-aided molecular design, vol. 31, no. 3, pp. 267–273,
2017.
[204] H. Song, R. Wang, S. Wang, and J. Lin, “A low-molecular-weight compound
discovered through virtual database screening inhibits stat3 function in breast cancer
cells,” Proceedings of the National Academy of Sciences, vol. 102, no. 13, pp.
4700–4705, 2005.
[205] B. Allen, S. Mehta, N. Ayad, and S. Schürer, “Ligand-and structure-based virtual
screening to discover dual egfr and brd4 inhibitors,” 2015.
[206] A. Munir, S. Azam, A. Mehmood, Z. Khan, A. Mehmood, and S. Aqdas,
“Structure-based pharmacophore modeling, virtual screening and molecular docking
for the treatment of esr1 mutations in breast cancer,” Drug Des, vol. 5, no. 3, p.
1000137, 2016.
[207] D. Goldberg, D. Nichols, B. M. Oki, and D. Terry, “Using collaborative filtering to
weave an information tapestry,” Communications of the ACM, vol. 35, no. 12, pp.
61–70, 1992.
[208] C. C. Aggarwal, “Neighborhood-based collaborative filtering,” in Recommender
systems. Springer, 2016, pp. 29–70.
[209] D. Erhan, P.-J. L’Heureux, S. Y. Yue, and Y. Bengio, “Collaborative filtering on a
family of biological targets,” Journal of chemical information and modeling, vol. 46,
no. 2, pp. 626–635, 2006.
[210] G. E. Dahl, N. Jaitly, and R. Salakhutdinov, “Multi-task neural networks for qsar
predictions,” arXiv preprint arXiv:1406.1231, 2014.
[211] C. Empereur-Mot, H. Guillemain, A. Latouche, J.-F. Zagury, V. Viallon, and
M. Montes, “Predictiveness curves in virtual screening,” Journal of cheminformatics,
vol. 7, no. 1, p. 52, 2015.
[212] J.-F. Truchon and C. I. Bayly, “Evaluating virtual screening methods: good and bad
metrics for the “early recognition” problem,” Journal of chemical information and
modeling, vol. 47, no. 2, pp. 488–508, 2007.
[213] N. Triballeau, F. Acher, I. Brabet, J.-P. Pin, and H.-O. Bertrand, “Virtual screening
workflow development guided by the “receiver operating characteristic” curve
approach. application to high-throughput docking on metabotropic glutamate
receptor subtype 4,” Journal of medicinal chemistry, vol. 48, no. 7, pp. 2534–2547,
2005.
[214] L. v. d. Maaten and G. Hinton, “Visualizing data using t-sne,” Journal of machine
learning research, vol. 9, no. Nov, pp. 2579–2605, 2008.
136
[215] C. D. Abernethy, G. M. Codd, M. D. Spicer, and M. K. Taylor, “A highly stable
N-heterocyclic carbene complex of trichloro-oxo-vanadium(v) displaying novel
Cl—C(carbene) bonding interactions,” J. Am. Chem. Soc., vol. 125, no. 5, pp.
1128–1129, 2003.
[216] [Online]. Available: http://pubs.acs.org/books/references.shtml
[217] A. J. Arduengo, III, H. V. R. Dias, R. L. Harlow, and M. Kline, “Electronic
stabilization of nucleophilic carbenes,” J. Am. Chem. Soc., vol. 114, no. 14, pp.
5530–5534, 1992.
[218] A. J. Arduengo, III, S. F. Gamper, J. C. Calabrese, and F. Davidson,
“Low-coordinate carbene complexes of nickel(0) and platinum(0),” vol. 116, no. 10,
pp. 4391–4394, 1994.
[219] L. N. Appelhans, D. Zuccaccia, A. Kovacevic, A. R. Chianese, J. R. Miecznikowski,
A. Macchioni, E. Clot, O. Eisenstein, and R. H. Crabtree, “An anion-dependent
switch in selectivity results from a change of C—H activation mechanism in the
reaction of an imidazolium salt with IrH5(PPh3)2,” J. Am. Chem. Soc., vol. 127,
no. 46, pp. 16 299–16 311, 2005.
[220] A. M. Coghill and L. R. Garson, Eds., The ACS Style Guide, 3rd ed. New York:
Oxford University Press, Inc. and The American Chemical Society, 2006.
[221] F. A. Cotton, G. Wilkinson, C. A. Murillio, and M. Bochmann, Advanced Inorganic
Chemistry, 6th ed. Chichester, United Kingdom: Wiley, 1999.
[222] “Communication from the european commission to the european council and the
european parliament: 20 20 by 2020: Europe’s climate change opportunity,” Brussels,
Belgium, Tech. Rep., 2008.
[223] H. Chen, O. Engkvist, Y. Wang, M. Olivecrona, and T. Blaschke, “The rise of deep
learning in drug discovery,” Drug discovery today, vol. 23, no. 6, pp. 1241–1250, 2018.
[224] E. Friedman-Hill, Writing Rules in Jess, 1st ed. Greenwich, CT, USA: Manning
Publications Co., 2003.
[225] A. L. Johnson, “1-(alkylsubstituted phenyl)imidazoles useful in acth reverse assay,”
US Patent 3 637 731, 1972.
[226] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R.
Cheeseman, Montgomery, Jr., J. A., T. Vreven, K. N. Kudin, J. C. Burant, J. M.
Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani,
N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda,
J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene,
X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo,
R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli,
J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J.
137
Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas,
D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui,
A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko,
P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y.
Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W.
Wong, C. Gonzalez, and J. A. Pople, Gaussian 03, Gaussian, Inc., Wallingford, CT,
USA, Gaussian, Inc., Wallingford, CT, 2004.
[227] A. Abarca, P. Gómez-Sal, A. Martín, M. Mena, J. M. Poblet, and C. Yélamos,
“Ammonolysis of mono(pentamethylcyclopentadienyl) titanium(iv) derivatives,”
Inorg. Chem., vol. 39, no. 4, pp. 642–651, 2000.
[228] Z. Guo and D. Cremer, “Methods for a Rapid and Automated Description of
Proteins,” in Rev. Comp. Chem., K. Lipkowics and D. Boyd, Eds. John Wiley &
Sons, New York, 2016, pp. 369–438.
[229] D. Cremer and E. Kraka, “From molecular vibrations to bonding, chemical reactions,
and reaction mechanism,” Curr. Org. Chem, vol. 14, pp. 1524–1560, 2010.
[230] D. Chen, N. Oezguen, P. Urvil, C. Ferguson, S. M. Dann, and T. C. Savidge,
“Regulation of protein-ligand binding affinity by hydrogen bond pairing,” Science
Advances, vol. 2, p. e1501240, 2016.
[231] Y. Itoh, Y. Nakashima, S. Tsukamoto, T. Kurohara, M. Suzuki, Y. Sakae, M. Oda,
Y. Okamoto, and T. Suzuki, “N+-C-H· · ·O hydrogen bonds in protein-ligand
complexes,” Scientific Reports, vol. 9, 2019, dOI: 10.1038/s41598-018-36987-9.
[232] W. Zhou, H. Yan, and Q. Hao, “Analysis of surface structures of hydrogen bonding in
protein–ligand interactions using the alpha shape model,” Chem. Phys. Lett., vol.
545, pp. 125–131, 2012.
[233] M. A. Williams and J. E. Ladbury, Hydrogen Bonds in Protein-Ligand Complexes.
John Wiley & Sons, Ltd, 2005, ch. 6, pp. 137–161.
[234] S. K. Panigrahi, “Strong and weak hydrogen bonds in protein-ligand complexes of
kinases: a comparative study,” Amino Acids, vol. 34, pp. 617–633, 2008.
[235] K. Kumar, S. M. Woo, T. Siu, W. A. Cortopassi, F. Duarte, and R. S. Paton,
“Cation−π interactions in protein–ligand binding: Theory and data-mining reveal
different roles for lysine and arginine,” Chem. Sci., vol. 9, pp. 2655–2665, 2018.
[236] M. Brylinski, “Aromatic interactions at the ligand-protein interface: Implications for
the development of docking scoring functions,” Chemical Biology & Drug Design,
vol. 91, pp. 380–390, 2017.
[237] J. P. Gallivan and D. A. Dougherty, “Cation-π interactions in structural biology,”
Proc. Natl. Acad. Sci. U.S.A, vol. 96, pp. 9459–9464, 1999.
138
[238] R. Patil, S. Das, A. Stanley, L. Yadav, A. Sudhakar, and A. K. Varma, “Optimized
hydrophobic interactions and hydrogen bonding at the target-ligand interface leads
the pathways of drug-designing,” PLoS ONE, vol. 5, p. e12029, 2010.
[239] C. E. Eyers, M. Vonderach, S. Ferries, K. Jeacock, and P. A. Eyers, “Understanding
protein–drug interactions using ion mobility–mass spectrometry,” Curr. Opin. Chem.
Biol., vol. 42, pp. 167–176, 2018.
[240] H. Zhou and A. Sharma, “Therapeutic protein-drug interactions: plausible
mechanisms and assessment strategies,” Expert Opin. Drug Metab. Toxicol, vol. 12,
pp. 1323–1331, 2016.
[241] G. M. West, C. L. Tucker, T. Xu, S. K. Park, X. Han, J. R. Yates, and M. C.
Fitzgerald, “Quantitative proteomics approach for identifying protein-drug
interactions in complex mixtures using protein stability measurements,” Proc. Natl.
Acad. Sci. U.S.A, vol. 107, pp. 9078–9082, 2010.
[242] D. B. Kitchen, H. Decornez, J. R. Furr, and J. Bajorath, “Docking and scoring in
virtual screening for drug discovery: Methods and applications,” Nat. Rev. Drug
Discovery, vol. 3, pp. 935–949, 2004.
[243] J. Hughes, S. Rees, S. Kalindjian, and K. Philpott, “Principles of early drug
discovery,” Br. J. Pharmacol., vol. 162, pp. 1239–1249, 2011.
[244] G. Sliwoski, S. Kothiwale, J. Meiler, and E. W. Lowe, “Computational methods in
drug discovery,” Pharmacol. Rev., vol. 66, pp. 334–395, 2013.
[245] P. D. Lyne, “Structure-based virtual screening: An overview,” Drug Discovery Today,
vol. 7, pp. 1047–1055, 2002.
[246] Y.-C. Chen, “Beware of docking!” Trends Pharmacol. Sci., vol. 36, pp. 78–95, 2015.
[247] N. S. Pagadala, K. Syed, and J. Tuszynski, “Software for molecular docking: A
review,” Biophys. Rev., vol. 9, pp. 91–102, 2017.
[248] A. Lavecchia, “Machine-learning approaches in drug discovery: methods and
applications,” Drug Discov. Today, vol. 20, pp. 318–331, 2015.
[249] Y.-C. Lo, S. E. Rensi, W. Torng, and R. B. Altman, “Machine learning in
chemoinformatics and drug discovery,” Drug Discov. Today, vol. 23, pp. 1538–1546,
2018.
[250] A. N. Lima, E. A. Philot, G. H. G. Trossini, L. P. B. Scott, V. G. Maltarollo, and
K. M. Honorio, “Use of machine learning approaches for novel drug discovery,” Expert
Opin. Drug Discovery, vol. 11, pp. 225–239, 2016.
[251] L. Zhang, J. Tan, D. Han, and H. Zhu, “From machine learning to deep learning:
progress in machine intelligence for rational drug discovery,” Drug Discov. Today,
vol. 22, pp. 1680–1685, 2017.
139
[252] H. Chen, O. Engkvist, Y. Wang, M. Olivecrona, and T. Blaschke, “The rise of deep
learning in drug discovery,” Drug Discov. Today, vol. 23, pp. 1241–1250, 2018.
[253] F. Ghasemi, A. Mehridehnavi, A. Pérez-Garrido, and H. Pérez-Sánchez, “Neural
network and deep-learning algorithms used in QSAR studies: merits and drawbacks,”
Drug Discov. Today, vol. 23, pp. 1784–1790, 2018.
[254] I. I. Baskin, D. Winkler, and I. V. Tetko, “A renaissance of neural networks in drug
discovery,” Expert Opin. Drug Discovery, vol. 11, pp. 785–795, 2016.
[255] A. S. Rifaioglu, H. Atas, M. J. Martin, R. Cetin-Atalay, V. Atalay, and T. Doğan,
“Recent applications of deep learning and machine intelligence on in silico drug
discovery: methods, tools and databases,” Brief. Bioinform, pp. 1–36, 2018.
[256] J. Panteleev, H. Gao, and L. Jia, “Recent applications of machine learning in
medicinal chemistry,” Bioorg. Med. Chem. Lett, vol. 28, pp. 2807–2815, 2018.
[257] Y. Jing, Y. Bian, Z. Hu, L. Wang, and X.-Q. S. Xie, “Deep learning for drug design:
an artificial intelligence paradigm for drug discovery in the big data era,” The AAPS
Journal, vol. 20, p. 58, 2018.
[258] G. Hessler and K.-H. Baringhaus, “Artificial intelligence in drug design,” Molecules,
vol. 23, p. 2520, 2018.
[259] D. Dana, S. Gadhiya, L. S. Surin, D. Li, F. Naaz, Q. Ali, L. Paka, M. Yamin,
M. Narayan, I. Goldberg, and P. Narayan, “Deep learning in drug discovery and
medicine; scratching the surface,” Molecules, vol. 23, p. 2384, 2018.
[260] C. Shen, J. Ding, Z. Wang, D. Cao, X. Ding, and T. Hou, “From machine learning to
deep learning: Advances in scoring functions for protein–ligand docking,” WIREs
Comput Mol Sci, p. e1429, 2019.
[261] M. Bredel and E. Jacoby, “Chemogenomics: An emerging strategy for rapid target
and drug discovery,” Nat. Rev. Genet, vol. 5, pp. 262–275, 2004.
[262] S. Zheng, Y. Li, S. Chen, J. Xu, and Y. Yang, “Predicting drug protein interaction
using quasi-visual question answering system,” 2019, dOI: 10.1101/588178.
[263] I. Lee, J. Keum, and H. Nam, “DeepConv-DTI: Prediction of drug-target interactions
via deep learning with convolution on protein sequences,” PLoS Comput. Biol,
vol. 15, p. e1007129, 2019.
[264] S. Ranganathan, D. Izotov, E. Kraka, and D. Cremer, “Description and recognition of
regular and distorted secondary structures in proteins using the automated protein
structure analysis method,” Proteins, vol. 76, pp. 418–438, 2009.
[265] T. Mikolov, K. Chen, G. Corrado, and J. Dean, “Efficient estimation of word
representations in vector space,” 2013, arXiv:1301.3781.
140
[266] Y. Goldberg and O. Levy, “word2vec explained: deriving mikolov et al.’s
negative-sampling word-embedding method,” 2014, arXiv:1402.3722.
[267] T. Mikolov, I. Sutskever, K. Chen, G. Corrado, and J. Dean, “Distributed
representations of words and phrases and their compositionality,” 2013,
arXiv:1310.4546.
[268] F. Scarselli, M. Gori, A. C. Tsoi, M. Hagenbuchner, and G. Monfardini, “The graph
neural network model,” IEEE Trans. Neural Netw., vol. 20, pp. 61–80, 2009.
[269] S. Ekins, A. C. Puhl, K. M. Zorn, T. R. Lane, D. P. Russo, J. J. Klein, A. J. Hickey,
and A. M. Clark, “Exploiting machine learning for end-to-end drug discovery and
development,” Nat. Mater, vol. 18, pp. 435–441, 2019.
[270] A. Murzin, “Scop: A structural classification of proteins database for the
investigation of sequences and structures,” J. Mol. Biol., vol. 247, pp. 536–540, 1995.
[271] S. Dietmann and L. Holm, “Identification of homology in protein structure
classification,” Nat. Struct. Biol., vol. 8, pp. 953–957, 2001.
[272] C. Orengo, A. Michie, S. Jones, D. Jones, M. Swindells, and J. Thornton, “CATH – a
hierarchic classification of protein domain structures,” Structure, vol. 5, pp.
1093–1109, 1997.
[273] J. Martin, G. Letellier, A. Marin, J.-F. Taly, A. G. de Brevern, and J.-F. Gibrat,
“Protein secondary structure assignment revisited: A detailed analysis of different
assignment methods,” BMC Struct. Biol, vol. 5, p. 17, 2005.
[274] W. Kabsch and C. Sander, “Dictionary of protein secondary structure: Pattern
recognition of hydrogen-bonded and geometrical features,” Biopolymers, vol. 22, pp.
2577–2637, 1983.
[275] D. Frishman and P. Argos, “Knowledge-based protein secondary structure
assignment,” Proteins, vol. 23, pp. 566–579, 1995.
[276] F. M. Richards and C. E. Kundrot, “Identification of structural motifs from protein
coordinate data: Secondary structure and first-level supersecondary structure,”
Proteins, vol. 3, pp. 71–84, 1988.
[277] R. Day, D. A. Beck, R. S. Armen, and V. Daggett, “A consensus view of fold space:
Combining SCOP, CATH, and the dali domain dictionary,” Protein Sci, vol. 12, pp.
2150–2160, 2003.
[278] C. M. Venkatachalam, “Stereochemical criteria for polypeptides and proteins. v.
conformation of a system of three linked peptide units,” Biopolymers, vol. 6, pp.
1425–1436, 1968.
141
[279] N. Triballeau, F. Acher, I. Brabet, J.-P. Pin, and H.-O. Bertrand, “Virtual screening
workflow development guided by the “receiver operating characteristic” curve
approach. application to high-throughput docking on metabotropic glutamate
receptor subtype 4,” J. Med. Chem., vol. 48, pp. 2534–2547, 2005.
[280] D. A. Pearlman and P. S. Charifson, “Improved scoring of ligand-protein interactions
using OWFEG free energy grids,” J. Med. Chem., vol. 44, pp. 502–511, 2001.
[281] C. Empereur-mot, H. Guillemain, A. Latouche, J.-F. Zagury, V. Viallon, and
M. Montes, “Predictiveness curves in virtual screening,” J. Cheminf., vol. 7, p. 52,
2015.
[282] K. Bleakley and Y. Yamanishi, “Supervised prediction of drug–target interactions
using bipartite local models,” Bioinformatics, vol. 25, pp. 2397–2403, 2009.
[283] T. van Laarhoven, S. B. Nabuurs, and E. Marchiori, “Gaussian interaction profile
kernels for predicting drug–target interaction,” Bioinformatics, vol. 27, pp.
3036–3043, 2011.
[284] M. Gonen, “Predicting drug-target interactions from chemical and genomic kernels
using bayesian matrix factorization,” Bioinformatics, vol. 28, pp. 2304–2310, 2012.
[285] M. Hamanaka, K. Taneishi, H. Iwata, J. Ye, J. Pei, J. Hou, and Y. Okuno,
“CGBVS-DNN: Prediction of compound-protein interactions based on deep learning,”
Mol. Inf., vol. 36, p. 1600045, 2016.
[286] K. Tian, M. Shao, Y. Wang, J. Guan, and S. Zhou, “Boosting compound-protein
interaction prediction by deep learning,” Methods, vol. 110, pp. 64–72, 2016.
[287] H. Liu, J. Sun, J. Guan, J. Zheng, and S. Zhou, “Improving compound–protein
interaction prediction by building up highly credible negative samples,”
Bioinformatics, vol. 31, pp. i221–i229, 2015.
[288] S. Gunther, M. Kuhn, M. Dunkel, M. Campillos, C. Senger, E. Petsalaki, J. Ahmed,
E. G. Urdiales, A. Gewiess, L. J. Jensen, R. Schneider, R. Skoblo, R. B. Russell,
P. E. Bourne, P. Bork, and R. Preissner, “SuperTarget and matador: Resources for
exploring drug-target relationships,” Nucleic Acids Res., vol. 36, pp. D919–D922,
2007.
[289] D. S. Wishart, C. Knox, A. C. Guo, D. Cheng, S. Shrivastava, D. Tzur, B. Gautam,
and M. Hassanali, “DrugBank: A knowledgebase for drugs, drug actions and drug
targets,” Nucleic Acids Res., vol. 36, pp. D901–D906, 2007.
[290] Y. Tabei and Y. Yamanishi, “Scalable prediction of compound-protein interactions
using minwise hashing,” BMC Systems Biology, vol. 7, p. S3, 2013.
[291] M. K. Gilson, T. Liu, M. Baitaluk, G. Nicola, L. Hwang, and J. Chong, “BindingDB
in 2015: A public database for medicinal chemistry, computational chemistry and
systems pharmacology,” Nucleic Acids Research, vol. 44, pp. D1045–D1053, 2015.
142
[292] L. Wang, Z.-H. You, X. Chen, S.-X. Xia, F. Liu, X. Yan, Y. Zhou, and K.-J. Song, “A
computational-based method for predicting drug–target interactions by using stacked
autoencoder deep neural network,” J. Comput. Biol., vol. 25, pp. 361–373, 2018.
[293] O. Trott and A. J. Olson, “AutoDock vina: Improving the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading,” J.
Comput. Chem., vol. 31, pp. 455–461, 2009.
[294] M. Ragoza, J. Hochuli, E. Idrobo, J. Sunseri, and D. R. Koes, “Protein–ligand scoring
with convolutional neural networks,” J. Chem. Inf. Model., vol. 57, pp. 942–957,
2017.
[295] R. R. Selvaraju, M. Cogswell, A. Das, R. Vedantam, D. Parikh, and D. Batra,
“Grad-cam: Visual explanations from deep networks via gradient-based localization,”
2016, arXiv:1610.02391.
[296] Y. Wang, N. Y. Chirgadze, S. L. Briggs, S. Khan, E. V. Jensen, and T. P. Burris, “A
second binding site for hydroxytamoxifen within the coactivator-binding groove of
estrogen receptor beta,” Proc. Natl. Acad. Sci. U.S.A, vol. 103, pp. 9908–9911, 2006.
[297] J. M. Hsieh, K. Tsirulnikov, M. R. Sawaya, N. Magilnick, N. Abuladze, I. Kurtz,
J. Abramson, and A. Pushkin, “Structures of aminoacylase 3 in complex with
acetylated substrates,” Proc. Natl. Acad. Sci. U.S.A, vol. 107, pp. 17 962–17 967,
2010.
[298] T. Warne, M. J. Serrano-Vega, J. G. Baker, R. Moukhametzianov, P. C. Edwards,
R. Henderson, A. G. W. Leslie, C. G. Tate, and G. F. X. Schertler, “Structure of a
β1-adrenergic g-protein-coupled receptor,” Nature, vol. 454, pp. 486–491, 2008.
[299] E. Variani, X. Lei, E. McDermott, I. L. Moreno, and J. Gonzalez-Dominguez, “Deep
neural networks for small footprint text-dependent speaker verification,” in 2014
IEEE International Conference on Acoustics, Speech and Signal Processing
(ICASSP). IEEE, 2014, pp. 4052–4056.
[300] D. Snyder, D. Garcia-Romero, G. Sell, D. Povey, and S. Khudanpur, “X-vectors:
Robust dnn embeddings for speaker recognition,” in 2018 IEEE International
Conference on Acoustics, Speech and Signal Processing (ICASSP). IEEE, 2018, pp.
5329–5333.
[301] S. Ramoji, A. Mohan, B. Mysore, A. Bhatia, P. Singh, H. Vardhan, and
S. Ganapathy, “The leap speaker recognition system for nist sre 2018 challenge,” in
ICASSP 2019-2019 IEEE International Conference on Acoustics, Speech and Signal
Processing (ICASSP). IEEE, 2019, pp. 5771–5775.
[302] S. N. Hewitt, D. M. Dranow, B. G. Horst, J. A. Abendroth, B. Forte, I. Hallyburton,
C. Jansen, B. Baragaña, R. Choi, K. L. Rivas, M. A. Hulverson, M. Dumais, T. E.
Edwards, D. D. Lorimer, A. H. Fairlamb, D. W. Gray, K. D. Read, A. M. Lehane,
K. Kirk, P. J. Myler, A. Wernimont, C. Walpole, R. Stacy, L. K. Barrett, I. H.
143
Gilbert, and W. C. V. Voorhis, “Biochemical and structural characterization of
selective allosteric inhibitors of the plasmodium falciparum drug target,
prolyl-tRNA-synthetase,” ACS Infect. Dis., vol. 3, pp. 34–44, 2016.
[303] M. Duran-Frigola, A. Fernández-Torras, M. Bertoni, and P. Aloy, “Formatting
biological big data for modern machine learning in drug discovery,” Wiley Interdiscip.
Rev. Comput. Mol. Sci, vol. 9, p. e1408, 2018.
[304] Y. Hong, B. Hou, H. Jiang, and J. Zhang, “Machine learning and artificial neural
network accelerated computational discoveries in materials science,” Wiley
Interdiscip. Rev. Comput. Mol. Sci, p. e1450, 2019.
[305] H. J. Kulik, “Making machine learning a useful tool in the accelerated discovery of
transition metal complexes,” Wiley Interdiscip. Rev. Comput. Mol. Sci, p. e1439,
2019.
[306] P. Cimermancic, P. Weinkam, T. J. Rettenmaier, L. Bichmann, D. A. Keedy, R. A.
Woldeyes, D. Schneidman-Duhovny, O. N. Demerdash, J. C. Mitchell, J. A. Wells,
J. S. Fraser, and A. Sali, “CryptoSite: Expanding the druggable proteome by
characterization and prediction of cryptic binding sites,” J. Mol. Bio., vol. 428, pp.
709–719, 2016.
[307] S. Vajda, D. Beglov, A. E. Wakefield, M. Egbert, and A. Whitty, “Cryptic binding
sites on proteins: definition, detection, and druggability,” Curr. Opin. Chem. Biol.,
vol. 44, pp. 1–8, 2018.
[308] R. A. Laskowski, F. Gerick, and J. M. Thornton, “The structural basis of allosteric
regulation in proteins,” FEBS Letters, vol. 583, pp. 1692–1698, 2009.
[309] D. Beglov, D. R. Hall, A. E. Wakefield, L. Luo, K. N. Allen, D. Kozakov, A. Whitty,
and S. Vajda, “Exploring the structural origins of cryptic sites on proteins,” Proc.
Natl. Acad. Sci. U.S.A., vol. 115, pp. E3416–E3425, 2018.
[310] L. Zou, F. Ruan, M. Huang, L. Liang, H. Huang, Z. Hong, J. Yu, M. Kang, Y. Song,
J. Xia, Q. Guo, T. Song, J. He, H.-L. Yen, M. Peiris, and J. Wu, “SARS-CoV-2 viral
load in upper respiratory specimens of infected patients,” New Eng J Med., vol. 382,
pp. 1177–1179, 2020.
[311] B. R. Amman, S. A. Carroll, Z. D. Reed, T. K. Sealy, S. Balinandi, R. Swanepoel,
A. Kemp, B. R. Erickson, J. A. Comer, S. Campbell, D. L. Cannon, M. L. Khristova,
P. Atimnedi, C. D. Paddock, R. J. K. Crockett, T. D. Flietstra, K. L. Warfield,
R. Unfer, E. Katongole-Mbidde, R. Downing, J. W. Tappero, S. R. Zaki, P. E. Rollin,
T. G. Ksiazek, S. T. Nichol, and J. S. Towner, “Seasonal pulses of marburg virus
circulation in juvenile rousettus aegyptiacus bats coincide with periods of increased
risk of human infection,” PLoS Pathogens, vol. 8, p. e1002877, 2012.
[312] G. R. Bowman, E. R. Bolin, K. M. Hart, B. C. Maguire, and S. Marqusee, “Discovery
of multiple hidden allosteric sites by combining markov state models and
experiments,” Proc. Natl. Acad. Sci. U.S.A, vol. 112, pp. 2734–2739, 2015.
144
[313] O. Schueler-Furman and S. J. Wodak, “Computational approaches to investigating
allostery,” Curr. Opin. Chem. Biol., vol. 41, pp. 159–171, 2016.
[314] S. G. Rohrer and K. Baumann, “Maximum unbiased validation (MUV) data sets for
virtual screening based on PubChem bioactivity data,” J Chem Inf Model, vol. 49,
no. 2, pp. 169–184, 2009.
[315] J. Yang, C. Shen, and N. Huang, “Predicting or pretending: Artificial intelligence for
protein-ligand interactions lack of sufficiently large and unbiased datasets,” Front.
Pharmacol., vol. 11, 2020.
[316] J. Sieg, F. Flachsenberg, and M. Rarey, “In need of bias control: Evaluating chemical
data for machine learning in structure-based virtual screening,” J. Chem. Inf. Model.,
vol. 59, no. 3, pp. 947–961, 2019.
[317] M. von Korff, J. Freyss, and T. Sander, “Comparison of ligand- and structure-based
virtual screening on the DUD data set,” J. Chem. Inf. Model., vol. 49, pp. 209–231,
2009.
[318] V. Venkatraman, V. I. Pérez-Nueno, L. Mavridis, and D. W. Ritchie, “Comprehensive
comparison of ligand-based virtual screening tools against the DUD data set reveals
limitations of current 3d methods,” J. Chem. Inf. Model., vol. 50, pp. 2079–2093,
2010.
[319] S. Kearnes, K. McCloskey, M. Berndl, V. Pande, and P. Riley, “Molecular graph
convolutions: moving beyond fingerprints,” J. Comput. Aided Mol. Des., vol. 30, pp.
595–608, 2016.
[320] L. Masters, S. Eagon, and M. Heying, “Evaluation of consensus scoring methods for
AutoDock vina, smina and idock,” J. Mol. Graph. Model., vol. 96, p. 107532, 2020.
[321] S. S. Ericksen, H. Wu, H. Zhang, L. A. Michael, M. A. Newton, F. M. Hoffmann, and
S. A. Wildman, “Machine learning consensus scoring improves performance across
targets in structure-based virtual screening,” J. Chem. Inf. Model., vol. 57, pp.
1579–1590, 2017.
[322] J. B. Cross, D. C. Thompson, B. K. Rai, J. C. Baber, K. Y. Fan, Y. Hu, and
C. Humblet, “Comparison of several molecular docking programs: Pose prediction
and virtual screening accuracy,” J. Chem. Inf. Model., vol. 49, pp. 1455–1474, 2009.
[323] P. Kolb and J. Irwin, “Docking screens: Right for the right reasons?” Curr Top Med
Chem., vol. 9, pp. 755–770, 2009.
[324] T. Scior, A. Bender, G. Tresadern, J. L. Medina-Franco, K. Martínez-Mayorga,
T. Langer, K. Cuanalo-Contreras, and D. K. Agrafiotis, “Recognizing pitfalls in
virtual screening: A critical review,” J. Chem. Inf. Model., vol. 52, pp. 867–881, 2012.
145
[325] A. N. Jain and A. Nicholls, “Recommendations for evaluation of computational
methods,” J. Comput. Aided Mol. Des., vol. 22, pp. 133–139, 2008.
[326] A. Nicholls, “What do we know and when do we know it?” J. Comput. Aided Mol.
Des., vol. 22, pp. 239–255, 2008.
[327] M. McGann, A. Nicholls, and I. Enyedy, “The statistics of virtual screening and lead
optimization,” J. Comput. Aided Mol. Des., vol. 29, pp. 923–936, 2015.
[328] N. Furnham, G. L. Holliday, T. A. P. de Beer, J. O. B. Jacobsen, W. R. Pearson, and
J. M. Thornton, “The catalytic site atlas 2.0: cataloging catalytic sites and residues
identified in enzymes,” Nucleic Acids Res., vol. 42, pp. D485–D489, 2013.
[329] M. McGann, “FRED and HYBRID docking performance on standardized datasets,”
J. Comput. Aided Mol. Des., vol. 26, no. 8, pp. 897–906, 2012.
[330] J.-F. Truchon and C. I. Bayly, “Evaluating virtual screening methods: good and bad
metrics for the “early recognition” problem,” J. Chem. Inf. Model., vol. 47, pp.
488–508, 2007.
[331] T. Salimans, I. Goodfellow, W. Zaremba, V. Cheung, A. Radford, and X. Chen,
“Improved techniques for training gans,” arXiv preprint arXiv:1606.03498, 2016.
[332] M. Heusel, H. Ramsauer, T. Unterthiner, B. Nessler, and S. Hochreiter, “Gans
trained by a two time-scale update rule converge to a local nash equilibrium,” arXiv
preprint arXiv:1706.08500, 2017.
[333] O. Russakovsky, J. Deng, H. Su, J. Krause, S. Satheesh, S. Ma, Z. Huang,
A. Karpathy, A. Khosla, M. Bernstein et al., “Imagenet large scale visual recognition
challenge,” International journal of computer vision, vol. 115, no. 3, pp. 211–252,
2015.
[334] C. Szegedy, S. Ioffe, V. Vanhoucke, and A. Alemi, “Inception-v4, inception-resnet and
the impact of residual connections on learning,” in Proceedings of the AAAI
Conference on Artificial Intelligence, vol. 31, no. 1, 2017.
[335] W. Brendel and M. Bethge, “Approximating cnns with bag-of-local-features models
works surprisingly well on imagenet,” arXiv preprint arXiv:1904.00760, 2019.
[336] “Inception Score,” https://medium.com/octavian-ai/
a-simple-explanation-of-the-inception-score-372dff6a8c7a, [].
[337] J. Y. Koh, J. Baldridge, H. Lee, and Y. Yang, “Text-to-image generation grounded by
fine-grained user attention,” in Proceedings of the IEEE/CVF Winter Conference on
Applications of Computer Vision, 2021, pp. 237–246.
[338] T.-Y. Lin, M. Maire, S. Belongie, J. Hays, P. Perona, D. Ramanan, P. Dollár, and
C. L. Zitnick, “Microsoft coco: Common objects in context,” in European conference
on computer vision. Springer, 2014, pp. 740–755.
146
[339] C. Wah, S. Branson, P. Welinder, P. Perona, and S. Belongie, “The caltech-ucsd
birds-200-2011 dataset,” 2011.
[340] T. Karras, S. Laine, M. Aittala, J. Hellsten, J. Lehtinen, and T. Aila, “Analyzing and
improving the image quality of stylegan,” in Proceedings of the IEEE/CVF
Conference on Computer Vision and Pattern Recognition, 2020, pp. 8110–8119.
[341] E. Collins, R. Bala, B. Price, and S. Susstrunk, “Editing in style: Uncovering the
local semantics of gans,” in Proceedings of the IEEE/CVF Conference on Computer
Vision and Pattern Recognition, 2020, pp. 5771–5780.
[342] E. Härkönen, A. Hertzmann, J. Lehtinen, and S. Paris, “Ganspace: Discovering
interpretable gan controls,” arXiv preprint arXiv:2004.02546, 2020.
[343] Y. Shen, J. Gu, X. Tang, and B. Zhou, “Interpreting the latent space of gans for
semantic face editing,” in Proceedings of the IEEE/CVF Conference on Computer
Vision and Pattern Recognition, 2020, pp. 9243–9252.
[344] A. Tewari, M. Elgharib, G. Bharaj, F. Bernard, H.-P. Seidel, P. Pérez, M. Zollhofer,
and C. Theobalt, “Stylerig: Rigging stylegan for 3d control over portrait images,” in
Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern
Recognition, 2020, pp. 6142–6151.
147
